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Abstract
The metal-catalysed allylic oxidation of alkenes has emerged as a powerful 
method for the functionalisation of sp3 C-H bonds. This transformation has allowed 
for the expedient preparation of synthetically useful materials from hydrocarbon 
building blocks. With the development of air stable and environmentally benign 
copper(I)-NHC catalysts from readily available materials, it has been shown that 
these catalysts can participate in the allylic oxidation of alkenes in a effective 
manner. We have developed a powerful protocol for the functionalisation of alkenes 
into allylic alcohols and enones, by the use of different terminal oxidants in a 
divergent fashion. The highly regio- and chemoselective copper(I)-NHC-catalysed 
allylic oxidation has been examined in the syntheses of functionalised 
cyclopentenones and cyclohexenones, which has provided mechanistic insights into 
the oxidation. The system displays excellent tolerance of a plethora of sensitive 
functional groups and provides a general approach with high efficiency. It has been 
shown that high regio selectivity is not necessary straightforward and can depend on 
many factors, including stereoelectronic interactions. The studies towards the 
enantioselective variant via the desymmetrisation of the proposed prochiral 
intennediate utilising a range of chiral copper(I)-NHC catalysts was unsuccessful. 
The synthetic utility of this transfonnation has been validated by the total synthesis 
of (±)-untenone A in the shortest and most efficient approach to date. Studies 
towards the total synthesis of cephalimysin A are currently ongoing, which would 
employ the late stage copper(I)-NHC-catalysed allylic oxidation on a densely 
functionalised intennediate.
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Chapter 1
Copper(I)-NHC-Catalysed Allylic Oxidation of Alkenes to Allylic Esters
1.1. Introduction
1.1.1. Background and Significance
Carbon-oxygen bonds decorate countless pharmacologically important active 
agents. Hence, making the chemo-, regio- and stereoselective methods for the 
installation of this motif an indispensable tool in the armoury of organic chemists for 
both academic and industrial applications.1 The ability to directly and selectively 
oxidise sp3 C-H or sp2 C=C bonds to furnish sp3 C-0 bonds in a mild and 
environmentally benign manner represents an important area of research. In this 
context, a number of transition metal-catalysed methods have been developed for the 
racemic and asymmetric synthesis of allylic alcohols and esters.2 These methods 
often rely on expensive metals, ligands and often employ stoichiometric 
organometallic reagents, which are unsuitable for process development and industrial 
processes. Nonetheless, allylic oxidation has been employed for the construction of a 
plethora of natural products, pharmaceuticals and biological metabolites (Fig. l.l).3
o
Taxol Morphine Hydroxyprogesterone
Figure 1.1 Natural, Pharmaceutical and Biological Metabolite Products.
1
1.1.2. Stoichiometric Selenium Allylic Oxidation
The first allylic oxidation reactions were carried out using selenium reagents 
as stoichiometric oxidants to afford the requisite allylic alcohols, which produces 
significant quantities of toxic by-products and waste making purification difficult 
and the disposal of the waste expensive. In 1932, Riley et al. discovered that 
selenium(IV) dioxide is an efficient reagent for the allylic oxidation of alkenes with 
excellent chemo- and regioselectivity.4 Extensive progress has been made by several 
groups to establish the origin of the high degree of control through the examination 
of the mechanism of the oxidation.5 Nonetheless, it was not until 1973, when 
Sharpless proposed that the reaction proceeds via an ene reaction followed by a 
[2,3]-sigmatropic rearrangement that a mechanism was established. This proposal 
was later supported by computational studies (Scheme 1.1).6 For instance, the 
selenoxylic ester 1 can either furnish the allylic alcohol 2 or the a-P-unsaturated 
enone 3 by controlling the reaction conditions. These products are often formed in 
mixtures, which is in itself a limitation. This also explains why allylic oxidations 
utilising selenium(IV) always provide product where the oxidation has taken place at 
the most sterically congested allylic position, due to the two-step mechanism 
(Scheme 1.1).
Oxidation occurs at the sterically crowded allylic position
Scheme 1.1 Proposed Mechanism of Allylic Oxidation with Selenium(IV) Dioxide.
2
1.1.3. Catalytic Selenium Allylic Oxidation
The stoichiometric selenium-mediated allylic oxidation reaction has been 
superseded by the catalytic version, also developed by Sharpless, using selenium 
dioxide in the presence of te/Y-butyl hydroperoxide.7 The early versions of the 
catalytic selenium allylic oxidation reaction were performed using hydrogen 
peroxide, but these were relatively inefficient.7 The mechanism for the catalytic 
transformation was presumed to proceed via the perselenious acid and the 
reoxidation of selenium(0)/selenium(II) to the redox active selenium(IV) state.7 A 
benefit of using the selenium allylic oxidation reaction over current metal-catalysed 
methods, is that selenium dioxide reacts with a wide variety of alkenes, including 
exocyclic methylenes, which are generally inert to modern methods. For example, 
the treatment of the exocyclic alkene 4 with a sub-stoichiometric amount of selenium 
dioxide in the presence of /ert-butyl hydroperoxide to afford the allylic alcohol 5 in 
93% yield, which was a key intennediate in the total synthesis of resiniferatoxin 6 
(Scheme 1.2).
resiniferatoxin (6)
Scheme 1.2 Selenium Allylic Oxidation in the Total Synthesis of Resiniferatoxin 6.
1.1.4. Stoichiometric Metal-Acetate Allylic Oxidation
The construction of allylic esters utilising metal acetates M(OAc)n (generally 
M = Hgn, Pd11, Tlm, PbIV) has proven to be a popular area of investigation. 
Nevertheless, there are significant drawbacks to these reagents, due to the toxicity of
3
the heavy metal.8 These reagents generally provide good yields, albeit with poor 
regioselectivity for terminal alkenes which produce mixtures of the linear and branch 
allylic esters. The proposed mechanism for this oxidation reaction is similar to the 
aforementioned metal acetates, with the exception of mercury, which was proposed 
to proceed via a different pathway (Scheme 1.3).9a,c The palladium version is thought 
to occur via direct addition of PdX2 to the alkene to generate 7 (Path A) or by the a- 
H-abstraction to furnish the Tt-allyl intennediate 8 (Path B). The palladium Tt-allyl 
intermediate 8 would then be subjected to nucleophilic attack, either by the external 
trans attack (Path C) via 9 or by the internal cis attack (Path D) via 10 to afford 
mixtures of the primary and secondary acetates.10
MXn
(M = Pd)
M-X
(M = Hg)
,M-X
11
M
i
X
8
cTJx
10
X
A MXn C
, (M = Pd, Hg)
X-M
12
Scheme 1.3 Proposed Mechanism for Palladium(II) and Mercury(II) Allylic 
Oxidation.
Rappoport and coworkers proposed a variation on this mechanism in which a 
Tt-allyl mercury or ion pair intennediate was inconsistent with the product 
distribution.98*0 The formation of the allylic mercury acetate 11 from adduct 7, led to 
the rearrangement of the primary mercuric acetate 11 to the secondary crotyl 
mercuric acetate 12. The allylic ester isomerisation is presumably the result of the
4
non-Markovnikov acetoxymercumtion, followed by deacetoxymercuration involving 
the original acetoxy group. Nonetheless, the resulting oxidation is not general or 
selective, affording a 40:60 mixture of the secondary and primary esters,
respectively.93
Mercury(II) acetate was used in the allylic oxidation of avermectin A2a 13 in 
the total synthesis of avenuectin B2a 15 (Scheme 1.4). The oxidation of 13 gave the 
rearranged allylic acetate 14, which after further derivatisation provided the 
demethylated avenuectin B2a 15.11
Scheme 1.4 Mercury Acetate Allylic Oxidation in the Synthesis of Avermectin B2a 15-
1.1.5. Catalytic Palladium Allylic Oxidation
Catalytic palladium variants of the reaction have recently been developed, 
which is significantly less toxic than stoichiometric heavy metals. In 1982, Heumann 
et ah reported that catalytic quantities of palladium(II) chloride with copper(II) 
chloride as a reoxidant, provide the allylic acetate 18 in modest yield from the diene 
17 (Scheme 1.5).12 This reaction was improved by the same group utilising catalytic 
palladium(II) acetate with a />benzoquinone/Mn02 mixture as the reoxidant. In 
1981, Backvall and Nordberg reported a similar system for the allylic oxidation of 
the cyclohexadiene 15 to afford the /hs-allylic acetate 16.14 The improvement in
5
efficiency was attributed to the reoxidation of palladium(O) to palladium(II) by the 
quinone, which also acted as a ligand for the palladium catalyst.13,14
Backvail 1981
cat. Pd(OAc)2 
Benzoquinone
HOAc, 25 °C
OAc
16
Neumann 1982
cat. Pd(CI)2
Scheme 1.5 Initial Catalytic Palladium(II) Allylic Oxidation,
Recent developments into the palladium-catalysed allylic oxidation reaction
have been focused on the terminal alkenes to solve the problem associated with
regioselectivity in the formation of primary and secondary esters. In 2004, pioneering 
work by White and Chen demonstrated that the regioselectivity could be controlled 
via the catalyst (Scheme 1.6).15
OAc
Pd(OAc)2 (10 mol %) 
Sulfoxide 22 (10mol%)
R
21
b:l = 16:1 -26:1
Benzoquinone (2 eq) 
AcOH (4 eq) 
Dioxane, 43 °C
Pd(OAc)2 (10 mol %) 
Benzoquinone (2 eq)
DMSO:AcOH (1:1) 
40 °C l:b = 13:1 ->99:1 
£:Zsr11:1 ->20:1
0
Ph''8'"^
22 (1 eq)
Pd(OAc)/2
A Benzoquinone OAc
Pd(OAc)2 (1 eq) (2 eq)
CDCI3l 43 °C, 7 h 1 24 h H 21
Pd (OAc)
B
55%
b:l 12:1
Scheme 1.6 Palladium Catalyst Dichotomy and Mechanistic Insights.
This demonstrated that linear allylic acetates 20 could be prepared from the 
terminal alkene 19 with excellent linear/branched and E/Z selectivity, using the 
palladium(II) acetate/benzoquinone system in the presence of DMSO. This
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selectivity could be reversed by replacing DMSO with the sulfoxide 22, which 
provided the branched allylic acetates 21 in equally impressive branched/linear 
ratios.16 Additional studies have probed the origin of this selectivity by examining 
the active palladium species by ^-NMR. These studies indicated that the palladium 
dimer A was not observed by ^-NMR under catalytic conditions suggesting that it 
enters the catalytic cycle as the monomeric species B, because dimerisation is 
disfavoured at low concentration. They also proposed that the benzoquinone acts as 
the ligand in the functionalisation step, and that the active palladium/sulfoxide 
complex 22 aids the important initial C-H cleavage step.
In 2008, White et al reported an improved enantioselective allylic C-H 
oxidation using a chiral Lewis acid additive for terminal alkenes.17 A mixture of 
palladium/sulfoxide catalyst 23 in the presence of a chiral chromium salen Lewis 
acid 24, benzoquinone and acetic acid furnishes the enantiopure branched allylic 
acetate 21 (b:l up to 5.3:1) in excellent yield and enantioselectivity (up to 63% ee) 
(Scheme 1.7). This process currently provides the optimal method for the 
enantioselective allylic oxidation, which improved the previous method (36% ee) for
terminal alkenes. 18
23 (10 mol %)
24 (10 mol %) OAc
19 21
Benzoquinone (2 eq) ^
AcOH (1.1 eq)
EtOAc, 4A MS, 48 h l:b up to 5.3:1 
63-92% % ee up to 63%
Ph-S
Q
Pd(OAc)2
23
s'°Ph _TN-CrN='
teu-(>07'cH teu
teu teu 
24
Scheme 1.7 Enantioselective Palladiwn(II) Allylic C-H Oxidation.
Although the initial development of stoichiometric metal acetates, has led to 
modem palladium-catalysed methods, there are relatively few applications in total 
synthesis. White has recently applied the palladium-catalysed allylic oxidation to the 
latter stages of the total synthesis of 6-deoxyerythronolide B 27 (Scheme 1.8).19 
Treatment of the alkene 25 with the palladium catalyst 23 and benzoquinone,
7
provided the macrocycle 26 in 56% yield with excellent diasteroselectivity (Scheme 
1.8). The stereochemical outcome was attributed to chelation of the palladium Tt-allyl 
with the carboxylic acid, which provides an intermediate with product-like 
trans annular character.19
"Chelate"
Scheme 1.8 Intramolecular Palladium-Catalysed Allylic Oxidation Towards the 
Total Synthesis of 6-Deoxyerythronolide B 27.
1.1.6. Catalytic Copper Allylic Oxidation
Many of the enantioselective allylic oxidation methods that preceded the 
palladium-catalysed version were accomplished using catalytic copper(I) salts and 
stoichiometric perester oxidants, a reaction which is known as the Kharasch- 
Sosnovsky reaction. For instance, Kharasch and Sosnovsky reported the catalytic 
copper(I) allylic oxidation of acyclic and cyclic alkenes with /‘erf-butyl perbenzoate 
28 in refluxing benzene provides the allylic benzoates in excellent yield and 
selectivity.20 This process is optimal for terminal alkenes, from which only the 
secondary allylic benzoates were observed as products (Scheme 1.9).20 In these 
reactions, an excess of the alkene was required (up to ten equivalents) making this 
oxidation somewhat limited in scope.
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The mechanism proposed by Kharasch et al. is initiated with the homolytic 
cleavage of the perester oxygen-oxygen bond, to afford the copper(II)-carboxylate 29 
and the /er/-butoxy radical 30 (Scheme 1.9; A). The perester 28 is known to undergo 
thermal decomposition at 115 °C, thus path A can occur in the absence of metal 
salts.20
+•
o
Ph^O^°'fBu
28
(1 eq)
Cu(i)Br (5 mol %)
Benzene 
110 °C 1 -2 h 
or 90 °C 2-4 h 
40-73%
OBz OBz
(up to 10 eq)
O Cu+ O
Ph^O"0'fBu A ^Cu+
Ph'X}
+ • o-teu
28 29 30
H
1 . + • o-teu + HO-teu
30 31
O OBz
+ JL ^Cu+ —Plr^O + Cu+
29 32
Scheme 1.9 Initial Discovery and Proposed Mechanism for the Kharasch-Sosnovsky 
Reaction.
The tert-butoxy radical 30 undergoes a regioselective hydrogen abstraction of 
the allylic hydrogen, to generate the ally lie radical 31 and ferf-butanol (Scheme 1.9, 
B). The alkyl radical 31 tenninates with the copper(II)-carboxylate 29 to furnish the 
desired secondary allylic benzoate 32 and the regeneration of the copper catalyst (C). 
Kharasch noted that the absence of a primary allylic benzoate, contrasts a 
conventional free radical or carbocation intennediate, and that the allylic hydrogen 
displacement presumably occurs in a concerted manner. The propagation step (B) is 
chemoselective based on the bond dissociation energies of the C-H bond present, 
with weaker allylic/benzylic C-H bonds (<88 keal/mol), undergoing selective 
hydrogen abstraction (Fig. 1.2).21
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6 Cr" (XH A” HX - cr
71.1 82.3 86.3 88 93.2 95.1 98.2 110.9
(kcal/mol)
\
Stronger bond dissociation energies
Figure 1.2 Selected Bond Dissociation Energies (BDE’s).
Since Kharasch and Sosnovsky reported this reaction, many research groups 
have made significant advances in this area. Generally, reactions of acyclic alkenes 
are still underdeveloped, especially with asymmetric variants, whereas there are 
countless examples of the oxidation of simple cyclic alkenes. The majority of the 
asymmetric allylic oxidation reactions were implemented on cyclic alkenes, with 
Kharasch and Denney initially using chiral carboxylic acids, albeit with poor 
selectivity (Scheme 1.10).22 Studies from several groups using a variety of chiral 
ligands and carboxylic acids provided oxidations, albeit with modest 
enantioselectivities. For instance, Feringa and coworkers described a proline-copper 
complex in the oxidation reaction, which provided up to 61% enantiomeric excess 
(Scheme UO).23
Denney 1965
C02Et
co2h
Feringa 1995
oI
caf. CuAC2 (5 mol %) 
Proline (10 mol %)
PhCOateu 
20 0C, 16 h 
39%
(pure S, [a]D -112) 
OCOEt
O
61% ee
Andrus 1995
Ph'
caf. Cu(l)OTf-L* (5 mol %) OBz
PhCOg'Bu ?
pir"’'^
Benzene 
55 °C 
34%
36% ee
Scheme 1.10 Early Enantioselective Kharasch-Sosnovsky Attempts.
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It was not until 1995, that Pfaltz and Andrus independently reported a major 
breakthrough in this area, using C2-symmetric chiral copper(I)-bisoxazoline 
complexes to afford enantioemiched cyclic ally lie esters with 65-84% enantiomeric
excess.18,24 Andrus proposed a model for the origin of the asymmetric induction, 
where a copper(III) intermediate adopts a distorted square planar geometry (Fig. 1.3). 
The allyl and benzoate groups are positioned either above or below the plane of the 
copper-bisoxazoline rings, which is dependent on the non-bonding interactions with 
the flanking tot-butyl groups on the bisoxazoline ligand.18 The initial attack of the 
copper(II)-carboxylate on the allyl radical provides two diastereomeric adducts that 
lead to the respective enantiopure allylic acetates.
The copper(III) intermediate has also been supported from results obtained by 
Beckwith and Zavitsas, which demonstrated that the product can only originate from 
a copper (III) intermediate that proceeds through a pericyclic transition state.25
OBz
6
Figure 1.3 Selectivity Model using Chiral Copper(I)-Bisoxazoline Complexes.
In 2002, Andrus reported an optimised protocol that furnished the enantiopure 
allylic ester 33 in 99% enantiomeric excess from cyclopentene using the copper(I)- 
hexafluorophosphate-bisoxazoline complex 34 and tot-butyl /j-nitroperbenzoate 35. 
Nevertheless, the improved enantioselectivity was accompanied by diminished 
reactivity (Scheme 1.11).26
11
O + [j^Y^o'0-^
35
34 (15 mol %)
5 eq 1 eq
MeCN 
- 20 0C, 8 d 
41%
C02Ph-p-N02
6 33
99% ee
E,xB „
V-N N
C
34
V -
Ph uPF6 Ph
Scheme 1.11 Highly Enantioselective Kharasch-Sosnovsky Reaction by Andrus et al. 
Furthermore, the reaction had limited scope, with only cyclic unsubstituted alkenes 
(cyclopentene, cyclohexene, cycloheptene and 1,5-cyclooctadiene) providing 
reasonable reactions and good enantiomeric excess.
In a related study, Katsuki et al utilised this transformation for the oxidative 
desymmetrisation of racemic alkenes (Fig. 1.4).27 The cycloalkene 36 undergoes 
hydrogen atom abstraction to furnish the mew-intermediate 37 via an allyl radical to 
generate the allylic ester 38, bearing three stereogenic centres.
a a Hydrogen Atom 
■ ■ AbstractionU
R R R RDesymmetrisation \__/
OBz
3836 meso-intermediate 37
Figure 1.4 Desymmetrisation of Racemic Alkene 36.
The application of the desymmetrisation oxidation to other substrates provided 
variable results. Furthermore, treatment of the racemic oxygenated-dicyclopentenes 
39 with the copper(II)-trioxazoline complex 40 provided the allylic benzoate esters 
41, 42 and 43 in 78% yield as a mixture of regio- and stereoisomers (Scheme 1.12). 
The poor selectivity was attributed to rapid and unselective trapping of the allylic 
radical. Nevertheless, the allylic benzoate ester 41 was obtained with good 
enantioselectivity (80% ee).
Cu(OTf)2-40 (5 mol %)
RCL
RO*
39
(4 eq)
Acetone 
rt, 69 h 
78%
41 Ri = OBz, R2 = H
42 Ri = H, R2 = OBz
41:42:43 6.0:5.9:1 (80:12:42 ee%)
Scheme 1.12 Oxidative Asymmetr is ation of Racemic Alkenes 39 by Katsuki et al.
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In 2004, Clark et al adapted the work done by Katsuki by developing the 
enantioselective allylic oxidation of the racemic bridged-bicyclic alkene 44 (Scheme 
1.13).28 The oxidation was achieved using the copper(I)-pybox complex 45 to afford 
the benzoate ester 46 in 84% yield and with 70% enantiomeric excess under 
microwave irradiation. Clark reported the isolation of a single regioisomer, wherein 
the oxidation occurred at the a-position of the bridgehead allylic position. Base 
hydrolysis of the allylic benzoate ester 46 provided the allylic alcohol 47 without 
erosion of the enantiomeric excess, which provided a compound of known absolute 
configuration.
44
Cu(MeCN)4PF6 (5 mol %) 
45 (6 mol %) 
PhCOsteu (1 eq)
MeCN
60 0C, 10 h in microwave 
84%
£^0B2 NaOH
MeOH
H rt H
46 47
70% ee 70% ee
[a]20D-133
Scheme 1.13 Enantioselective Symmetrising-Desymmetrising Allylic Oxidation by 
Clark et al.
1.2. Copper(I)-NHC-Catalysed Allylic Oxidation of Cycloalkenes
1.2.1. Preliminary Results and Optimisation of Reaction Conditions
In 1991, Arduengo reported the stability and isolation of a crystalline TV- 
heterocyclic carbene (NHC) with TV-substituted adamantyl groups, to stabilise the 
carbene.29 The TV-heterocyclic carbenes are different from conventional carbenes, as 
they are electron rich and can form very strong a-bonds with a majority of metals 
(often stronger than phosphines). At the time, there were a handful of metal-NHC 
complexes known, with the Grubbs second generation and Hoveyda-Grubbs second 
generation demonstrating the synthetic utility of these ligands after their initial 
discovery.30 Copper(II) salts are generally air and moisture stable, whereas the
13
corresponding copper(I) salts are much less stable. The copper(I)-NHC catalyst 49 is
readily available from the commercial imidazolium salt 48, in the presence of base 
and copper(I) chloride (Scheme 1.14).31 The copper(I)-NHC catalyst 49 is isolated as
a pale yellow solid, which is stable in air.
NaOteu (1 eq) 
CuCI (1 eq)+1 \
- one pot transformation
- simple purification
- air stable copper(l)
Scheme 1.14 Preparation of Copper(I)-NHC Chloride 23.
We envisaged that the copper(I)-NHC catalysts would have comparable redox
potential to the ligand-free copper(I) salts, albeit with enhanced stability making
them suitable pre-catalysts for allylic oxidation, specifically the Kharasch-Sosnovsky
reaction. Treatment of the perbenzoate 28 with excess cyclopentene in acetonitrile
using a catalytic amount of 49 afforded the cyclopentenyl benzoate product 50 in
74% yield (Scheme 1.15).
Cu(l)-NHC 49 (5 mol %) 
PhCOateu 28 (1 eq)
MeCN, 45 °C, 15 h 
(10 eq) 74% 50
Scheme 1.15 Initial Screen of Copper(I)~NHC 49 in the Kharasch-Sosnovsky 
Reaction.
Hence, the copper(I)-NHC catalyst 49 is a more reactive catalyst than the 
original system. The improved reactivity is presumed to result from the increased 
electron density from the NHC ligand on the copper metal centre, which leads to the 
increased stability of the catalyst.
In order to improve the reactivity, a range of peresters with vaiying electronic 
and steric properties based on the Hammett equation were evaluated.32 The peresters
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were prepared from the commercially available acid chlorides 51 and fer/-butyl
26hydroperoxide, and obtained as stable oils and solids (Scheme 1.16).
o*
fBuOOH (1.2 eq) 
Pyridine (1,2 eq)
O
DCM, 0 °C RJ
0"0fBu
51
>90%
28, 35, 52-57
Scheme 1,16 Preparation of Aryl-substituted Per esters.
The individual peresters were then subjected to the Kharasch-Sosnovsky 
reaction using the copper(I)-NHC catalyst 49 under the standard reaction conditions 
to evaluate the effect on the rate of reaction and overall efficiency (Table 1.1).
Table 1.1 Evaluation of Aryl-substituted Per esters.a
Cu(l)-NHC 49 (5 mol %)
^ ArC03(Bu 28, 35,^52-57 (1 eq) ^-0C02Ar
(10 eq)
MeCN, 45 °C 
15-22 h 58-65
'Pr 'Pr
^Yi
Pr CiU/Pr 
Cl
49
Entry Perester Ar Product Yield ('
1 52 p-OMe-Ph -0.29 58 70
2 53 p-Me-Ph -0.17 59 77
3 28 Ph 0 60 74
4 54 jy-CFa-Ph 0.54 61 83
5 35 p~N02-Ph 0,77 62 86
6 55 o-Cl-Ph - 63 73
7 56 oN02-Ph - 64 58
8 57 oOMe-Ph - 65 56
^Reactions were performed on 0.25 mmol scale. Isolated yields.
Table 1.1 summarises the results of this study in which the ter/-butyl 4- 
nitrobenzoperoxoate 35 proved optimal with respect to the efficiency (Table 1.1, 
entry 5). In general, all the modified peresters were successful oxidants in the 
reaction with the electron poor examples providing optimal efficiency (entries 4 and 
5). The on7?o-substituted peresters 55-57, which are sterically and electronically
15
biased, provided reduced reactivity, for example 22 hours vs, 15 hours and reduced 
efficiency (entries 6-8). The ortho groups can potentially interfere in the formation of 
the copper(II)-carboxylate and/or in the recombination of the copper(II)-carboxylate 
with the alkyl radical (Scheme 1.5, A and C). Additional optimisation studies 
focused on the examination of different copper(I)-NHC catalysts (Fig. 1.5).
Figure 1.5 Prepared Copper(J)-NHC Catalysts.
Table 1.2 outlines the summary of this study, which provided some interesting 
trends, with regard to the catalyst counterion. For example, the chloride 49 and 
bromide 66 are excellent pre-catalysts, whereas the iodide 67 was veiy poor (Table 
1.2, entries 1-3). Additionally, outer-sphere counter ions (OTf and BF4) also led to 
reduced efficiencies (entries 4 and 5). Reducing the steric bias of the pre-catalyst 70 
furnished the ester 62 in 81% yield with an increased relative rate of reaction (entry 
6). Adjusting the catalyst loading was unsuccessful and die corresponding bromide 
71, gave comparable results to the bromide 66 (entries 7-9). The difference between 
IMes and IPr is presumably due to the steric environment around the metal centre. 
Interestingly, the electronic nature of the NHC did not seem to affect the oxidation, 
since the electron deficient para-ohloxo 72, electron rich 73 and 74, afford the ester 
62 in comparable yields over a similar time period (entries 10-12).
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Table 1.2 Evaluation of Copper(I)-NHC Catalysts.
Cu(l)-NHC 49, 66-74 (5 mol %) 
4-N02PhC03'Bu 35 (1 eq)
MeCN, 45 °C
O.
y° 62
N02
Entry Cu(I)-NHC Time Yield (%)4
1 49 15 86
2 66 22 78
3 67 48 24
4 68 48 41
5 69 48 43
6 70 6 81
7 70 (1 mol %) 18 45
8 70 (20 mol %) 2 14
9 71 15
10 72 15 75
11 73 15 75
12 74 15 84
“R£acnon^^er^performedTi^!2^nmoI^cale^IsoIated
yields.
Hence, this study indicates that the steric component of the NHC is much more 
important than the electronic component. A comparison of the electronics of the IPr 
and IMes NHC ligands indicate they are negligible (e.g. 2051.5 and 2050.7 TEP, 
respectively).33 Whereas, the steric hindrance is quite significant for these ligands 
(e.g. 47.6% and 36.3% using %Fbur, respectively) (Fig. 1.6).34
The study illustrated that more electronegative counter ions (Cl = 3.16, Br =
2.96,1 = 2,66)35 are detrimental to the reaction, but size could also play a part here as 
large counter ions could interfere with the radical recombination process (Cl = 0.181 
nm, Br = 0.196 nm, I = 0.220 nm).36
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N_N
'Pr »
MeN^^NMe
CAACSIMes
Figure 1.6 Comparison of%oVimvfor known [(NHC)AuClJ Complexes.
We sought to examine alternative solvents since the kinetic solvent effect 
(KSE) play a minor role in free radical reactions and solvents such as benzene, 
ethanol, carbon tetrachloride and even water are used due to their compatability with 
free radicals. Moreover, the hydrogen abstraction from a C-H bond by an alkoxy 
radical does not suffer from KSE, in contrast to the three other possible unimolecular 
alkoxy radical destroying reactions.38 Polar and hydrogen bonding donor solvents are 
known to promote the competition between hydrogen abstraction and p-scission of 
the fe/t-butoxy radical, hence it was important to investigate the effect of the solvent 
on the oxidation reaction (Scheme 1.17).39
I Me3CO • ------ ► Me2C=0 + Me • + teiiOH ;
Solvent ferfcButanol/Acetone
Benzene 3.5
Acetonitrile 1.6
Acetic acid 1.1
Scheme 1.17 Kinetic Solvent Effect in P-scission.
Table 1.3 summarises the results for this study. The catalyst 70 was only 
sparingly soluble in benzene, ethyl acetate and ethanol, making the reaction 
heterogeneous, which led to extended reaction times and moderate yields (entries 1, 
2 and 5). Alternatively, the catalyst is completely soluble in dichloromethane.
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acetone and nitromethane, albeit they were detrimental to the oxidation (entries 3, 4 
and 6 vs. 1). Acetonitrile provided the optimal solvent with full conversion after 6 
hours in 81% yield, which was improved at higher concentration to 87% yield (entry
7 vs. 9).
Table 1.3 Evaluation of Solvents.0
Cu(l)-NHC 70 (5 mol %) 
^NOaPhCOgteu 35 (1 eq)
Solvent, 45 °C
N02
62
Entry Solvent (0.125 M) £r(fo) Time (h) Yield (%)b
1 Benzene 2.3 48 43
2 Ethyl acetate 6.0 48 43
3 Dichloromethane 9.1 18 52
4 Acetone 21 22 67
5 Ethanol 24 144 7
6 Nitromethane 36 36 60
7 Acetonitrile 37 6 81
8 Acetonitrile (0.25 M) 37 6 82
9 Acetonitrile (1M) 37 6 87
“Reactions were performed on 0.25 mmol scale. “Isolated yields.
Interesting, the use of nitromethane afforded 60% yield, even though the
BDE of the nitromethane C-H bond is ~ 103 kcal/mol, compared to the C-N bond of 
~60 kcal/mol (Table 1.6, entry 6).40 We envision that the weaker C-N bond 
undergoes more facile homolytic cleavage under these conditions. This observation 
could provide an alternative mechanism alongside the one proposed tentatively by 
Kharasch, involving a possible carbon centred radical formed from the (3-scission, for
hydrogen abstraction.
In order to eliminate the possibility of a non-radical pathway for the copper(I)-
NHC-catalysed allylic oxidation, a radical scavenger (hydroquinone) was added in 
varying amounts using the optimised reaction conditions (Table 1.4).
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Table 1.4 Radical Scavenger Experiment
O
Cu(l)-NHC 70 (5 mol %) 
A-NOgPhCOa'Bu 35 (1 eq)
Hydroquinone 
Acetonitrile, 45 °C
Cr°
NOo
%
62
Entry Hydroquinone (eq) Yield (%)z
0.05
0.5
1
76
trace
aReactions were performed on 0.25 mmol scale. 
bIsolated yields.
In the presence of a catalytic amount of the radical scavenger, hydroquinone, the 
reaction still proceeds in excellent yield (Table 1.4, entry 1). However, the analogous
process perfonned in the presence of half or a full equivalent of hydroquinone results 
in the inhibition the oxidation reaction (entries 2 and 3). Uemura has suggested an 
ionic pathway for the rhodium(II) acetate allylic oxidation reaction, which was also 
inhibited by hydroquinone.41
Andrus and Chen 1997
Cu(l)Br (15 mol %) 
Perester 35 or 36 (1 eq)
Acetonitrile, 45 °C, 72 h 
54% for 62 or 89% for 63
R
Evans and Ng 2011
Cu(l)-NHC 70 (5 mol %) 
4-N02PhC03,Bu 35 (1 eq)
Acetonitrile, 45 °C, 6 h 
87%
no2
62
Scheme 1.18 Comparison of the Optimal Copper(I) Bromide v^. Copper(I)-NHC 
Catalyst
The utility of copper(I)-NHC catalysts is evident upon comparison to the 
achiral Kharasch-Sosnovsky reaction reported by Andrus and Chen. For instance, the 
ester 62 was obtained in 54% yield with 15 mol % copper(I) bromide in 72 hours,
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whereas the copper(I)-NHC catalyst 70 provides ester 62 in 87% yield, with 5 mol % 
catalyst loading and 12-fold increase in reaction rate (Scheme 1.18).42 Nevertheless, 
the former method provides the ester 63 in an improved 89% yield using the tert- 
butyl 2-chlorobenzoperoxoate 55 (Table 1.1, entry 6).
1.2.2. Scope and Limitations
The scope of the copper(I)-NHC-catalysed allylic oxidation reaction was 
investigated with a variety of cyclic and acyclic alkenes to examine the scope of the 
system (Scheme 1.19). Cyclohexene and cyclooctene are oxidised to furnish the 
allylic esters 75 and 76 in 81% and 46% yield, respectively under the standard 
conditions, whereas cyclooctene required a prolonged reaction time (12 hours vs. 48 
hours). Finally, the process was examined on heteroatom derivatives. Treatment of 
tetrahydrofuran under the optimised conditions afforded the tetrahydrofuran-2-yl 
ester 77 in 73% yield.
Q
Cu(l)-NHC 70 (5 mol %) 
4-N02PhC03,Bu 35 (1 eq)
OCOpAr
A
L UAcetonitrile, 45 0C, 12 h
81% 75
Cu(l)-NHC 70 (5 mol %) 
4-N02PhC03fBu 35 {1 eq)
0C02Ar
rS
Acetonitrile, 45 0C, 48 h \__/
46% 76
Cu(l)-NHC 70 (5 mol %)
4-N02PhC03fBu 35 (1 eq) ^^0C02Ar
Acetonitrile, 45 °C, 6 h
73% 77
Scheme 1.19 Scope of Copper(I)-NHC-Catalysed Allylic Oxidation.
Although the copper(I)-NHC-catalysed conditions proved to be superior for the 
oxidation of five- and six-membered cycloalkenes, including tetrahydrofuran, they 
are sub-optimal for substrates containing larger rings and for acyclic alkenes.
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1.2.3. Investigation into the Enantioselective Copper(I)-NHC-Catalysed 
Allylic Oxidation
Having established the Kharasch-Sosnovsky oxidation reaction using 
copper(I)-NHC catalysts, the enantioselective version was examined. Although, 
reactions promoted by copper-bisoxazoline complexes proceed with excellent 
enantiomeric excess, there are limitations. A particularly attractive feature of N- 
heterocyclic carbenes as ligands is that the stereo electronics can be tuned in a 
modular manner, making it an attractive scaffold for asymmetric reactions.43 Hence, 
a variety of chiral copper(I)-NHC complexes can be readily prepared from 
commercially available enantiopure amines (Fig. 1.7).
C!
79
Cl
78
Cl
80 81
Fig 1.7 Prepared Chiral Copper (I)-NHC Catalysts.
Table 1.5 outlines the outcome of the oxidation reactions using the chiral 
copper(I)-NHC catalysts. Although the copper(I)-NHC complexes 78-81 were 
efficient catalysts for allylic oxidation, producing the allylic ester 62 in 75-79% 
yield, the products were racemic (Table 1.5, entries 1-4). The IBiox[(-)-menthyl] 
NHC ligand 81 developed by Glorius et aL, was especially disappointing, since it is 
one of the most sterically demanding NHC ligands known, based on the buried 
volume (50.4% compared to 36.3% for the IMes ligand).45 The results indicate that 
there is a fundamental difference between the complexes containing chiral NHC 
ligands and copper(I)-bisoxazoline complexes. This is presumably the result of the
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linear conformation of the copper(I)-complex placing the steric environment distal to
the chiral environment in the enantiodeteimining step.44 
Table 1.5 Evaluation of Chiral Copper(I)-NHC Catalysts.0
Cu(l)-NHC 78-81 (5 mol %) 
4-N02PhC03'Bu 35 (1 eq)
Acetonitrile, 45 °C
N02
62
Entry
1
2
Cu(I)-NHC Yield (%)* eg (%)c
78 79 0
79 75 0
3 80 76 0
4 81 75 0
Reactions were performed on 0.25 mmol scale, 
isolated yields. cBy HPLC.
1.3. Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of Cycloalkenes
1.3.1 Introduction and Background
The Kharasch-Sosnovsky reaction is an effective method for the allylic 
oxidation of alkenes, but has been largely limited to simple substrates, namely 
unsubstituted alkenes due to problems with regiocontrol in unsymmetrical 
derivatives. For instance, the oxidation of 1-methylcyclohexene with perester 28 
using the copper complex of the chiral ligand 82 furnished a mixture of the allylic 
benzoates 84/85/86 in quantitative yield favouring 85:86 (1:1)46 Whereas, the 
oxidation using the copper complex of the chiral ligand 83 favoured 85 in 62% yield. 
Scheme 1.21 outlines the origin of the poor selectivity, in which the initial 
abstraction can occur at two potential allylic hydrogen sites: a to the R group to 
generate the allyl radical 87 and (3 to the R group to furnish the allyl radical 88. The 
allyl radical 87 terminates with the copper carboxylate to afford the a-benzoate ester 
85, whilst the allyl intermediate 88 terminates to furnish the tertiary benzoate ester 
84 or the (3-benzoate ester 86 (Scheme 1.21).
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P fait z 1995
CuOTf (5 mol %) 
82 (6 mol %)
PhCOgfeu 28 
Acetone, 0 °C
DBz
OBz
Singh 2006
Cu(OTf)2 {5 mol %) 
83 (6 mol %)
PhCOaku 28
Phenylhydrazine 
Acetone, rt
Ov PhPK P
84 (3°)
Scheme 1.20 Regioselectivity Issues with 1-Methylcyclohexene.
These observations are consistent with the experimental results and the fact 
that a bulky ligand is likely to reduce the amount of the tertiary allylic benzoate ester 
84. It is also conceivable that the allylic hydrogen abstraction would generate the 
allyl radical 88 over radical radical 87.
PhCOoCu+/- PhCOpCu+/*
BzCX
85 (a)
OBz
se m
Scheme 1.21 Proposed Regiomeric Outcome ofPfaltz and Singh’s Work.
1.3.2. Preliminary Results, Optimisation of Reaction Conditions and 
Mechanistic Insights
The allylic oxidation of 1-phenylcyclohexene 89 was examined using the tert- 
butyl 4-nitrobenzoperoxoate 35 and a range of copper(I)-NHC catalysts as outlined 
in Table 1.6.
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Treatment of 89 (1 equivalent) with the copper(I)-NHC catalyst 70 under the 
standard conditions furnished the ally lie esters 90 and 91 in 20% yield, albeit with 
good regioselectivity (10:1) (Table 1.6, entry 1). Interestingly, the p-allylic ester 90 
was isolated as the major product, which contrasts results obtained by Pfaltz and 
Singh using their respective oxidation conditions.46 
Table 1.6 Preliminary Ally lie Oxidation of 1-Phenylcyclohexene 89.a
Ph
Cu(l)-NHC (5 mol %) 
4-N02PhC03fBu 35 (1 eq) Ph
Acetonitrile, A
89
(1 eq)
OCOAr
Ph
OCOAr
90 91
Entry Cu(I)-NHC Temp. (°C) Yield 90+91 (%)4 90:91c
1 70 45 20 10:1
2 70 60 21 5:1
3 49 45 25 >19:1
4 74 45 21 10:1
Reactions were performed on 0.25 mmol scale. "Isolated yields. 
'Determined by ^-NMR on crude mixtures.
Although the oxidation with IPr 49 and SIMes 74 catalysts produced 
excellent regioselectivity (up to 19:1), the yields are poor (entries 3 and 4). Low 
yields were attributed to the formation of biphenyl 92 as a major byproduct. The 
biaiyl 92 is presumably derived from the over-oxidation of the mono-allylic ester 90 
to furnish the b/s-allylic ester 93 and subsequent double elimination (Scheme 1.22).
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PhX) Oxidation Ph Over-oxidation
89
OCOAr
90
Ph
rOCOArt
‘‘OCOAr
93
Elimination Ph
Rearomatisation 
-2 ArC02H
92
Scheme 1.22 Proposed Formation of Biphenyl Side-Product 92.
The unusual selectivity prompted further investigation using the substituted 
cyclohexene 89. Table 1.7 outlines the results from the examination of the effect of 
solvent in reactions promoted by the copper(I)-NHC catalyst 49. Increasing the tert- 
butyl 4-nitrobenzoperoxoate 35 results in a modest increase in yield, albeit with 
lower regioselectivity (Table 1.7, entry 1). Dimethylsulfoxide and dichloromethane 
were ineffective (entries 2 and 3), whereas, when the tert-b\ity\ 4- 
nitrobenzoperoxoate 35 was utilised as the limiting reagent, a similar yield and 
regioselectivity were obtained (entiy 4 vs. entry 1). This observation is important 
because, ideally for widespread application, the alkene would generally be the 
limiting species. Unfortunately, the fer/-butyl 4-nitrobenzoperoxoate 35 provides 
poor yields and regioselectivity with the copper(I)-NHC catalysts due to the further 
oxidation of 90 (vide supra).
Table 1.7 Evaluation of Solvents using Copper (I)-NHC Catalyst 49.a
Cu(l)-NHC 49 (5 mol %)
Ph^^ ^NOjjPhCCVBu 35
OCOAr
Ph Ph
89
(1 eq)
Solvent 
45 °C, 48 h OCOAr
90 91
Entry Solvent 35 (eq) Yield 90+91 (%)* 90:93'
1 Acetonitrile 1.5 38 4:1
2 Dimethylsulfoxide 1.5 28 7:1
3 Dichloromethane 1.5 29 5:1
4d Acetonitrile 1 34 4:1
aReactions were performed on 0.25 mmol scale, isolated yields. ‘Determined by
^-NMR on crude mixtures. d5 eq of alkene used.
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In light of this limitation, an alternative strategy for the allylic oxidation of 89 
was examined. The tert-h\xty\ peracetate is cheap and commercially available, which 
avoids the de novo synthesis of the perester. Moreover, the generated allylic acetate 
(acetic acid, pKa = 4.76) is a poorer leaving group to the corresponding allylic p- 
nitrobenzoate (p-nitrobenzoic acid, pKa = 3.41), which was expected to avoid the 
over-oxidation/elimination pathway.47
Table 1.8 highlights the allylic oxidation of 1-phenylcyclohexene 89 with the
copper(I)-NHC catalyst 49 and the ferPbutyl peracetate 94 in a range of solvents. 
Although the reactions proceed in modest yields, acetonitrile and benzene provided
optimal regioselectivity (>19:1).
Table 1.8 Evaluation of Solvents using tert-Butyl Peracetate 94.a
Ph
TO
89
(1 eq)
Cu(l)-NHC 49 (5 mol %) 
MeCOsteu 94 (5 eq)
OAc
Ph
Solvent 
80 0C, 18 h
Ph
OAc
95 96
Entry Solvent Yield 95+96 (%)6 95:96c
1 Acetonitrile 34 19:1
2 Dichloroethane 30 8:1
3 terZ-Butanol 41 8:1
4 Toluene 46 12:1
5 Ethyl acetate 24 11:1
6 Benzene 42 19:1
"Reactions were performed on 0.25 mmol scale, isolated yields. 
'Determined by ^-NMR on crude mixtures.
Table 1.9 outlines further optimisation, which involved vaiying the
alkene/perester stoichiometry and the copper(I)-NHC catalyst loading. Treatment of 
excess 89 with the perester as the limiting reagent furnished an improved yield of 
95/96, albeit with poor regioselectivity (Table 1.9, entiles 1-3). Alternatively, using
excess perester afforded a modest result (entiy 4). Unfortunately, the regioselectivity 
decreased as the perester stoichiometry increased (entries 4-6). The optimal results
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were obtained using toluene and 10 equivalents of the perester with 10 mol % 
copper(I)-NHC catalyst 66 (entry 9). This furnished the allylic acetates 95/96 in 70% 
yield with >19:1 regioselectivity, favouring 95. The allylic oxidation reaction in 
toluene is unusual, as there was low conversion during the first 24 hours, but 
enhanced rates over the next 24 hour period. The explanation for this phenomenon is 
not obvious, but it was proposed that the catalyst is altered over the course of the 
oxidation reaction thus producing a more reactive catalytic species.
Table 1.9 Further Optimisation using tert-Butyl Peracetate 94 a
Entry Alkene 89 (eq)
Perester 
94 (eq)
Cu(I)-NHC 
(mol %) Solvent
Yield 95+96b 
(%) 95:96c
1 5 1 49(5) Benzene 57 4:1
2 2 1 49(5) Benzene 37 4:1
3 5 1 49(10) Benzene 57 3:1
4 1 3 49 (10) Benzene 43 11:1
5 1 5 49 (10) Benzene 56 9:1
6 1 10 49 (10) Benzene 61 6:1
7 1 5 49 (10) Toluene 32 12:1
8 1 10 49 (10) Toluene 78 19:1
9 1 10 66 (10) Toluene 70 >19:1
“Reactions were performed on 0.25 mmol scale. LIsolated yields. determined by d-NMR on
crude mixtures.
1.3.3. Scope and Limitations
Scheme 1.23 highlights the scope of the regioselective copper(I)-NHC- 
catalysed allylic oxidation using the tert-bwty\ peracetate 94 to furnish the allylic 
acetates 95, 97 and 98 with variable yield, but excellent selectivity. The reaction was 
limited to aryl-substituted cyclohexenes, as deviation from these resulted in several 
side-products.
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Cu(!)-NHC 66 (10 mol %) 
MeC03,Bu 94 (10 eq)
Toluene 
80 °C
(1 eq) OAc
30%, £19:1 70%, a19:1 57%, £19:1
Scheme 1.23 Scope of Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation.
The copper(I)-NHC-catalysed allylic oxidation of methyl-1-cyclohexene 
carboxylate 99 with tert-buiyl peracetate 94 did not furnish the expected allylic ester 
100 but the 1,4-enedione 101 in 40% yield (Scheme 1.24). The fonnation of this 
enone 101 has been previously documented using other metal-catalysts and oxidants, 
and will be discussed in the next chapter {vide infra).4*
Cu(l)-NHC 66 (10 mol %) 
MeCOgteu 94 (10 eq)
X * MeO
Toluene 
80 °C
99
(1 eq)
Cu(l)-NHC 66 (10 mol %) 
MeCCVBu 94 (10 eq)
Toluene 
80 °C
99 40%
(1 eq)
Scheme 1.24 Enone Side-Product 101 from Allylic Oxidation of Methyl-1- 
Cyclohexene Carboxylate 99.
1.3.4. Proposed Mechanism for Copper(I)-NHC-Catalysed Allylic 
Oxidation
The high regioselectivities for this transformation are unique to the copper(I)- 
NHC system, since the Zus-oxazoline and pybox ligands are inefficient in generating 
the allylic esters selectively.24,46 A modified mechanism for regioselective copper(I)-
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NHC-catalysed allylic oxidation is outlined in Scheme 1.25. Homolytic cleavage of 
/er/-butyl peracetate by the copper(I)-NHC catalyst 102, generates the /ert-butoxy 
radical 103 and the copper(II)-NHC-carboxylate 104.
Scheme 1.25 Proposed Mechanism for the Regioselective Copper(I)-NHC-Catalysed 
Allylic Oxidation using tert-Butylperacetate 94.
The terf-butoxy radical 103 can undergo a reversible hydrogen abstraction of 
the two allylic hydrogens of the tri-substituted alkene 105 to furnish the allyl radicals 
106 or 107. The formation of the copper(III)-intermediate 108 would be disfavoured 
because of the steric interaction of the alkene substitution and the NHC ligand, whilst 
the formation of the copper(III)-intennediate 109 is more favourable. It was 
envisaged that the radical 107 is syphoned through to the intermediate 109, whereas 
the radical 106 is re-protonated and recycled. Facile reductive elimination of the 
unstable copper(II)-intermediate 109 affords the allylic acetate 110 and the 
regeneration of the copper(I)-NHC catalyst 102.
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1.4. Conclusions
In conclusion, the examination of copper(I)-NHC-catalysed allylic oxidation of 
cycloalkenes has been explored. These bench stable catalysts, prepared from readily 
available and cost-effective materials, in a one-pot procedure, provide a number of 
advantages over conventional copper(I) salts. For instance, the enhanced reactivity in 
the Kharasch-Sosnovsky reaction makes these catalysts a viable alternative for they 
are effective in the preparation of allylic esters. Although, the enantioselective allylic 
oxidation reaction was poor, there is a plethora of chiral NHC ligands, which may 
provide improved selectivity. During the optimisation of the Kharasch-Sosnovsky 
reaction, some mechanistic insights into the optimal copper(I)-NHC catalyst have 
been uncovered, which translate to the effective regioselective allylic oxidation of 
tri-substituted cycloalkenes. The allylic oxidation of tri-substituted cycloalkenes into 
the corresponding allylic esters is often problematic, however the copper(I)-NHC- 
catalysed system provides a new reaction manifold. Nevertheless, the transformation 
is still limited, especially with acyclic and non-aryl substituted cycloalkenes. A 
modified mechanism for the regioselective copper(I)-NHC-catalysed allylic 
oxidation reaction, explains the origin of the high regiocontrol through 
catalyst/ligand control. Finally, the copper(I)-NHC-catalysed allylic oxidation of 
cycloalkenes with ter/-butyl peracetate 94 also provides an enone product, the origin 
of which will be described in the following chapter {vide infra).
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1.5 Experimental
1.5.1. General
Analytical thin layer chromatography (TLC) was performed on Merck 60 F254 
pre-coated silica gel plates. Visualisation was accomplished with a UV light and/or a 
KMn04 solution. Flash column chromatography (FCC) was perfonned using Merck 
Silica Gel 60 (230-400 mesh). Solvents for extraction and FCC were technical grade. 
Reported solvent mixtures for both TLC and FCC were volume/volume mixtures.
^-NMR and 13C-NMR were recorded on Broker DRX-500 NMR 
speedometers in the indicated deuterated solvents. For ^-NMR, CDCI3 was set to 
7.26 ppm (CDCI3 singlet) and for i3C-NMR to 77.16 ppm (CDC13 center of triplet). 
All values for lH-NMR and 13C-NMR chemical shifts for deuterated solvents were 
obtained from Cambridge Isotope Labs. Data are reported in the following order: 
chemical shift in ppm (5) (multiplicity, which are indicated by br (broadened), s 
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet)); assignment of 2nd order 
pattern, if applicable; coupling constants (J, Hz); integration. All 13C-NMR spectra 
were reported using descriptor (o) and (e), refers to whether the peak is odd or even, 
respectively, and correlates to an attached proton test (APT) experiment. Infrared 
spectra (IR) were obtained on Perkin-Elmer spectrum one series FTIR spectrometer. 
Peaks are reported in cm"1 with the following relative intensities: vs (veiy strong), s 
(strong), m (medium), w (weak). Mass spectra were perfonned by the Department of 
Chemistry, Liverpool Mass Spectroscopy Department and EPSRC National Mass 
Spectrometry Service Centre, Swansea. High-resolution electron-impact (El 
ionisation voltages of 70 eV), chemical ionisation (Cl, reagent gas CH4) and 
electrospray (ESI) mass spectra were obtained on a TermoFinnigan MAT 95 XP 
spectrometer.
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Unless otherwise indicated all reactions were carried out in flame-dried 
glassware and under an atmosphere of argon. Syringes and needles were oven-dried 
and then cooled in a desiccator. Dichloromethane (DCM), diethyl ether (EtiO), 
toluene (PhMe), benzene (Phil), hexane and tetrahydrofuran (THF) were dried over 
alumina column solvent system using the method of Grubbs. Acetonitrile (MeCN) 
was used directly from Acros, as extra dry over 4A molecular sieves. 
Dimethylsulfoxide (DMSO) was purchased from Fischer chemical company and 
used without further purification. All starting materials were purchased from Acros, 
Aldrich, Alfa Aesar or Strem chemical companies and used without further 
purification unless otherwise noted.
1.5.2. Experimental Procedures
General procedure for the preparation of the peresters:
To a stirred solution of dichloromethane (5 mL) and pyridine (0.97 mL, 12 
mmol) at 0 °C was added the corresponding acid chloride (10 mmol) dropwise. The 
reaction mixture was stirred for 10 minutes at 0 °C, to which tert-butyX 
hydroperoxide (5.5 M in decane, 2.18 mL, 12 mmol) was added dropwise. The 
reaction mixture was warmed slowly to room temperature and stirred for 6 hours. 
The reaction was then diluted with dichloromethane (50 mL), washed with water (50 
mL) and brine (50 mL). The organic layer was dried with MgSCU and concentrated 
under vacuum (bath temperature kept below 30 °C) to yield a crude residue. The 
crude residue was purified using flash chromatography on silica gel (diethyl 
ether/hexane) to yield the desired perester as an oil/solid.
Va<Bu
te/Y-Butyl benzoperoxoate 28.49
Colour and state: Pale yellow oil R/= 0.4 (Hexane:Diethyl ether
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= 95:5).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using benzoyl chloride in 91%.
‘H NMR (500 MHz, CDC13) 8 7.96 (d, /= 6.9 Hz, 2H), 7.59 (t, J= 7.5 Hz, 1H), 
7.46 (t, J= 7.5 Hz, 2H), 1.42 (s, 9H).
IR (Neat) 2982 (w), 2935 (w), 1752 (s), 1611 (m), 1237 (s) cm'1.
O AOfe/tf-Butyl 4-nitrobenzoperoxoate 35.
o2n
0'° teu
Colour and state: Pale yellow solid. R/ 0.4
(Hexane:Diethyl ether = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using 4-nitrobenzoyl chloride in 96%. 
lJl NMR (500 MHz, CDC13) 5 8.32 (d, J = 8.8 Hz, 2H), 8.14 (d, J = 8.8 Hz, 2H),
1.43 (s, 9H).
IR (Neat) 3127 (w), 2984 (w), 2934 (w), 1755 (s), 1608 (w), 1524 (s), 1346 (s), 1247 
(s) cm'1.
50General procedure for the preparation of the copper-NHC catalysts:
To a stirred solution of amine (44 mmol) in l-propanol/HiO (4:1, 10 mL) was 
added glyoxal (20 mmol) in 1-propanol (5 mL). The reaction mixture was stirred at 
60 °C for 1-16 horns and cooled to ambient temperature. Distilled water (20 mL) was 
added to the mixture and the precipitation was filtered under vacuum. The solid was 
dried under high vacuum overnight to yield pure bis-imms solid (95%).
To a stirred solution of chloromethyl ethyl ether (15 mmol) in THF (7.5 mL) 
was added the 6/s-imine (15 mmol) dissolved in THF (5 mL) with a drop of catalytic 
water. The reaction mixture was stirred at 40 °C for 16 hours and cooled to ambient
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temperature. The black reaction mixture was filtered under vacuum and the crude 
solid was washed with EtOAc (100 mL) to yield pure imidazolium chloride solid 
(70%).
To a flask in the glove-box was added imidazolium salt (5 mmol), sodium 
fer^-butoxide (5.5 mmol) and copper(I) halide (5.5 mmol). The reaction was charged 
with THF (50 mL) and stirred at room temperature for 6 hours. The reaction mixture 
was filtered through a celite plug and the filtrate was concentmted under vacuum to 
yield a crude solid. The crude solid was recrystallised from CILCh/EtOAc to yield 
pure copper-NHC solid (60%).
To a flask in the glove-box was added copper-NHC (1 mmol) and silver salt 
(1.1 mmol). The reaction was charged with MeCN (10 mL) and stirred at rt for 1 
hours. The reaction mixture was filtered through a celite plug and the filtrate was 
concentrated under vacuum to yield pure copper-NHC solid (75%).
(l,3-bis(2,6-diisopropylphenyl)-lH-imidazol-2(3H)-
ylidene)copper(I) chloride 49.50
'Pr C;u,Prx
Cl Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
^ NMR (500 MHz, CDC13) 8 7.49 (t, / = 7.8 Hz, 2H), 7.30 (d, J = 7.8 Hz, 4H),
7.13 (s, 2H), 2.55 (sept, /= 6.9 Hz, 4H), 1.30 (d, /= 6.9 Hz, 12H), 1.23 (d, 6.9
Hz, 12H).
IR (Neat) 3054 (w), 2964 (w), 2871 (w), 1594 (w), 1468 (w), 1265 (m) cm'1.
MeO
ter/-Butyl 4-methoxybenzoperoxoate 52.49
Colour and state: Colorless oil. R/ = 0.4 (Hexane:Diethyl
35
ether = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using 4-methoxybenzoyl chloride in 
92%.
lU NMR (500 MHz, CDC13) 5 7.92 (d, /= 8.8 Hz, 2H), 6.94 (d, J = 8.8 Hz, 2H), 
3.87 (s, 3H), 1.41 (s, 9H).
IR (Neat) 2981 (w), 2936 (w), 2842 (w), 1747 (s), 1605 (s), 1510 (m), 1242 (s) cm'1.
O
VX<Bu
tert-Butyl 4-methylbenzoperoxoate 53.49
Colour and state: Pale yellow oil. Ry = 0.4 (Hexane:Diethyl
ether = 95:5),
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using 4-methylbenzoyl chloride in 
92%.
‘H NMR (500 MHz, CDCI3) 8 7.85 (d, J= 8.2 Hz, 2H), 7.26 (d, J = 8.2 Hz, 2H),
2.42 (s, 3H), 1.41 (s, 9H).
IR (Neat) 3065 (w), 2982 (w), 2936 (w), 1755 (s), 1600 (w), 1451 (m), 1233 (s) cm'
F3C
O te/T*-Butyl 4-(trifluoromethyl)benzoperoxoate 54.
Colour and state: Pale yellow oil. R/= 0.3 (Hexane:Diethyl 
ether = 95:5).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using 4-(trifluoromethyl)benzoyl 
chloride in 90%.
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^ NMR (500 MHz, CDC13) 5 B.08 (d, J = 7.8 Hz, 2H), 7.74 (d, J = 8.2 Hz, 2H), 
1.43 (s, 9H).
13C NMR (125 MHz, CDC13) 8 163.33 (e), 135.01 (e, q, JC-f = 32.8 Hz, CCF), 
131.14 (e), 129.71 (o), 125.83 (0, q, JC-f=3-6 Hz, CCCF), 123.57 (e, q,JC-F = 272.4 
Hz, CF), 84.58 (e), 26.35 (0).
IR (Neat) 2984 (w), 2938 (w), 1763 (s), 1586 (w), 1412 (m), 1323 (s), 1235 (s) cm'1. 
HRMS (Cl, [M+NH4]+) calcd for C12H17F3O3N 280.11605, found 280.11680.
Cl
,0. *Bu
tertf-Butyl 2-chlorobenzoperoxoate 55.49
Colour and state: Pale yellow oil. R/= 0.4 (Hexane:Diethyl ether
= 95:5).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using 2-chlorobenzoyl chloride in 93%. 
^ NMR (500 MHz, CDC13) 8 7.71 (d, J= 6.9 Hz, 1H), 7.44-7.48 (m, 2H), 7.34 (t, J
= 7.5 Hz, 1H), 1.42 (s, 9H).
IR (Neat) 2982 (w), 2936 (w), 1769 (s), 1591 (m), 1436 (m), 1367 (m), 1229 (s) cm'
O terf-Butyl 2-nitrobenzoperoxoate 56.49
fBu Colour and state: Pale yellow solid. R/ = 0.4 (Hexane:Diethyl
ether = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the peresters using 2-nitrobenzoyl chloride in 95%. 
lK NMR (500 MHz, CDC13) 8 8.77 (t, J = 1.8 Hz, 1H), 8.46 (d, J = 8.2 Hz, 1H),
8.30 (d, 7.8 Hz, 1H), 7.70 (t, /= 7.8 Hz, 1H), 1.44 (s, 9H).
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IR (Neat) 3092 (w), 2983 (w), 2937 (w), 1759 (s), 1617 (w), 1533 (s), 1440 (w), 
1349 (s), 1234 (s) cm'1.
O terf-Butyl 2-methoxybenzoperoxoate 57.49
Colour and state: Pale yellow oil. R/= 0.4 (Hexane:Diethyl ether
OMe
= 90:10).
Representative Experimental Procedure’. Prepared in accordance to the general 
procedure for the preparation of the peresters using 2-methoxybenzoyl chloride in
93%.
^ NMR (500 MHz, CDC13) 5 7.70 (d, J = 7.8 Hz, 1H), 7.49 (t, J = 7.8 Hz, 1H),
7.00 (t, /= 7.5 Hz, 1H), 6.97 (d, J= 8.4 Hz, 1H), 3.90 (s, 3H), 1.42 (s, 9H).
IR (Neat) 2981 (w), 2938 (w), 1742 (s), 1600 (m), 1490 (m), 1366 (m), 1254 (s) cm'
General procedure for the copper(I)-NHC-catalysed allylic oxidation:
To a flask was added copper-NHC-catalyst 70 (0.0125 mmol) and MeCN (1 
mL). The reaction mixture was stirred for 10 minutes and the alkene/heterocycle (2.5 
mmol) was added, followed by the perester (0.25 mmol). The reaction was stirred at 
45 °C for the allocated time and cooled to ambient temperature. The reaction mixture 
was concentrated under vacuum and the residue was purified using flash 
chromatography on silica gel (diethyl ether/hexane) to yield pure desired product.
Cyclopent-2-enyl 4-methoxybenzoate 58.51
O Colour and state: Colourless oil. R/= 0.4 (EtiCkHexane
= 30:70).
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Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 52 and 
cyclopentene in 70%.
‘H NMR (500 MHz, CDCI3) 5 7.98 (d, J= 8.2 Hz, 2H), 6.90 (d, J= 8.2 Hz, 2H), 
6.15-6.14 (m, 1H), 5.94-5.91 (m, 2H), 3.85 (s, 3H), 2.62-2.56 (in, 1H), 2.43-2.34 (m, 
2H), 1.98-1.91 (m, 1H).
13C NMR (125 MHz, CDC13) 8 166.46, 163.33, 137.60, 131.71, 129.69, 123.25, 
113.61, 80.90, 55.55, 31.31, 30.06.
IR (Neat) 2935 (w), 2841 (w), 1703 (s), 1605 (s), 1510 (m), 1254 (s) cm"1.
Cyclopent-2-enyl 4-methybenzoate 59.
Colour and state: Colourless oil. R/ = 0.4 (EtiChHexane =
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 53 and 
cyclopentene in 77%.
lU NMR (500 MHz, CDC13) 5 7.92 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H),
6.16-6.14 (m, 1H), 5.95-5.92 (m, 2H), 2.63-2.56 (m, 1H), 2.44-2.35 (m, 5H), 1.99- 
1.92 (m, 1H).
13C NMR (125 MHz, CDC13) 5 166.77, 143.48, 137.68, 129.72, 129.60, 129.10, 
128.05, 81.02, 31.31, 30.03, 21.77.
IR (Neat) 2924 (w), 2855 (w), 1709 (s), 1611 (m), 1452 (w), 1269 (s) cm’1.
HRMS (Cl, [M+NH4]+) calcd for Ci3Hi802N 220.13375, found 220.13448.
O
O
OCyclopent-2-enyl benzoate 60.51Colour and state: Colourless oil. R/ = 0.4 (EtiO:Hexane =
39
10:90).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 28 and 
cyclopentene in 74%.
lK NMR (500 MHz, CDC13) 8 8.03 (d, J = 8.2 Hz, 2H), 7.54 (t, / = 7.5 Hz, 1H), 
7.42 (t, /= 7.5 Hz, 2H), 6.17-6.16 (m, 1H), 5.96-5.94 (m, 2H), 2.63-2.52 (m, 1H), 
2.44-2.36 (m, 2H), 2.00-1.94 (m, 1H).
13C NMR (125 MHz, CDC13) 8 166.70, 137.84, 132.88, 130,81, 129.70, 129.50, 
128.40,81.25,31.32, 30.02.
IR (Neat) 2937 (w), 2855 (w), 1711 (s), 1602 (w), 1451 (m), 1269 (s) cm'1.
CF3 Cyclopent-2-enyl 4-(trifhioromethyl)benzoate 61.
Colour and state: Colourless oil. R/= 0.4 (Et20:Hexane =
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 54 and 
cyclopentene in 83%.
'H NMR (500 MHz, CDC13) 8 8.14 (d, J= 8.2 Hz, 2H), 7.69 (d, J - 8.2 Hz, 2H),
6.20-6.18 (m, 1H), 5.98-5.94 (m, 2H), 2.65-2.57 (m, 1H), 2A6-231 (m, 2H), 2.02- 
1.95 (m, 1H).
13C NMR (125 MHz, CDC13) 8 165.48 (e), 138.37 (o), 134.30 (e, q, JC-f = 32.3 Hz, 
CCF), 130.12(0), 129.14(o), 125.45 (o, q,/C-F = 3.7 Hz, CCCF), 123.57 (e, q,Jc^ = 
272.4 Hz, CF), 81.99 (o), 31.34 (e), 29.99 (e).
IR (Neat) 2941 (w), 2858 (w), 1717 (s), 1586 (w), 1411 (m), 1270 (s), 1166 (m), 
1099 (s), 1066 (m) cm'1.
HRMS (Cl, [M+NH4]+) calcd for Ci3Hi5F302N 274.10549, found 274.10572.
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o.
N02 Cyclopent-2-enyl 4-nitrobenzoate 62.51
Colour and state: Colourless solid. R/= 0.4 (Et20:Hexane
= 20:80).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)~NHC-catalysed allylic oxidation using perester 35 and 
cyclopentene in 87%.
lK NMR (500 MHz, CDC13) 5 8.28 (d, /= 8.8 Hz, 2H), 8.20 (d, J= 8.8 Hz, 2H),
6.22-6.21 (m, 1H), 5.99-5.94 (m, 2H), 2.65-2.57 (m, 1H), 2.47-2.39 (m, 2H), 2.03- 
1.96 (m, 1H).
13C NMR (125 MHz, CDC13) 5 164.76, 150.54, 138.70, 136.21, 130.82, 128.87, 
123.59, 82.46,31.33,29.93.
IR (Neat) 3112 (w), 2948 (w), 2862 (w), 1708 (s), 1608 (m), 1524 (s), 1280 (s) cm'1.
Cl
O,
Cyclopent-2-enyl 2-chlorobenzoate 63.
Colour and state: Colourless oil. R/ = 0.4 (Et20:Hexane =
10:90).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 55 and 
cyclop entene in 73%.
NMR (500 MHz, CDC13) 6 7.78 (d, /= 7.5 Hz, 1H), 7.43 (t, /= 7.8 Hz, 1H),
7.38 (d, 7.8 Hz, 1H), 7.30 (t, J= 7.8 Hz, 1H), 6.19-6.17 (m, 1H), 5.97-5.95 (m,
2H), 2.63-2.54 (m, 1H), 2.43-2.35 (m, 2H), 2.05-1.96 (m, 1H).
13C NMR (125 MHz, CDC13) 8 165.88, 138.33, 133.61, 132.38, 131.32, 131.06,
130.83, 129.11, 126.63, 81.98,31.29, 29.92.
IR (Neat) 3063 (w), 2943 (w), 2854 (w), 1721 (s), 1592 (m), 1287 (s), 1247 (s) cm'1. 
HRMS (Cl, [M+NHUf) calcd for C12H15CIO2N 240.07913, found 240.07973.
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o2n.
°- ^ ll
o
Cyclopent-2-enyl 2-nitrobenzoate 64.52
Colour and state: Colourless solid. R/ = 0.4 (Et20:Hexane =
20:80).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 56 and 
cyclopentene in 58%.
NMR (500 MHz, CDCI3) 5 8.84 (t, /= 1.8 Hz, 1H), 8.40 (d, J = 8.2 Hz, 1H),
8.37 (d, J= 7.8 Hz, 1H), 7.64 (t, J= 7.8 Hz, 1H), 6.22-6.20 (m, 1H), 6.00-5.94 (m, 
2H), 2.67-2.58 (m, 1H), 2.47-2.38 (m, 2H), 2.06-1.97 (m, 1H).
13C NMR (125 MHz, CDC13) 5 165.48, 139.03, 133.00, 131.61, 129.93, 128.43, 
128.30, 123.96, 83.06, 31.27, 29.44.
IR (Neat) 3086 (w), 2919 (w), 2851 (w), 1716 (s), 1616 (m), 1531 (s), 1259 (s) cm'1.
MeO,rr°
O
Cyclop ent-2-enyl 2-methoxybenzoate 65.
Colour and state: Colourless oil. R/ = 0.4 (Et20:Hexane =
30:70).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 57 and 
cyclopentene in 56%.
lH NMR (500 MHz, CDC13) 5 7.76 (d, J = 7.8 Hz, 1H), 7.44 (t, J = 7.8 Hz, 1H),
6.96 (d, J= 7.8 Hz, 1H), 6.95 (t, /= 7.8 Hz, 1H), 6.15-6.13 (m, 1H), 5.96-5.93 (m, 
2H), 3.90 (s, 3H), 2.62-2.54 (m, 1H), 2.42-2.34 (m, 2H), 1.99-1.93 (m, 1H).
13C NMR (125 MHz, CDCI3) 5 166.16, 159.29, 137.67, 133.40, 131.61, 129.62,
120.66, 120.16, 112.13, 81.03, 56.11, 31.30, 30.02.
IR (Neat) 3056 (w), 2942 (w), 2854 (w), 1719 (s), 1601 (m), 1250 (s) cm'1. 
HRMS (Cl, [M+H]+) calcd for Ci3Hi503 219.10212, found 219.10153.
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(l,3“bis(2,6-diisopropylphenyl)-lH-imidazol-2(3H)-
ylidene)copper(I) bromide 66.50
,pr CuiPy'
Br Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
^ NMR (500 MHz, CDC13) 5 7.50 (t, J = 7.8 Hz, 2H), 7.30 (d, J = 7.8 Hz, 4H), 
7.14 (s, 2H), 2.56 (sept, /= 6.5 Hz, 4H), 1.30 (d, J= 6.5 Hz, 12H), 1.23 (d, 6.5
Hz, 12H).
IR (Neat) 3054 (w), 2967 (w), 2869 (w), 1578 (w), 1469 (w), 1265 (m) cm"1.
(l,3-bis(2,6-diisopropylphenyl)~lH”imidazol-2(3H)- 
II ^ Y ylidene)copper(I) iodide 67.50
/pr ^U/’pr
I Colour and state: Colourless solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
‘H NMR (500 MHz, CDC13) 8 7.47 (t, J = 7.8 Hz, 2H), 7.14 (d, J = 7.8 Hz, 4H), 
7.00 (s, 2H), 2.29 (sept, /= 6.8 Hz, 4H), 1.03 (d, J= 6.8 Hz, 12H), 0.83 (d, 7 = 6.8 
Hz, 12H).
IR (Neat) 3074 (w), 2965 (m), 2871 (w), 1565 (w), 1460 (m), 1279 (w) cm’1.
(l,3-bis(2,6-diisopropylphenyl)-lH-imidazol-2(3H)-
ylidene)copper(I) trifluoromethanesulfonate 68.50
/pr Cu,pr,
OTf Colour and state: Colourless solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
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'H NMR (500 MHz, CDCI3) 6 7.53 (t, J = 7.8 Hz, 2H), 7.32 (d, J = 7.8 Hz, 4H), 
7.20 (s, 2H), 2.51 (sept, J= 6.8 Hz, 4H), 1.27 (d, J= 6.8 Hz, 12H), 1.23 (d, J= 6.8 
Hz, 12H).
IR (Neat) 2964 (m), 2929 (w), 2872 (w), 1595 (w), 1470 (m), 1276 (m), 1236 (s), 
1200 (s), 1177 (s) cm'1.
(l,3-bis(2,6-diisopropylphenyl)-lH-imidazol-2(3H)-
ylidene)copper(I) tetrafluoroborate 69.
Colour and state: Colourless solid.
50
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
'H NMR (500 MHz, CDC13) 8 7.46 (t, J = 7.8 Hz, 2H), 7.12 (d, J = 7.8 Hz, 4H),
7.09 (s, 2H), 2.25 (sept, J= 6.8 Hz, 4H), 1.27-1.24 (m, 24H).
IR (Neat) 2963 (m), 2871 (w), 1594 (w), 1469 (m) 1058 (s) cm'1.
(1,3-dimesityl-l IT-iniidazol-2(3H)- 
ylidene)copper(I) chloride 70.50
u Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
'H NMR (500 MHz, CDC13) 8 7.05 (s, 2H), 7.00 (s, 4H), 2.35 (s, 6H), 2.10 (s, 12H). 
IR (Neat) 2977 (w), 2948 (w), 2914 (w), 1608 (w), 1486 (s), 1235 (m) cm'1.
(X,3-dimesityl-lH-imidazol-2(3H)- 
ylidene)copper(I) bromide 71.50
Colour and state: Pale yellow solid.
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Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
lU NMR (500 MHz, CDC13) 5 7.05 (s, 2H), 7.00 (s, 4H), 2.35 (s, 6H), 2.11 (s, 12H). 
IR (Neat) 2975 (w), 2946 (w), 2914 (w), 1608 (w), 1486 (m), 1235 (m) cm'1.
Cl
f=\
Cu
Cl
(l,3-bis(4-chlorophenyl)-lH-imidazol-2(3H)- 
Cl ylidene)copper(I) chloride 72.50
Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
'H NMR (500 MHz, CDCI3) 8 7.65 (d, J= 8.3 Hz, 4H), 7.53 (d, J = 8.3 Hz, 4H),
7.39 (s, 2H).
IR (Neat) 3003 (w), 3054 (w), 2982 (w), 1594 (w), 1492 (s), 1409 (m), 1277 (m) cm'
i
'Pr 'Pr (l,3-bis(2,6-diisopropylphenyl)imidazolidin-2--
ylidene)copper(I) chloride 73.50
/pr Cu/pr/^/
Cl Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
NMR (500 MHz, CDC13) 6 7.40 (t, /= 7.8 Hz, 2H), 7.25 (d, /= 7.8 Hz, 4H),
4.02 (s, 4H), 3.06 (sept, 6.8 Hz, 4H), 1.37 (d, </= 6.8 Hz, 12H), 1.34 (d, J= 6.8 
Hz, 12H).
IR (Neat) 2962 (m), 2928 (w), 2868 (m), 1591 (w), 1482 (s), 1268 (s) cm'1.
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(l)3-dimesitylimidazolidin-2-ylidene)copper(I)
u Colour and state: Pale yellow solid.
Representative Experimental Procedure". Prepared in accordance to the general 
procedure for the preparation of the copper-NHC catalysts.
*H NMR (500 MHz, CDC13) 8 6.95 (s, 4H), 3.95 (s, 4H), 2.32 (s, 6H), 2.30 (s, 12H). 
IR (Neat) 2973 (w), 2948 (w), 2917 (w), 1609 (w), 1485 (s), 1262 (s) cm'1.
O Cyclohex-2-enyl 4-nitrobenzoate 75.
} Colour and state: Colourless solid. R/ = 0.4 (EtaOiHexane =
^"no2
20:80). mp = 90-92 °C.
Representative Experimental Procedure". Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 35 and 
cyclohexene in 81%.
‘H NMR (500 MHz, CDC13) 5 8.28 (d, J= 8.8 Hz, 2H), 8.22 (d, 8.8 Hz, 2H),
6.07-6.04 (m, 1H), 5.85-5,83 (m, 1H), 5.54 (m, 1H), 2.19-2.14 (m, 1H), 2.09-1.97 
(m, 2H), 1.94-1.80 (m, 2H), 1.77-1.69 (m, 1H).
13C NMR (125 MHz, CDC13) 6 164.41, 150.53, 136.30, 133.75, 130.81, 125.07, 
123.57, 69.90, 28.39, 25.01, 18.91.
IR (Neat) 2939 (w), 2867 (w), 1719 (s), 1607 (w), 1527 (s), 1272 (s) cm'1.
(Z)-Cyclooct-2-en-l-yl 4-nitrobenzoate 76.51
Colour and state: Colourless oil. R/ = 0.5 (Et20:Hexane = 
20:80).
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Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 35 and 
cyclooctene in 46%.
^ NMR (500 MHz, CDC13) 8 8.28 (d, 8.8 Hz, 2H), 8.22 (d, J = 8.8 Hz, 2H),
5.95-5.91 (m, 1H), 5.76 (ddt, J= 9.9, 6.8, 1.6 Hz, 1H), 5.61 (ddd, /= 10.8, 7.0, 1.1 
Hz, 1H), 2.37-2.29 (m, 1H), 2.21-2.16 (m, 1H), 2.09-2.03 (m, 1H), 1.77-1.40 (m, 
7H).
13C NMR (125 MHz, CDC13) 5 164.22, 150.60, 136.27, 130.82, 130.65, 130.05, 
123.63, 74.35, 35.20, 28.91, 26.58, 25.98, 23.48.
IR (Neat) 2925 (m), 2859 (w), 1716 (s), 1605 (w), 1521 (s), 1276 (s) cm'1.
O,
°>
O
NOs Tetrahydrofuran-2-yl 4-nitrobenzoate 77.
Colour and state: Colourless solid. R/= 0.3 (Et20:Hexane
= 50:50). mp = 74-76 °C.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalysed allylic oxidation using perester 35 and 
tetrahydrofiiran in 73%.
XH NMR (500 MHz, CDC13) 8 8.28 (d, J= 8.8 Hz, 2H), 8.19 (d, 8.8 Hz, 2H),
4.17 (dt, y = 8.2, 5.0 Hz, 1H), 4.04 (t, 7.9 Hz, 1H), 2.24-2.01 (m, 4H).
13C NMR (125 MHz, CDC13) 8 164.24, 135.92, 130.90, 123.65, 100.85, 69.52,
32.48, 29.84, 23.02.
IR (Neat) 2919 (w), 1726 (s), 1607 (w), 1527 (s), 1272 (s) cm'1.
HRMS (ESI, [M+Na]+) calcd for CnHuNOsNa 260.0535, found 260.0531.
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General procedure for the preparation of the chiral copper-NHC 
catalysts:44
To a flask in the glove-box was added palladium acetate (0.25 mmol), 
BINAP (0.6 mmol) and sodium ferAbutoxide (15 mmol). The flask was charged with 
toluene (17 mL) and stirred for 20 minutes. Enantiopure amine (5 mmol) and aiyl 
bromide (10.5 mmol) were added to the reaction mixture and stined at 110 °C for 16 
hours. The reaction was then cooled to ambient temperature and concentrated under 
vacuum to minimum volume. The reaction residue was purified using flash 
chromatography on silica gel (CHiC^iMeOH) to yield pure bis-imme solid.
To a flask was added to-imine (2 mmol), ammonium tetrafluoroborate (2 
mmol) and triethyl orthoformate (20 mmol). The reaction was stirred at 120 °C for 16 
hours and cooled to ambient temperature. The crude product was purified using flash 
chromatography on silica gel (CH2Cl2:MeOH) to yield pure chiral NHC salt.
To a flask in the glove-box was added chiral NHC salt (1 mmol), sodium tert- 
butoxide (1.1 mmol) and copper(I) halide (1.1 mmol). The reaction was charged with 
THE (10 mL) and stirred at room temperature for 6 hours. The reaction mixture was 
filtered through a celite plug and the filtrate was concentrated under vacuum to yield 
a crude solid. The crude solid was recrystallised from C^CVEtOAc to yield pure 
chiral copper-NHC solid.
Ph Ph ((4R,5R)“l,3-dimesityl-4,5-diphenylimidazolidin-2- 
ylidene)copper(I) chloride 78.44
qi Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the chiral copper-NHC catalysts.
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‘H NMR (500 MHz, CDC13) 5 7.25 (t, J= 7.6 Hz, 2H), 7.22 (t, /= 7.6 Hz, 4H), 7.09 
(d, J= 7.2 Hz, 4H), 6.81 (b, 2H), 6.67 (b, 2H), 5.44 (s, 2H), 2.37 (s, 6H), 1.99 (s, 
6H), 1.52 (s, 6H).
IR (Neat) 3093 (w), 3035 (w), 2967 (w), 1688 (w), 1595 (w), 1492 (s), 1276 (m) cm'
((3aR,7aR)"l,3-dimesityl-lH-benzo[d]imidazol- 
2(3H,3aH,4H,5H,6H,7H,7aH)-ylidene)copper(I) 
chloride 79.44
Colour and state: Pale yellow solid.
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the preparation of the chiral copper-NHC catalysts.
'H NMR (500 MHz, CDCI3) 8 6.93 (d, J= 15.6 Hz, 4H), 3.59-3.57 (m, 2H), 2.30-
2.27 (m, 18H), 1.87-1.84 (m, 4H), 1.52-1.48 (m, 2H), 1.28-1.20 (m, 2H).
IR (Neat) 3093 (w), 2938 (w), 2865 (w), 1686 (w), 1594 (w), 1491 (s), 1276 (m) cm'
(l,3-bis((R)-l-phenylpropyl)“lH-imidazol-2(3H)- 
ylidene)copper(I) chloride 80.44
Colour and state: Pale yellow solid.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the preparation of the chiral copper-NHC catalysts.
‘H NMR (500 MHz, CDC13) 5 7.38-7.30 (m, 10H), 6.90 (s, 2H), 5.53 (t, /= 6.9 Hz, 
2H), 2.34-2.17 (m, 4H), 0.92 (t, J= 12 Hz, 6H).
IR (Neat) 3091 (w), 2965 (w), 2874 (w), 1686 (w), 1594 (w), 1493 (s), 1276 (m) cnf
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IBiox[(-)-menthyl]copper(I) chloride 81.33,34 
Colour and state: Pale yellow solid.
Representative Experimental Procedure’. Prepared in 
accordance to the general procedure for the preparation of the chiral copper-NHC 
catalysts.
^ NMR (500 MHz, CDC13) 5 4.65 (d, Jr= 9.4 Hz, 2H), 4.42 (d, 9.4 Hz, 2H),
3.16-3.32 (m, 2H), 2.20-2.35 (m, 2H), 2.02-2.15 (m, 4H), 1.89-1.94 (m, 2H), 1.67- 
1.73 (m, 2H), 1.20-1.38 (111, 4H), 0.93-0.95 (m, 14H), 0.30 (d, J= 6.8 Hz, 6H).
IR (Neat) 2958 (w), 2924 (m,), 2856 (w), 1750 (s), 1432 (w), 1294 (vs) cm'1.
General procedure for the regioselective copper(I)-NHC-catalysed allylic 
oxidation:
To a flask was added copper-NHC (10 mol %) and PhMe (2.5 mL). The 
reaction mixture was stirred for 10 minutes and alkene (0.25 mmol) was added, 
followed by perester (2.5 mmol). The reaction was stirred at 80 °C for 12 hours and 
cooled to ambient temperature. The reaction mixture purified using flash 
chromatography on silica gel (diethyl ether/hexane) to yield pure desired product.
O 3-Phenycyclohex-2-enyl 4-nitrobenzoate 90.53
| | Colour and state: Colourless solid. R/ = 0.5■^no2
(EtiCkHexane = 20:80).
Representative Experimental Procedure: Prepared in 
accordance to the general procedure for the regioselective copper(I)-NHC-catalysed 
allylic oxidation using perester 35 and 1-phenylcyclohexene in 38%.
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’H NMR (500 MHz, CDCI3) 8 8.29 (d, J= 8.8 Hz, 2H), 8.24 (d,J= 8.8 Hz, 2H), 
7.44 (d, J= 7.8 Hz, 2H), 7.35 (t, /= 7.8 Hz, 2H), 7.30 (t, 7= 7.8 Hz, 2H), 6.22 (m, 
1H), 5.75 (m, 1H), 2.62 (tn, 1H), 2.45 (m, 1H), 1.98 (m, 4H).
IR (Neat) 2938 (w), 2869 (w), 1715 (s), 1607 (w), 1524 (s), 1263 (s) cm'1.
54O 3-Phenycyclohex-2~enyl acetate 95.
Colour and state: Colourless oil. R/= 0.4 (Et20:Hexane - 5:95).
Representative Experimental Procedure: Prepared in accordance 
to the general procedure for the regioselective copper(I)-NHC- 
catalysed allylic oxidation using fert-butyl peracetate and 1-phenylcyclohexene in
70%.
^ NMR (500 MHz, CDC13) 5 7.41 (d, /= 7.2 Hz, 2H), 7.33 (t, /= 7.2 Hz, 2H),
7.28 (d, /= 7.2 Hz, 2H), 6.08 (m, 1H), 5.46 (m, 1H), 2.53 (m, 1H), 2.38 (m, 1H), 
2.08 (s, 3H), 1.93 (m, 2H), 1.79 (m, 2H).
IR (Neat) 2936 (w), 2867 (w), 1728 (s), 1599 (w), 1235 (s) cm'1.
O
O 4'-inethoxy-3,4,5,6-tetrahydro-[l ,1 '-biphenylJ-S-yl
acetate 97.
Colour and state: Colourless oil. R/ = 0.4 (Et20:Hexane = 
10:90).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the regioselective copper(I)-NHC“Catalysed allylic oxidation using 
/er/-butyl peracetate and 4-methoxyphenyl-l-cyclohexene in 57%.
NMR (500 MHz, CDC13) 5 7.37-7.34 (m, 2H), 6.87-6.84 (m, 2H), 6.02-6.01 (m, 
1H), 5.46-5.43 (m, 1H), 3.81 (s, 3H), 2.52-2.47 (m, 1H), 2.38-2.32 (m, 1H), 2.07 (s, 
3H), 1.94-1.88 (m, 2H), 1.80-1.75 (m, 2H).
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13C NMR (125 MHz, CDC13) 5 171.02 (e), 159.36 (e), 141.61 (e), 133.61 (e), 126.63 
(0), 120.69 (o), 113.75 (o), 69.18 (o), 55.37 (0), 28.13 (e), 27.45 (e), 21.57 (o), 19.49 
(e).
IR (Neat) 2942 (w), 1722 (s), 1605 (m), 1512 (m), 1373 (m), 1237 (vs), 1182 (s), 
1024 (vs) cm'1.
HRMS (ESI, [M+Na]^) calcd for CisHigOsNa 269.1154, found 269.1161.
O 4'-(trifluoromethyl)-3,4,5,6-tetrahydro-[l,l,-biphenyl]-3- 
yl acetate 98.
Colour and state: Colourless oil. R/ = 0.4 (Et20:Hexane ~ 
5:95).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the regioselective copper(I)-NHC-catalysed allylic oxidation using 
/er/-butyl peracetate and 4“(trifluoromethyl)phenyl-l-cyclohexene in 30%.
'H NMR (500 MHz, CDC13) 3 7.58-7.57 (m, 2H), 7.51-7.49 (m, 2H), 6.15-6.14 (m.
1H), 5.46-5.44 (m, 1H), 2.55-2.49 (m, 1H), 2.41-2.36 (in, 1H), 2.08 (s, 3H), 1.98- 
1.91 (m, 1H), 1.85-1.77 (m, 1H).
13C NMR (125 MHz, CDCI3) 6 170.84 (e), 144.68 (e), 141.07 (e), 129.61 (e, q, Jc.f 
= 32.8 Hz, CCF), 124.26 (e, q, Jcf = 272.0 Hz, CF), 125.81 (o), 125.32 (0, q, Jc.f = 
3.8 Hz, CCCF), 124.51 (0), 68.72 (o), 27.89 (e), 27.32 (e), 21.38 (0), 19.40 (e).
IR (Neat) 2940 (w), 1732 (s), 1615 (w), 1324 (vs), 1234 (vs), 1163 (s), 1114 (vs), 
1069 (s), 1015 (m) cm'1.
HRMS (ESI, [M+Naf) calcd for C^HisChFsNa 307.0922, found 307.0923.
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Chapter 2
Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of Alkenes to a, p-
Unsaturated Ketones
2.1 Introduction
2.1.1. Background and Significance
a, /?-Unsaturated ketones (enones) are an important class of compounds in 
organic synthesis, because they are useful substrates for a range of synthetically 
transformations (Fig. 2.1).1 A myriad of methods have been developed for the 
synthesis of this versatile functionality, e.g. alkenylation of carbonyl groups, cross­
metathesis of terminal alkenes, Homer-Wadsworth-Emmons reaction of aldehydes 
and the oxidation of allylic alcohols.2 Nevertheless, there are several drawbacks to 
each of these methods, namely, the use of stoichiometric organometallics, expensive 
transition metals and reagents.
HO R 1,4-addition
1,2-addition vinyl epoxide
H' allylic alcohol
[4+2] a, p-unsaturated ketone
R
Tebbe
R-NH;
NaBH,hetero [4+2]
HN
OH
P hydroxy-carbonyls
dienes allylic amines
Figure 2.1 Transformations of a, p-Unsaturated Ketones.
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The preparation of enones is not trivial and has hampered many total 
syntheses of natural products. For example, this problem was highlighted in the total 
synthesis of ginkgolide B 8, for the conversion of the cyclopentene 1 into the a, (3- 
unsaturated ketone 7 (Scheme 2.1).3 The cyclopentene 1 was brominated under 
photochemical conditions to furnish the allylic bromides 2-4 in 80% overall yield, 
although the mixture is inconsequential to the formation of the desired enone 7. The 
isomers were separated and the allylic nitrate esters 5 and 6 were converted to the 
enone 7 in 50% overall yield. Hence, this sequence underlined the necessity for a 
more direct route to this functionality.
(6:3:1)
10 M AgN03, MeCN
HQ H
ginkgolide B (8)
2. PDC, DCM
1. Zn, AcOH
2. PDC, DCM
Scheme 2.1 Corey’s Enone Formation in the Total Synthesis of Ginkgolide B 8.
2.1.2. Stoichiometric Methods
The first allylic oxidation reactions of alkenes to give a, /?-unsaturated ketones 
were carried out using stoichiometric selenium and chromium reagents.4 These 
reagents are highly toxic, and on large scale, provide problems with waste disposal
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and purification. Although selenium and chromium reagents are still utilised, they are 
limited in the context of chemo- and regioselectivity, and thus more selective and 
catalytic methods have been pursued. Although the mechanism for selenium(IV) 
dioxide allylic oxidation is well established, the corresponding chromium(VI) variant 
is poorly understood by comparison.5
Reinde! 1928
a-ergostenol (9) a-ergostenone(IO)
Heilbron 1932
a-ergostenol (9)
C22H34O2
or
C21H32O2
B
a-ergostenone (10)
Scheme 2.2 First Reported Chromium Oxidation.
Chromium-mediated oxidation reactions with both stoichiometric and catalytic 
variants are relatively common. In 1928, Reindel reported the chromium oxidation of 
a-ergostenol 9 to a-ergostenone 10 using chromium anhydride (Scheme 2.2).6 In 
1932, Heilbron reported that the major product was not a-ergostenone 10 under 
identical conditions, but an unknown compound B.7
Whitmore et ah later reported that chromic anhydride and acetic acid solution 
effect the allylic oxidation of cyclohexene 11 to cyclohexenone 12 in 37% yield, 
with adipic acid 13 as the major product.8 Interestingly, they also reported the allylic 
oxidation of 1-methylcyclohexene 13 under the same conditions to provide 1- 
methylcyclohexene-3-one 14 in 20% yield, and l-methylcyclohexene-6-one 15 in 
2% yield (Scheme 2.3).
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o
oo
11
Cr03 (1.5 eq)
AcOH 
35 °C, 40 h 
37% 12
HO
OH
13
Cr03(1.5 eq)
14
AcOH 
35 °C, 40 h 
22%
O
1615 (10:1)
Scheme 2.3 CrOs and Acetic Acid Allylic Oxidation by Whitmore et al.
The reasoning behind the choice of alkenes is due to the fact that cyclic 
allylic C-H bonds are weaker than the corresponding acyclic bonds (82.3 kcal/mol 
vs. 86.3 kcal/mol), which makes the allylic oxidation of cycloalkenes much more 
facile.9 Cyclic alkenes are also preferred over acyclic alkenes due to the “cyclic 
activation” of the allylic hydrogens.103 Cyclic alkenes have the ability to align the 
allylic hydrogen with the double bond, thereby reducing the conformational change 
between the ground state and the transition state. Cyclic alkenes have enhanced 
reactivity over acyclic alkenes due to a combination of factors, including resonance, 
polar and steric effects.10b These features coupled with the lower bond dissociation 
energies; make cyclic alkenes the optimal substrates for allylic oxidation chemistiy.
H
6
71.1
(kcal/mol)
82.3 86.3 88 93.2 95.1 98.2
5
110.9
Stronger bond dissociation energies
Figure 2.2 Selected Bond Dissociation Energies (BDE’s).
In 1969, Dauben et al. reported the allylic oxidation of cycloalkenes with 
chromium trioxide-pyridine complex (Collins reagent).11,12 Dauben subjected a wide 
range of substituted-alkenes to the chromium allylic oxidation and compared the 
yields to the previously reported methods (Scheme 2.4). For example, treatment of
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the steroid 17 with the chromium trioxide-pyridine complex provided the enone 18 in 
76% yield at room temperature, which compares favourably to the method using tert-
butyl chromate (Scheme 2.4).13
As above
95%
(67% with ferf-butyl chromate)
19 20
14
/4s above
75%
(22% with CrOg/AcOH)
As above
78%
26
O
15 (6.8:1) 27
As above
77%
28 29
O
30
(6.5:2.5:1)
Scheme 2.4 Allylic Oxidation using Chromium Trioxide-Pyridine Complex.
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Alternatively, the alkenes 19 and 21 were oxidised to the enones 20 and 22 in 95% 
and 48% yield, respectively, in which the tertiary hydrogens on bridgehead allylic 
positions are not preferentially attacked due to the absence of resonance 
stabilisation.14 Additionally, acyclic alkenes, for example 19 and 23, are not oxidised 
(Scheme 2.4). Conformationally flexible alkenes with more than one allylic site (e.g. 
alkenes 14, 23, 26 and 28) lead to mixtures of enones. Alkenes 14 and 23 are 
oxidised in good yield, albeit with poor regioselectivity. Interestingly, Dauben and 
Whitmore report contrasting selectivity for the formation of enone 15, in which 
Whitmore reported higher regioselectivity (10:1), albeit in lower yield (75% vs. 22% 
yield).8 The unsubstituted alkenes 26 and 28 provided different regioselectivity, 
wherein the major products are 15 in 78% yield (15:27 = 6.8:1) and 29 in 77% yield 
(29:30:31 = 6.5:2.5:1).
Equatorial Interaction 
(Non-Bonding)
Axial Interaction 
(Bonding)
Figure 2.3 Stereoelectronic Stabilisation of Axial Hydrogen Abstraction over 
Equatorial.
Corey and Turner independently demonstrated that the prefered hydrogen 
abstraction is axial over equatorial, due to the favourable stereoelectronic effect from 
the developing p-orbital mixing with the 7r-system (Fig. 2.3).1516 The high 
regioselectivity in the allylic oxidation of polycyclic substrates is due to the 
conformational rigidity. For example, the axial C-6 hydrogen is hindered by the 
angular C-10 methyl group, which promotes C-3 abstraction (Fig. 2.4). The same 
argument can also be applied to the flexible, monocyclic examples, where the axial 
C-4 methyl group protects the C-6 hydrogen, whereas the C-3 hydrogen is not
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affected by this 1,3-diaxial interaction. This is highlighted in the alkene 28, which
affords a mixture of enones 29/30/31 (Scheme 2.5). 12
RIGID
Figure 2.4 Conformation of Rigid and Flexible Alkenes.
The major enone 29 comes from the abstraction of the C-3 hydrogen to 
furnish the intennediate 28ii, followed by isomerisation presumably leading to the 
more stable allylic radical 28iii followed by its oxidation to the enone 29 (Scheme 
2.5). The enone 31 results from the intennediate 28ii, which is disfavoured due to 
the steric hindrance of the gem-dimethyl groups. The competing hydrogen 
abstraction of alkene 28 at C-6 leads to the intennediate 28i, which is oxidised to 
afford the enone 30. The distribution of the enones indicates that the initial 
abstraction of alkene 28 is 3:1 in favour of the C-3 hydrogen over the C-6 hydrogen, 
due to the 1,3-diaxial interaction between the axial C-6 hydrogen and C-4 methyl
group 12
28ii 28iii 29 (50%)
O
31 (7%)
Scheme 2.5 Product Distribution of Alkene 28.
In 1978, Salmond discovered that chromium trioxide-3,5-dimethylpyrazole 
(Cr03.3,5-DMP) was a superior oxidant compared to Collins reagent for the allylic
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oxidation of steroidal alkenes (Scheme 2.6).18 For instance, the oxidation of 
cholesterol benzoate 32 is more efficient than related chromium oxidants.19 This was
attributed to improved solubility of the reagent, which promotes intermolecular 
hydrogen abstraction via the increased basicity of the proximal nitrogen in the 
pyrazole nucleus.20
(12 eq)
DCM, -20 0C, 0.5 h
c.f. 1. Sodium chromate, acetic acid/acetic anhydride, 72-96 h, 38%
2. Collins reagent, DCM, celite, 50 h, 68%
3. Pyridinium chlorochromate, DCM, N.R.
Scheme 2.6 Chromium Allylic Oxidations on Cholesterol Benzoate 32,
Scheme 2.7 outlines the two mechanisms proposed by Salmond for the 
Cr03.3,5-DMP allylic oxidation reaction. The first pathway proceeds through an ene- 
type process with 33 to generate 34, which then undergoes a sigmatropic [2,3]- 
rearrangement to furnish the intermediate 36 (Path A, Scheme 2.7).21,22 This pathway 
is not possible with the Collins reagent as there are no vacant coordination sites for 
complexation with Tc-electrons and no basic nitrogen for assisted removal of the 
allylic hydrogen
J H 
n^Cr^ N.°s^ ^
33
H
Ene
HO*
HO'
o 
Cl r
Cr=0
N
NH+
"A3
33
HO_cr=0 
HO'I 
N
rN
[2,3]
N'
O.Oi,Cr
O' 'OH
36
O OH
37
Scheme 2.7 Proposed Mechanisms of Cr03.3,5-BMP Allylic Oxidations.
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The alternative pathway involves a one-electron oxidation of the double bond 
by Cr03.3;5-DMP to provide the radical cation, which undergoes a proton 
abstraction by the pyrazole ligand to furnish the allyl radical 35 (Path B, Scheme 
2 7) 23 jjie apyi radical 35 undergoes a further one electron transfer to afford the 
intermediate 36, which is the same intermediate formed in path A. This intennediate 
rearranges to provide the a, /?-unsaturated aldehyde 37 and regenerate the Cr03.3,5- 
DMP reagent.24,25 Hence, the regeneration of the oxidant should enable the oxidation 
to become catalytic, but Cr03.3,5-DMP is generally used in large excess. For 
example, Shing utilised 20 equivalents of Cr03.3,5-DMP (80 grams) to effect the 
allylic oxidation of the electron deficient alkene 38 to afford the enone 39 in 70% 
yield, in the total synthesis of (-)-samaderine Y 40 (Scheme 2.8).26
(10 g scale)
CrCM.S-DMP 
(20 eq, 80 g)
DCM, reflux 
70%
(70% conversion)
(-)-samaderine Y (40)
Scheme 2.8 Cr03.3,5-DMP Allylic Oxidation in the Total Synthesis of (-)-
Samaderine Y 40.
2.1.3. Metal-Catalysed Methods
2.I.3.I. Molecular Oxygen as the Terminal Oxidant
The development of metal-catalysed allylic oxidation reactions using 
environmentally benign reagents namely, molecular oxygen and hydrogen peroxide 
has been the focus of intense synthetic attention.27 In 1967, Collman reported the 
transition metal-catalysed autoxidation of cyclohexene 11 under a atmosphere of 
molecular oxygen to furnish cyclohexen-3-one 12 in 20-50% yield with cyclohexene 
oxide 41 as the minor product (Scheme 2.9)28 The autoxidation proceeds with an 
array of transition metals, which includes rhodium, platinum and iridium. The
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oxidation proceeds through a hydroperoxide intermediate, which has also been
reported for the thermal autoxidation of cyclohexene.29
cat MLn 
Og
25-60 °C, 24 h 
11 20-50% 12 41
MLn = RhCI(CO)(PPh3)2, Pt02(PPh3)2, lrl(CO)(PPh3)2l lrCI(N2)(PPh3)2 or RhCI(PPh3)3
Scheme 2.9 Transition Metal-Catalysed Autoxidation Reaction by Collman et al.
In 1968, Kurkov performed the autoxidation of cyclohexene 11 and 
ethylbenzene, and demonstrated that the reaction proceeds via a free-radical chain 
mechanism (Table 2.1).30 Both the rhodium and cobalt-catalysed autoxidation 
reactions occur with similar product mixtures (Table 2.1, entries 1-4).
Table 2.1 Metal-Catalysed Autoxidation of Cyclohexene 11 by Kurkov et al
cat MLn 
Oa
60 0C, 10 h
11 12 42 43
Entry Catalyst Conv. (%) Yield (%)
12a 42a 43b Other"
1 RhCl(PPh3)3 63 35 28 27 14
2 Rh(acac)3 78 51 20 18 11
3 Rh(2-EH)3 62 57 20 15 8
4 Co(2-EH)2 79 48 20 21 11
s* RhCl(PPh3)3 0 - - - -
6 None 1 - - - -
“Determined by GLPC. bDetermmed iodometrically. 'Unidentified products. dIn
the presence of 2 mol % of hydroquinone.
A number of additional products were isolated, including the 2-cyclohexen-l- 
yl hydroperoxide 43, which was previously proposed as an intennediate in the 
process. Hydroperoxide 43 was proposed to fragment to the enone 12 and the allylic 
alcohol 42. The free-radical nature of the autoxidation reaction was supported by the
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observation that there was complete inhibition of the oxidation in the presence of 
hydroquinone, a free-radical scavenger (entry 5).30
In 1969, Baldwin provided additional evidence for the intennediacy of an 
allyl radical during the allylic oxidation of (+)-carvomenthene 44 (Scheme 2.10).31 
The oxidation of optically active (+)-carvomenthene 44 generates two allyl radical 
intennediates, prochiral-44i and 44ii, in which the former provided the enone 46 as 
the racemate and the piperitone product 48 with retention of optical purity.
45 46 48
Scheme 2.10 Allyl Radical via the Autoxidation of (+)-Carvomenthene 44.
The Haber-Weiss type mechanism has been proposed for the transition-metal- 
catalysed free-radical chain reaction based on the following observations.32 This 
mechanism can be initiated by many transition metals that can undergo a one- 
electron transfer, e.g. Fe2+ * Fe3+, Cu1+ * Cu2+, Co2+ * Co3+, Rh2+ * Rh3+, and two- 
electron transfer, for example, Sn2'1' Sn4+, Tl1+ * TI31, RhI+ Rh3+, Cr3+ Cr5+
(Fig 2.5).33’34
One-electron transfer
ROOM + M(ll) ------► ROO • + H+ + M(l)
ROOM + M{l) ------► ROM + OH’ + M(ll)
Two-electron transfer
2ROOH + M(lll) ------2ROO- ■F 2H+ + M{l)
2ROOH + M{l) ------► 2RO • + 20H' + M(lll)
Figure 2.5 Haber-Weiss Mechanism of One/Two-Electron Transfer.
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2.1.3.2. Peroxides as the Terminal Oxidant
Robertson, Waters and Medvedev reported the transition metal 
decomposition of hydroperoxides to RO and ROO*.35"37 For instance, they reported 
that the rate of autoxidation of tetralin 49 with molecular oxygen, without the 
presence of metal salts afforded approximately 30% yield of 51 and 52 based on 
hydroperoxide 50 content. However, the rate gradually declined after the “induction 
period” of phases A and B (Fig. 2.6).35 In the presence of metal salts (Cu+, Fe2+ or 
Co2+), phases A and B can potentially be bypassed, to access the tetralol 51, tetralone 
52 and hydroxyl radical 53. Haber and Weiss demonstrated that hydroperoxides are 
decomposed with metal salts, especially ones that undergo one-electron transfer, 
leading to the increased formation of secondaiy initiators, such as hydroxyl radical 
53. Hence, the role of the metal salts was identified as the “secondary catalyst”, to 
aid the decomposition of the initially formed hydroperoxide 50 to generate the 
“active catalyst”.38,39
OOH OH O
49 49i 50 51 52 53
No metal (Slow)
............................... ... >
i i Presence of metal (Bypasses Phases A and B) i   ................................... ................ S
Figure 2.6 Effect of Metal Salt on the Rate of Autoxidation of Tetralin 49.
In 1951, Nudenberg investigated the free-radical decomposition of a range of 
alkyl hydroperoxides (Scheme 2.11).40 Alkyl peroxides were exposed to ferrous 
ammonium sulphate hexahydrate in the presence of butadiene 54, underwent 
decomposition to give the corresponding alkoxy radicals.41 The addition of a 
hydroxyl radical to butadiene 54 provided the free radical 55, which dimerised to 
afford 56 and 57.40
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1. ROOH + Fe2+ RO • + FeOH2+
2. RO- + H2C=CHCH=CH254 -------► (ROC^g)- 55
3. 2(ROC4H6). 55 -------► (ROCH2CH=CHCH2-)2 56
4. 2 (ROC4H6) - 55 -------► ROCH2CH=CHCH2CH(CH=CH2)CH2OR 57
Scheme 2.11 Addition of Alkoxy Radicals to Conjugated Systems by Nudenberg et al.
Nudenberg also reported the addition of free radical 59 to acceptors (alkenes), 
which was initiated by the decomposition of tert-butyl hydroperoxide with trace 
amounts of cobalt salts (Scheme 2.12).42 The decomposition of tert~\mty\ 
hydroperoxide proceeds by a chain mechanism to afford the oxygen-centred radicals 
ROO 59 and RO* 58, along with molecular oxygen.43
1. ROOH + Co2+ —-► RO- 58 + Co3+ + OH’
2. ROOH + Co3+ — ROO- 59 + Co2+ + H+
3. RO- + Co2+ —-*■ RO' + Co3+
4. RO- + ROOH ——Decomposition into ketone + alcohol + RO
5. ROO • 59 4- Co2+ R+ + Co2+ + 02
Scheme 2.12 Addition of Alkoxy Radicals to Alkenes by Nudenberg et al.
The evolution of oxygen from the decomposition of ROO* 59 by cobalt salts 
could be suppressed if acceptors of free ROO* 59 radicals were present (Scheme 
2.12).42 For example, in the presence of 1-octene 60, the free radical 59 affected an 
allylic hydrogen abstraction reaction to generate the isomeric alkyl radicals 601 and
70
60ii, which reacted with ROO* 59 to furnish the enone 62 and aldehyde 64 from the 
decomposition of the respective peroxides 61 and 63.42
2.I.3.3. Chromium-Catalysed Allylic Oxidations
Significant progress has been made into the allylic oxidation of alkenes using 
hydroperoxides with transition metal catalysts.45 For instance, Nudenberg has applied 
copper, iron and cobalt in the allylic oxidation of several alkenes.40'43 More recently, 
catalytic chromium(O) and chromium(III) with te/Y-butyl hydroperoxide have been 
utilised for allylic oxidation.4d Pearson serendipitously discovered that 
Mo(CO)2(CH3CN)4 catalyses the oxidation of cyclopentene 65 to cyclopentenone 66 
using tert-\mty\ hydroperoxide (Scheme 2.13).46
P
eat Mo(CO)2(CH3CN)4
'BuOOH / *1 ^ + /
ivteUgC MeCN, reflux, 38 h Me°2C Me02C
65 66 67
Scheme 2.13 Allylic Oxidation using Catalytic Molybdenum by Pearson et al.
Interestingly, chromium-carbonyl catalysts were effective in this 
transformation, especially when the in situ generated Cr(CO)3(CH3CN)3 catalyst was 
employed (Scheme 2.14) 47 Treatment of cyclopentene 65 with Cr(CO)6 in refluxing 
acetonitrile to generate the Cr(CO)3(CH3CN)3 complex afforded the cyclopentenone 
66 exclusively in 83% yield (Scheme 2.14). Although it was feasible to utilise 
catalytic quantities of Cr(CO)6 (5 mol %), sub-stoichiometric quantities (0.5 eq) were 
required to provide a good rate of reaction and prevent the formation of the side 
products (Scheme 2.14)46
/
MeOjC
65
Cr(CO)6 (0.5 eq) 
(Cr(CO)3(CH3CN)3 in-situ) .0
teuOOH (1.2 eq) 
MeCN, reflux, 18 h 
83%
/
MeO^C
66
Scheme 2.14 Allylic Oxidation using Catalytic Chromium by Pearson et al.
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Cr(CO)6 (0.5 eq) 
(Cr(CO)3(CH3CN)3 in-situ)
teuOOH (3 eq)
IVIeCN, reflux, 15 h 
80%
(74% with 16.2 eq of Collins reagent)
V
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Cr(CO)6 (0.5 eq) 
(Cr(CO)3(CH3CN)3 in-situ)
teuOOH (3 eq)
MeCN, reflux, 18 h 
65%
(48% with 6.8 eq of Collins reagent)
V
o
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OH
70
Cr(CO)6 (0.5 eq) 
(Cr(CO)3(CH3CN)3 in-situ)
'BuOOH (1.2 eq) 
MeCN, reflux, 12 h 
60%
OH
CT ^
71
Scheme 2.15 Cr(CO)(}-Catalysed Ally lie Oxidation.
The chromium-catalysed allylic oxidation reaction was superior to the 
previous methods, as demonstrated by the substrate scope (Scheme 2.15).12 The 
oxidation reaction provided excellent chemoselectivity, as exemplified by the 
oxidation of alcohol 70 to provide the enone 71 without competitive oxidation of the 
secondaiy alcohol.40
Scheme 2.16 Pearson's Conditions Towards the Total Synthesis of (±)-14- 
Deoxyisoamijiol 74.
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The chromium-catalysed allylic oxidation reaction was also used in the total 
synthesis of (±)-14-deoxyisoamijiol 74 (Scheme 2.16).48 Treatment of the alkene 72 
with catalytic Cr(CO)6 and tert-butyl hydroperoxide afforded the enone 73 in 44% 
yield (75% BORSM) with the chemoselective oxidation of the cyclohexene over the 
cyclopentene. Interestingly, the oxidation of 72 with more conventional oxidants 
provided the over-oxidised product 75 and the allylic alcohol 76.49
The mechanism for the chromium-catalysed oxidation reaction has been 
explored, in which two possible pathways have been proposed (Scheme 2.17). The 
first pathway involves the oxidation of chromium(O) to the active chromium(VI) 
species 76 by te/7-butyl hydroperoxide (Scheme 2.17, Path A).50 The oxidation of the 
alkane with 76 leads to the desired carbonyl product and the chromium(IV) species 
77 which regenerates 76 with tert-butyl hydroperoxide. The second pathway involves 
the fonnation of polymeric chromium(III) oxide 78 and a chromium(VT) species 
(Scheme 2.17, Path B). The former 78 is known to possess superior catalytic activity 
compared to Cr(CO)6.50 Chromium(III)-catalysed allylic oxidations have not been 
examined extensively and many of the earlier conditions employ mixed-metal 
systems, e.g. MCr204 (where M = Co, Cu, Ni)] and molecular oxygen.51
'BuOOH
Path A
Cr° ------► Cr°{'BuOOH)n
'BuOOH
O
Crlv
a oOl - ^ w N(jfVI
'BuCf ‘OH T 'BuO' OH 
fBuOH ^ 76
Path B
'BuOOH
02
rch2r
(CrIM=0)n -------
78 'BuOOH
RCH2R
Scheme 2.17 Proposed Mechanism for the Active Chromium Catalyst.
Schultz utilised pyridinium dichromate (PDC) for an allylic oxidation in the 
synthesis of the p-opiod receptor 81 (Scheme 2.18).52 Treatment of 79 with catalytic
73
PDC and aqueous 70% ter?-butyl hydroperoxide furnished the enone 80 in 51% 
yield. The conditions are exceptionally mild with low catalyst loading (2.5 mol %) 
using cheap and readily available aqueous te/7-butyl hydroperoxide.
Scheme 2.18 PDC-catalysed Allylic Oxidation In the Synthesis of the pi-Opiod
Receptor 81.
2.I.3.4. Selenium-Catalysed Allylic Oxidations
In 2004, Crich reported the use of a recyclable selenium catalyst for allylic 
oxidation, which provided similar regies electivity to the analogous stoichiometric 
selenium(IV) oxidations (Scheme 2.19).53 Treatment of the cholesteryl benzoate 31 
with C8Fi7Se02H (10 mol %) and PhI02 (3 eq) furnished the enone 82 in 65% yield 
with 92% recovery of the fluorous selenium catalyst.
C8F17Se02H (10 mol %)
Ph
83
/As above
63%
Phx>
84
/As above
62%
21 85
Scheme 2.19 Selenium-Catalysed Allylic Oxidation.
The allylic oxidation follows Guillemonat’s rules for regioselectivity, which
nicely complements the selectivity outlined in previous investigations.54 Treatment
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of the alkenes 83 and 21 with the selenium catalyst in the presence of the oxidant 
provided the enone 84 and aldehyde 85 in good yield and with excellent 
regioselectivity (Scheme 2.19). Selenium based oxidation reactions are inherently 
problematic due to high toxicity and waste disposal issues, but nevertheless, this 
catalytic variant provides an interesting alternative.55
Crich proposed that the catalytic selenium oxidation with PI1IO2 proceeds as 
outlined in Scheme 2.20, which parallels the mechanism of selenium dioxide 
oxidation reactions. Hence, the process involves an initial ene reaction, followed by a 
[2,3]-sigmatropic arrangement to the selenic ester, which is then eliminated to
provide the carbonyl functionality. 56
0=Se( c Ene HO-,
'R' R
X = OH, OSeRp or OgSeRp
RpSe(0)X + OrA^-r,
PhlOu
O- ,Rp
-Usie->r\
[2,3]
.Se
O Rp
R ^ R'
Scheme 2.20 Proposed Mechanism for the Selenium-Catalysed Allylic Oxidation.
2.I.3.5. Iron-Catalysed Allylic Oxidations
Barton et ah demonstrated the iron-catalysed allylic oxidation reactions on 
terpenes, using Gif systems.57 It was presumed that the Gif chemistry replicated 
nature’s aerobic system by the oxidation of iron(0) to iron(III). The chemistry was 
originally developed for the oxidation of saturated hydrocarbon systems via the in 
situ fonnation of iron(V) oxide using various Gif systems developed by Barton (Fig. 
2.7).58
GoAgg" system Fe(lll) + H202 H+ o
■ Fe(lll)—-O—OH —► Fe(V) + H20
GoAgg1 system Fe(N) + K02
Figure 2.7 Gif Chemistry.
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The Gif chemistry was applied to the allylic oxidation of |3-(-)-pinene 86 and 
jR-(+)-limonene 90 using Fe(III)-TBHP and Fe(III)-TBHP-PA conditions under 
aerobic atmosphere.59 Treatment of (3-(-)-pinene 86 with FeCb.bF^O, tert-buty\ 
hydroperoxide and picolinic acid in pyridine/acetic acid furnished the pinocarvone 
87, myrtenal 88 and nopinone 89 in low yield with modest selectivity (Scheme 2.21). 
The oxidation required air; since the yield was significantly reduced under an 
atmosphere of argon with moderate increase in yields over prolonged reaction 
times.59-60
FeCl3.6H20 (20 mol %) 
teiiOOH (1 eq)
Picolinic acid (60 mol %)
Pyridine/AcOH (10:1)
18 h
20% (33:15:1)
Scheme 2.21 Iron(III)-Catalysed Allylic Oxidation of jB-(-)-Pinene 86.
Alternatively, treatment of i?-(+)-limonene 90 with the catalytic iron(III) 
provided mixtures of carvone 91, carveol 92, perillaldehyde 93 and 4-(2- 
propenyl)toluene 94 (Scheme 2.22).59 The oxidation was dependent on picolinic acid 
(PA) and air, but the selectivities and yields are modest.
86
(6 eq)
90
(6 eq)
FeCI3.6H20 (20 mol %) 0
Picolinic acid (60 mol %)
teuOOH (1 eq) I
Pyridine/AcOH (10:1) ^
48 h 91
18% (14:1:1:1)
CHO
93
+
Scheme 2.22 lron(III)-Catalysed Allylic Oxidation ofR-(+)-Limonene 90.
The proposed mechanism for the iron(III)-catalysed allylic oxidation of R- 
(+)-Limonene 90 is outlined in Scheme 2.23. The anticipated Fe(V)=0 species reacts 
with either the secondary or primary allylic C-H bond to afford the intennediates A 
and B.61 The reaction of A (at both the a- and y-carbon) with molecular oxygen 
provides the racemic intermediate D. Carvone 91 and carveol 92 are derived from the 
decomposition of D, whereas perillaldehyde 93 is derived from the fragmentation of
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the primary allylic metal hydroperoxide E. Intermediate A can also undergo 
elimination to provide the cyclohexadiene C, which reacts with Fe(V)=0 to furnish F 
that can readily rearomatise to 4-(2-propenyl)toluene 9460
B E 93
Scheme 2.23 Proposed Mechanism for the Iron(III)-Catalysed Allylic Oxidation of 
R-(+)-Limonene 90.
2.I.3.6. Metal-Catalysed Allylic Oxidations of As-Steroids
The allylic oxidation of steroids has attracted a great deal of attention, which 
can be attributed to the necessity to derivatise these bioactive intennediates to elicit a 
new biological response. For example, the oxidation of A5-steroids to the 
corresponding 5-en-7-ones inhibit the enzymatic conversion of dihydrolanosterol 
into cholesterol.63 Many metal catalysts have been employed with te/7-butyl 
hydroperoxide to prepare these allylic oxidation products from A5-steroids in good 
yield (Table 2.2).64
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Table 2.2 Metal-Catalysed Allylic Oxidation of Cholesteryl Acetate 95.
Entry
(mol %) (eq) (°C) (h)
Yield
(%)
1 Fe(acac)3(9) 19.5 Benzene 85 24 74
2 RuCl3(0.7) 10 Cyclohexane 20 24 75
3 BiCl3 (10) 10 Acetonitrile 70 20 88
4 CoPPS2 (0.048) 6 Benzene 70 20 80
Treatment of cholesteryl acetate 95 with tris(acetylacetonato)iron(III) (9 mol 
%) and tert-butyl hydroperoxide afforded the corresponding enone 96 in 74% yield, 
albeit using 19.5 equivalents of terf-butyl hydroperoxide (Table 2.2, entry 1). 
Salvador has reported the catalytic bismuth oxidation of 95 to furnish 96 in 88% 
yield (entry 3),66 whereas Miller and coworkers at Merck have described the catalytic 
ruthenium oxidation of 95 with catalytic quantities of RuC13 (0.7 mol %) to generate 
96 in 75% yield (entry 2).67 Finally, Jurado-Gonzalez developed a cobalt(II) 
phosphonate modified silica oxidation to afford 96 in 80% yield (entry 4).68
2.1.3.7. Copper-Catalysed Allylic Oxidations
Robertson and Waters reported the copper-catalysed allylic oxidation using 
copper salts to assist the decomposition of hydroperoxides via Haber-Weiss 
process.35 In 1990, Haynes expanded this process with the decomposition of the 
hydroperoxide 97 using Cu(OTf)2, co-catalysed with Fe(phenanthroline)3(PF6)3. The 
addition of the hydroperoxide-radical to the alkene furnished a mixture of the 
dicarbonyl hydroperoxide 98 and peroxy hemiacetal 99 in 53% overall yield 
(Scheme 2.24).69
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Fe(lll) (3 mol %) 
Cu(OTf)2 (10 mol %)
02) MeCN 
0 °C, 0.5 h
53%
O,
Scheme 2.24 Copper-Catalysed Decomposition of Hydroperoxide 97 Towards The 
Syntheses of Artemisitene and Artemisinin.
The copper catalyst promotes homolytic cleavage of the hydroperoxide 97 to 
provide the dioxetanyl alkyl radical intermediate 100 (Scheme 2.24). The alkyl 
radical 100 is trapped by dioxygen to give the dioxetane hydroperoxide 101, which is 
cleaved to provide the dicarbonyl hydroperoxide 98. Interestingly, the iron catalysis
was ineffective in the absence of the copper salt, which may be attributed to the 
competing reduction of 100 by iron(II) to generate undesired products.70 
Table 2.3 Copper-Catalysed Allylic Oxidation of A5-Sf-Acetoxy Steroid 102.
cat Cu ,,rJ 0ts
AcO'^'Cu
102
teuOOH
MeCN/N2
AcO'^'
103
Entry Catalyst 
(mol %)
'BuOOH
(eq)
Temp
(°C)
Time
(h)
Yield
(%)
1 Cul(l) 6 SO 20 83
2a CuBr (2) 6 55 24 80
3a CuCl(1.5) 6 55 18 81
4a CuCl2 (2) 6 55 24 81
5 Cu(3) 5 50 16 84
"By-products detected by TLC but not detectable in 'H-NiYIR spectrum
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In 1997, Salvador et al reported the copper-catalysed ally lie oxidation of the 
A5-3/?-acetoxy steroid 102 with tert-butyl hydroperoxide to afford 103 in up to 84% 
yield (Table 2.3).71 Treatment of the A5-3/?-acetoxy steroid 102 with a range of 
copper catalysts in the presence of tert-butyl hydroperoxide afforded the enone 
product 103 in high yields.71 Acetonitrile was the optimal solvent, since it allowed 
the oxidation to proceed under lower temperatures and catalyst loading. The optimal 
results were obtained using copper(I) iodide and copper powder, which furnished 
103 in 83% and 84% yield, respectively (Table 2.3, entries 1 and 5). The copper- 
catalysed allylic oxidation protocol exhibited similar reactivity to the previously 
developed methods for the oxidation of A5-steroids, albeit that the reaction was cheap 
and environmentally benign.
Limited progress has been made in copper-catalysed allylic oxidation 
reactions; however, the development of a recyclable surface functionalised silica- 
supported copper catalyst 104 is particularly pertinent (Fig. 2.8). The silica-supported 
catalyst 104 has similar efficiency as the non-supported catalyst, but can be reused in 
subsequent oxidation reactions.72
r°\ V /=\ /=\ p -o
—0-Si'^^N=C-^ j>-C=N—d Cu2+ ^CH3
__ j—C> '—/ H ^—/ 0‘ O
Figure 2.8 Silica-Supported Copper Catalyst 104.
The copper-catalysed allylic oxidation reaction has also been conducted in 
ionic liquids (Scheme 2.25).73 Treatment of the dienes 105 and 107 with copper(II) 
chloride and tert-butyl hydroperoxide in [bmim]PF6 furnished the enones 106 and 
108 in 70% and 53% yield, respectively. The [bmimJPFe can be recycled up to 6 
times, but additional copper(II) chloride (15 mol %) was added in each cycle making 
its utility impractical.74
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CuCI2.2H20 (20 mol %) 
fBuOOH (5 eq)
[bmim]PF6 
60 °C, 4 h O
70% 106
CuCl2.2H20 (20 mol %) 
teuOOH (5 eq)
------------- ►-
[bmim]PFe 
60 °C, 5 h
53% O 108
Scheme 2.25 Combination of Copper-Salt and Ionic Liquid in Allylic Oxidation.
In 2003, Allal reported the metal-catalysed allylic oxidation of a-pinene 109 
with a variety of metal catalysts (Scheme 2.26).75 The allylic oxidation of a-pinene 
109 provided a large mixture of oxidised products with verbenone 111 as the major 
product. Copper(II) chloride was the optimal catalyst for this transfonnation, 
affording the enone 111 in 78% yield (22% of the other isomers). Other metal 
catalysts were inefficient in this oxidation reaction, generating mixtures of products 
in poor yield and with low selectivities.75
107
105
MeCN, o2
109 70 °C1 12 h 110 111 112 113 114 115 116
100%
Scheme 2.26 Metal-Catalysed Allylic Oxidation of a-Pinene 109.
In 1998, Schultz reported the use of a copper-catalysed allylic oxidation 
reaction in the total synthesis of (-)-cepharamine 119 (Scheme 2.27).76 Treatment of 
the lactone 117 with copper(I) bromide and fen'-butyl hydroperoxide afforded the 
enone 118 in 56% yield. Nevertheless, the oxidation reaction required sub- 
stoichiometric copper(I) bromide and a large excess of /ert-butyl hydroperoxide.
81
OMe OMe
CuBr (0.5 eq)
teuOOH (34 eq) 
PhH, 60 °C, 6h 
56%
MeN-
(-)-cepharamlne (119)
Scheme 2,27 Copper-Catalysed Allylic Oxidation in the Total Synthesis of (-)-
Cepharamine 119.
2.1.3.8. Palladium-Catalysed Allylic Oxidations
In 2002, Corey and Yu described the palladium-catalysed allylic oxidation of 
acyclic and cyclic alkenes to generate 1,4-enediones and enones (Scheme 2.28).77,78
Treatment of 1-acetylcyclopentene 120 with Pd(OH)2/C, potassium carbonate and 
tert-butyl hydroperoxide afforded the enedione 121 in 81% yield after 48 hours.78 
Alternatively, treatment of the acyclic enone 122 under analogous conditions
provided the enedione 123 in 90% yield. This protocol provided excellent yields of a
variety of 1,4-enediones under mild conditions.
o
120
Pd(OH)2/C (5 mol %) 
'BuOOH (5 eq)
K2CO3 (0.5 eq) 
DCM, 24 °C, 48 h 
81%
O
121
O
122
Pd(OH)2/C (5 mol %)
'BuOOH (5 eq) o
DCM, 24 0C, 36 h 123 O
90%
Scheme 2.28 Pd(OH)2/C-CatalysedAllylic Oxidation hy Corey et al.
Further studies demonstrated that the 1,4-enediones are formed from the
fragmentation of the mixed peroxide intermediate, which was isolated (Scheme 
2.29).79 For example, treatment of 1-phenylcyclohexene 83 with Pd(OAc)2 (2.5 mol 
%) and potassium carbonate (0.25 eq) afforded the mixed peroxide 124.77 Mimoun 
has reported that palladium(II) carboxylates are converted into RC02Pd(00/Bu) by 
treatment with tert-buiy\ hydroperoxides, which undergo peroxy palladation of
82
alkenes.80 When the substrate has only one y-hydrogen, for example in enedione 125,
the corresponding te/Y-butylperoxy ether 126 is formed (Scheme 2.29).78
Ph
83
Pd(OAc)2 (2.5 mol %) 
fBuOOH (5 eq)
K2C03 (0.25 eq) 
DCM, 0 °C1 72 h 
62%
ooteu
Ph
124
O
125
Pd{OH)2/C (5 mol %) 
teiiOOH (5 eq)
K2CO3 (0.125 eq) 
DCM, 4 °C, 48 h 
81%
O
126 OOteu
Scheme 2.29 Pd(OH)2/C -Catalysed Allylic Oxidation to tert-Butylperoxy Ethers.
The proposed mechanism for the palladium-catalysed allylic oxidation
reaction is outlined in Scheme 2.30. Treatment of Pd(II) with ter/-butyl 
hydroperoxide generates the TluOO 59 by homolytic cleavage.69,81 Hydrogen 
abstraction of alkene 120 with ThiOO 59 provides the alkyl radical 1201, followed 
by transfer of tert-butyl peroxide from 127 to afford the mixed peroxide 128. 82 tert- 
Butylperoxy ether 128 undergoes the base-catalysed elimination of the mixed 
peroxide to furnish the enedione 121.83,84 The enedione 121 could also arise from the
direct capture of 120i with molecular oxygen, followed by hydroperoxide
elimination. Pd(II) is regenerated from the oxidation of Pd(I) 129 with tert-buty\
hydroperoxide to complete the cycle.78
Pd(ll) + teuOOH
+ 'BuOO*59
120
O
1201
teuOOH
teuOOPdX 127
teuOH + Pd(ll) Pd(!)X
teuOOH -J29
Scheme 2.30 Proposed Mechanism of the Pd(OH)2/C-Catalysed Allylic Oxidation.
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The Pd(OH)2/C-catalysed allylic oxidation system is relatively general, but 
the removal of the residual palladium is difficult, making this protocol somewhat 
tedious.85 Nonetheless, Chiu and Liu applied the palladium-catalysed allylic 
oxidation reaction in the synthesis of the core of guanacastepene A 132 (Scheme 
2.31).86 Treatment of the hydroazulenone 130 with Pd(OH)2/C, fer/-butyl 
hydroperoxide and potassium carbonate furnished the enedione 131 in 65% yield
after 52 hours 87
Pd(OH)2/C (5 mol %) 
'BuOOH (10 eq)
K2CO3 (0.5 eq)
DCM, 4 °C> 52 h 
65%
130 131
Scheme 2.31 Palladium-Catalysed Allylic Oxidation Towards the Synthesis of 
Guanacastepene A 132.
2.I.3.9. Rhodium-Catalysed Allylic Oxidations
Rhodium(I) complexes have previously demonstrated poor activity in the 
allylic oxidation reactions using molecular oxygen.28,30 Modest levels of conversion 
combined with harsh reaction conditions made this procedure impractical. Uemura 
and Patil reported that cyclohexene 11 undergoes the allylic oxidation in the presence 
of Rli2(OAc)4 with 70% aqueous /er/-butyl hydroperoxide in acetic acid to afford the 
cyclohexenone 12 and allylic acetate 133 with varying selectivities depending on the 
stoichiometry of cyclohexene (Scheme 2,32),79 For example, 1:1 stoichiometry of 
alkene and oxidant provided 31% yield of 12/133 (9.5:1), whereas a 2:1 
stoichiometry, increased the yield and lowered the selectivity (48%, 4.6: l).79
Interestingly, when the oxidation reaction was perfonned with tert-buty\ 
hydroperoxide in the presence of a radical scavenger (6-fer/-butyl-e>-cresol or 
hydroquinone), oxidation was unaffected. However, when molecular oxygen was
84
used, hydroquinone inhibited the reaction.30 This suggested that the pathway 
involving molecular oxygen is free-radical in nature similar to the Rh(I)-catalysed 
autoxidation, whereas the process involving ter/-butyl hydroperoxide maybe ionic.
O OAc
O
Rh2(OAc)4 (0.5 mol %)
70% aq. teuOOH (1 eq)
11 AcOH, rt, 72 h 12 133
1 eq Of 11 = 31% (12:133, 9.5:1)
2 eq of 11 = 48% (12:133, 4.6:1)
Scheme 2.32 Rh2(OAc)4-CataIysed Ally lie Oxidation of Cyclohexene 11.
In 2004, Doyle et al reported a breakthrough in metal-catalysed allylic 
oxidation by employing Rli2(cap)4 with unprecedented activity.89 The Rh2(cap)4 
catalyst (as low as 0.1 mol %) could perform the allylic oxidations in excellent yield 
at room temperature (Scheme 2.33).
MeO
134
Rh2(cap)4 (0.1 mol %) 
huOOH (5 eq)
K2C03 (0.5 eq) 
DCM, rt, 1 h 
92%
Rh2(cap)4 (1 mol %) 
'BuOOH (10 eq)
O
MeO
135
O
K2C03 (0.5 eq) 
DCM, rt, 24 h 
64%
Rh2(cap)4 (1 mol %) 
'BuOOH (10 eq)
K2C03 (0.5 eq) 
DCM, 40 °C, 3 h 
83%
Scheme 2.33 Rh2(cap)4-Catalysed Allylic Oxidation by Doyle et al
The enhanced catalytic activity was particularly beneficial for the efficient 
oxidation of electron-poor alkenes, which are not reactive generally (Scheme 2.33).
For example, treatment of 1-nitrocyclohexene 136 with Rh2(cap)4 (1 mol %), 
potassium carbonate and tert-butyl hydroperoxide afforded the enone 137 in 64% 
yield.89
OoN
136
138
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The explanation behind the catalytic activity of Rh2(cap)4 is the ability of the 
metal to undergo a 1-electron oxidation.90 Doyle reported that Rh2(cap)4 undergoes a 
reversible oxidation at 55 mV via cyclic voltammetry, which corresponds to a Rh24+ 
< > Rh25+ redox couple.91 The ability of Rh2(cap)4 to undergo a 1-electron oxidation 
(Em = 11 mV), compared to Rh2(OAc)4 and Rh2(pfb)4 (Em =1170 mV and >1800 
mV, respectively) is remarkable.92 The low Em is due to the increased electron 
density of Rh2(cap)4 as compared to the other Rh(II) complexes, suggests that it can 
access the Rh25+ oxidation state more readily.91
The proposed mechanism for the Rh2(cap)4 catalysed allylic oxidation 
reaction is thought to involve a 1-electron oxidation of 140 with tert-butyl 
hydroperoxide to furnish the fe/Y-butyl peroxy radical 59 and the tentatively assigned 
Rh25+ species 141 (Scheme 2.34).69’81 Species 141 is converted to the dirhodium 
peroxyether complex 142 under the reaction conditions, which is evident by the 
colour change from light blue to deep red in dichloromethane. The evidence for the 
generation of the intermediate 142 comes from the UV-visible spectrum of the 
catalyst after addition of tert-butyl hydroperoxide. The data revealed a low-energy 
adsorption at 974 nm (5-5* transitions), which is consistent with a mixed-valent 
dinuclear metal species.93 The dirhodium peroxyether complex 142 was isolated as a 
deep red solid, but efforts to obtain a crystal structure of the complex have been 
unsuccessful.89 te/t-Butyl peroxy radical 59 undergoes the selective hydrogen 
abstraction of alkene 143 to afford the allylic radical 144.94 The recombination of the 
rhodium peroxide with the allylic radical 144 provides the ter/-butyl peroxyether 145 
and regenerates the Rh24+ catalyst to complete the cycle.95 Decomposition of 145 
leads to the enone 146 via proposed mechanism previously outlined.83,84 The 
presence of potassium carbonate was important, since yields were lower in its 
absence.83
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Scheme 2.34 Proposed Mechanism for Rh2(cap)4-Catalysed Allylic Oxidation.
The Rh2(cap)4-catalysed allylic oxidation protocol is superior to the 
previously reported metal systems, however it utilises the most expensive transition 
metal (Fig. 2.9).96 The synthesis and purification of Rli2(cap)4 is also not trivial, 
which mandates the development of a more cost effective alternative.90
Mn ($0.1/oz) < Zn ($l/oz) < Cu ($4/oz) < Ni ($12/oz) < Ag ($46/oz)
« Pd ($754/oz) « Au ($1507/oz) < Pt ($1812/oz) < Rh ($2225/oz)
Figure 2.9 Current Prices of Precious Metals.
2.1.3.10. Manganese-Catalysed Allylic Oxidations
In 2005, Shing reported the manganese-catalysed allylic oxidation in the total 
synthesis of (-)-samaderine Y 40 (Scheme 2.35).26 Treatment of the alkene 147 with 
Mn(0Ac)3.2H20 and /er/-butyl hydroperoxide afforded the enone 148 in 72% 
yield.26
Mn(0Ac)3.2H20 
(10 mol %)
TBS?o
TBSO*
teuOOH (5 eq)
3A MS, EtOAc, rt
72% I H H
148 (-)-samaderine Y 40
Scheme 2.35 Mn(0Ac)3.2H20-Catalysed Allylic Oxidation in the Total Synthesis of
(-)-Samaderine Y 40.
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In 2006, Shing also described the manganese-catalysed allylic oxidation of
several A5-steroids and simple alkenes in good yield using anhydrous fert-butyl
peroxide (Scheme 2.36).97 Treatment of cholesteryl acetate 95 and silyl ether 149 
with Mn(OAc)3.2H20 and ter/-butyl hydi*operoxide provided the enones 96 and 150 
in 87% and 99% yield, respectively. Treatment of pinene 109 under the modified 
standard conditions afforded the enone 111 in 63% yield, whilst the ketal 151 
furnished the enone 152 in 52% yield.78,89 Interestingly, (+)-3-carene 153 afforded 
the over-oxidised enedione 154 instead of the enone. Molecular sieves (3A) were an 
essential additive to remove water from the resulting decomposition of the fe/7-butyl 
hydroperoxide, since the water promotes the disproportionation of Mn(OAc)3.98
'BuOOH (5 eq)
3A MS, EtOAc, rt, 48 h Ac0 
87%
Mn(OAc)3.2H20 
(10 mol %)
95 96
As above (under 02)
63%
109 111
As above (under Ns)
99%
149 150
As above (under 02)
52%
151 152
As above (under 02)
60%
Scheme 2.36 Mn(OAc)3.2H20-Catalysed Allylic Oxidation by Shing et ah
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The proposed mechanism for manganese-catalysed allylic oxidation is similar 
to the palladium-catalysed mechanism (Scheme 2.37).78 Mn3(OAc)9 [Mn(OAc)3 as 
its trinuclear complex] undergoes the loss of AcOH to afford the complex 155.97 
Transfer of'BuOO 59 to the alkyl radical Hi provides the mixed peroxide 156 and 
the manganese complex 157. Complex 155 is regenerated from the series of reactions 
of 157 and 158 with fer/-butyl hydroperoxide. Alternatively, Hi can react with 
molecular oxygen to generate the hydroperoxide 43, followed by decomposition to 
afford the enone 12. The mixed peroxide 156 is assumed to decompose under the 
acidic conditions to give the enone 12.97
teuOOH AcOH
Mn30(0Ac)9
H20 - /
Mn30(0Ac)8 
OOteu 
155 \
'BuOOH \
H0-Mn30(0Ac)8
158
Mn30(0Ac)8 
157
teuO* 'BuOOH
(BuOH
'BuO-a
12
+ teuOH
or 11i
'BuOOH teuOO'SB
Scheme 2.37 Proposed Mechanism for Mn(0Ac)3.2H20-Catalysed Allylic Oxidation.
The Mn(OAc)3-catalysed allylic oxidation reaction was utilised in the late 
stages of the asymmetric total synthesis of platencin 161.99 Treatment of the alkene 
159 with Mn(OAc)3 and terr-butyl hydroperoxide under an oxygen atmosphere 
afforded the enone 160 in 80% yield (Scheme 2.38). The manganese-catalysed allylic 
oxidation protocol was impressive and proves to be a valuable alternative to the 
palladium- and rhodium-catalysed variants due to the lower cost of manganese.97
89
Mn(OAc)3 (0.35 eq) 
'BuOOH (4.8 eq), 02
EtOAc, 23 0C, 16 h
80% Me
Scheme 2.38 Mn(OAc)3-Catalysed Allylic Oxidation in the Total Synthesis of 
Platencin 161.
2.1.4. Regioselectivity in Allylic Oxidations
The ability to control regioselectivity in allylic oxidation reactions has proven 
particularly problematic, especially with flexible cycloalkenes.12 For instance, the 
substrate for these oxidations is generally a tri-substituted cycloalkene, to provide a 
steric bias for allylic hydrogen abstraction.78,89,97
Figure 2.10 Conformation of Tri-substituted Alkenes.
In 1978, Salomon reported the rhodium-catalysed autoxidation reaction of 
allylic trimethylsilyl-, carboethyoxyl- and isopropyl-substituted cycloalkenes 162, 
164 and 167 (Scheme 2.39).100 Treatment of the 3-(trimethylsilyl)cycloalkenes 162 
(where n = 0-3) with RhCl(PPh3)3 and tert-butyl hydroperoxide at 97 °C furnished 
the isomeric enone 163 in 60-84% yield as a single regioisomer.100 Ethyl cyclohex-2- 
enecarboxylate 164 was oxidised under the same conditions to provide a mixture of 
the isomeric enedione 165 and ethyl benzoate 166. Finally, the oxidation of 3- 
isopropylcyclopent-l-ene 167 resulted in a mixture of the isomeric 3- 
isopropylcyclopent-2-en-l-one 168 and 4-isopropylcyclopent-2-en-l-one 169 in 58% 
conversion. The failure to control regioselectivity is attributed to the isopropyl group 
failing to promote allylic C-H bond cleavage in an analogous manner to the 
carboethoxyl or trimethylsilyl group.100
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a™'
RhCI(PPh3)g (1 mol %) 
'BuOOH (2 eq), 02 O -TMS
162
97 0C, 1.5 h 
60-84% 
n^O-3
163
Cr
RhCI(PPh3)3 (1 mol %) 
.C02Et teuOOH (2 eq), 02 O.»^^C°2Et + ^^C02Et
165 (3:1) 166164
97 °C 
51%
RhCI(PPh3)3 (1 mol %) 
fBuOOH (2 eq), 02
167
97 °C
58% 0 168 (4:1) 169
Scheme 2.39 Regioselectivity Issues in Allylic Substituted-Cycloalkene Oxidation.
2.2. Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of 
Cyclopentenes
2.2.1. Preliminary Results and Optimisation of Reaction Conditions
We envisaged that the cyclopentene 175 would provide a high degree of 
control in the regioselective hydrogen abstraction to afford the enones 177/178 (Fig. 
2.11). The cyclopentene 175 would undergo a hydrogen abstraction to afford the 
allyl radical 176, followed by the free-radical recombination, which depending on the 
steric bias of the quaternary centre will furnish either the enone 177 or 178 
regioselectively.
Figure 2.11 Copper(I)-Catalysed Allylic Oxidation of Cyclopentene 175.
Preliminary studies examined the copper(I)-NHC catalysts, which were used 
for the fonnation of the allylic esters from cycloalkenes.102 Substituted- 
cyclopentenes were prepared to test the efficiency and selectivity of the copper(I)- 
NHC-catalysed allylic oxidation reaction. Tertiary- and quaternary-substituted 
cyclopentenes 170-174 were prepared from readily available starting materials
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(Scheme 2.40).103 The methyl cyclopent-3-enecarboxylate 170 was utilised to 
synthesise the tertiary- and quaternary-substituted cyclopentenes as outlined in
Scheme 2.40.104
o
o
OMe
Allyl bromide
NaH, THF 
90%
OMe cat. Grubbs II
DCM
93%
Me02C C02Me
6
cat. Grubbs It 
DCM 
85-93%
R = Ph
(p-H, OMe, F)
NaCI
DMSO, HaO 
65%
R. OH
PivCI
DMAP
DCM
>90%
IDA
R-X, THF 
80-95%
R= Me, Allyl, Pr
Alkyl-172 = Me, Allyl, Pr LiAIH4
Aryl-172 = Ph, p-OMe-Ph, p-F-Ph Et20
87%
UAIH4
Et20
90-95%
TIPSCI
DMAP, Imid 
DCM 
92%
.OH
Alkyl-173 = Me, Allyl, Pr 
Aryl-173 = Ph, p-OMe-Ph, p-F-Ph
O
R
X
OMe
Allylmagnesium
bromide
THF
98%
R OH
cat. Grubbs II
DCM
82-89%
R OH
6
R= Me, Allyl, Pr, Ph, p-F-Ph, p-OMe-Ph
TBSOTf
DIPEA
DCM
80-87%
R OTBS
6™
Scheme 2.40 Synthesis of Tertiary- and Quaternary-Substituted Cyclopentenes.
Treatment of the tertiaiy-substituted cyclopentene 171 with a range of 
copper(I) and copper(II) salts (with and without NHC ligands) using different 
oxidants furnished the mixture of enones 179/180 in 40% yield and with poor 
regioselectivity, favouring of 179 (Scheme 2.41).
,OTlPS
171
cat. Cu 
[o], rt, 72 h 
5-40%
,OTIPS .OTIPS
+ &°
O
179 | (3:1) | 180
cat. Cu = Cu(l)X, Cu(ll)X2, Cu(l)X-NHC 
[o] = fBuOOH, H202, 02 and PhC(Me)2OOH
Scheme 2.41 Copper-Catalysed Allylic Oxidation of Cyclopentene 171.
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The cyclopentene 171 presumably undergoes axial abstraction of either 
prochiral hydrogens to generate the allyl radical 171i (Fig. 2.12). The major enone 
179 would arise from the termination of the 'BuOO and the allyl radical 1711, 
followed by the decomposition of the subsequent mixed peroxide (Path A). 
Additionally, the minor enone 180 would arise from the termination of the 'BuOO 
and the allyl radical 1711 (Path B). The formation of enone 180 could be prevented 
with elaborate functionalisation of the tertiary R group, preventing this 
recombination. However, it was envisaged that quaternary-substituted cyclopentenes 
would provide a more sterically demanding environment for the allylic oxidation 
thus avoiding the minor pathway obseived in the tertiary-substituted cyclopentenes 
(Path B).
HJ
H
171
o'°
171i
R
c
>
1711
Path A MAJOR Path B MINOR
O
R
O
179 180
Figure 2.12 Proposed Regioselectivity Pathways of Tertiaiy-Substituted 
Cyclopentene 171.
This reasoning was tested on the quaternary-substituted cyclopentene 173 a 
using different copper(I)-NHC catalysts and oxidants in acetonitrile at room 
temperature (Table 2.4). Gratifyingly, improved regioselectivity was observed for the 
oxidation of (l-methylcyclopent-3-en-l-yl)methyl pivalate 173a to the enones 181a 
and 182a under the copper(I)-catalysed conditions (Table 2.4). Treatment of 173a
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with copper(I) chloride and terZ-butyl hydroperoxide afforded a mixture of enones 
181a/182a (12:1) in 12% yield (Table 2.4, entry 1). This was further improved using 
the more sterically hindered chloride catalyst 183 in 29% yield, whereas the bromide 
184 afforded a reduction in regioselectivity (entries 2 and 3). The more sterically 
hindered complex 185 provided similar reactivity to the chloride 183, whilst 
investigations into other oxidants were unsuccessful (entries 4-6).
Table 2.4 Preliminaiy Copper(I)-NHC-Catalysed Allylic Oxidation of Quaternary- 
Substituted Cyclopentene 173a.a
^'OPiv Cu(l)-NHC (5 mol %)
Oxidant 
MeCN, rt, 72 h
OPiv
173a
O
181a
\/~'OPiv
182a
'Pr
f=\
'Pr
183 184
'Tib
'Pr i 'Pr 
Cl
185
Entry Catalyst 
(5 mol %)
Oxidant 
(5 eq)
181a:182ab Yieldc
(%)
1 CuCl 'BuOOH 12:1 12
2 183 'BuOOH 12:1 29
3 184 'BuOOH 8:1 28
4 185 'BuOOH 12:1 27
5d 183 o2 - 0
6 183 PhC(Me)2OOH 12:1 17
“Reactions were performed on 0.25 mmol scale. bDetermmed by ^-NMR on 
crude mixtures. 'Isolated yields. dl atm of O2.
It was envisioned that additives would improve the efficiency of the reaction
m OQ
through their ability to promote elimination of the peroxyether intermediate. ’ ’ 
Table 2.5 outlines this investigation, in which the addition of 3A MS and bases was 
examined. For example, the addition of 3A MS did not improve the efficiency, 
providing similar mixtures of the enones (Table 2.5, entry 1). Sodium acetate was
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detrimental in the oxidation reaction and resulted in the reduction of regioselectivity 
in poor yield (entry 2). Carbonate bases were more effective with enhanced 
efficiency and lower reaction times (entries 3 and 4). Although the yield was 
improved, we believed that the poor conversion was due to the premature 
decomposition of the ter/-butyl hydroperoxide under the reaction conditions, which 
prompted examination of the rate of addition of the oxidant.105 
Table 2.5 Additive Screen in Copper(I)-NHC-Catalysed Allylic Oxidation of
Quaternary-Substituted Cyclopentene 173a.a
X/'-'-OPiv
O
Cu(l)-NHC 183 (5 mol %) \
teuOOH (5 eq) £ + X/'-OPivo*°
Additive
173a MeCN, rt 181a 182a
Entry Additive Time 181a:182ab Yield"
(1 eq) (h) (%)
id 3A MS 72 12:1 27
2 NaOAc 72 7:1 30
3 k2co3 48 12:1 47
4 NaHC03 24 12:1 49
5e NaHC03 24 18:1 65
6* NaHCOs 18 18:1 79
“Reactions were performed on 0.25 mmol scale. bDetermined
by ^-NMR on crude mixtures. isolated yields. d200
mg/mmol. cSyringe pump addition at 0.3 eq/h. fReaction
performed at 0.5 M concentration.
Gratifyingly, treatment of 173a with the syringe-pump addition of the tert- 
butyl hydroperoxide over 12 hours, afforded 181a/182a in 65% yield, favouring 
181a with 18:1 regioselectivity (Table 2.5, entiy 5). An additional improvement in 
the oxidation reaction was obtained at higher concentration (0.1 M vs. 0.5 M) and in 
this case, enones 181a/182a were furnished in 79% yield with excellent 
regioselectivity (entry 6). Interestingly, resubjection of the tertiary-substituted
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cyclopentene 171 to the optimal conditions furnished a mixture of 179/180 in 59%
yield with similar regioselectivity (Scheme 2.42)
,OTIPS Cu(l)-NHC 183 (5 mol %) 
teiiOOH (5 eq)
171
NaHCOg (1 eq) 
MeCN, rt, 18h 
59%
Scheme 2.42 Resubmission of the Optimal Conditions to Tertiary-Substituted 
Cyclopentene 171.
2.2.2. Scope and Limitations
With the optimal conditions in hand, the scope of the copper(I)-NHC- 
catalysed ally lie oxidation was investigated. Table 2.6 outlines the resulting ally lie 
oxidation of the CIL-OPiv-substituted quaternary cyclopentenes 173 to the 
corresponding enones 181/182. The oxidations all proceeded at room temperature 
with the syringe pump addition of ter/-butyl hydroperoxide over 18 hours, utilising 5 
mol % of copper(I)-NHC catalyst 183.
Table 2.6 Scope of CH2-OPiv-Substituted Quaternary Cyclopentenes 173.a
a Cu(l)-NHC 183 (5 mol %) _
nv/'-'OPiv —. *r-__v Ro
173
teuOOH (5 eq)
NaHC03 (1 eq) 
MeCN (0.5 M), rt, 18h
OPiv R\/^OPiv
182
Entry R 181:182b Yieldc (%)
1 Me 173a 18:1 80
2 Allyl 173b >19:1 77
3 «-Propyl 173c >19:1 81
4 />OMe~Ph 173d >19:1 85
5 Ph 173e >19:1 84
6 p-F-Ph 173f >19:1 85
"Reactions were performed on 0.25 mmol scale with syringe pump 
addition of rBuOOH at 0.3 eq/h. determined by d-NMR on crude 
mixtures, isolated yields.
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Alkyl substituents with increased steric bulk provided improved 
regioselectivity as expected (Table 2.6, entries 1-3). Substrates bearing aryl 
substituents underwent reaction with exceptional yields and regioselectivities; both 
the electron-deficient and electron-rich examples were suitable substrates (entries 4- 
6). Interestingly, reaction of the allyl substituted cyclopentene 173b afforded the 
enone 181b without competitive oxidation of the acyclic alkene (entry 2). This was 
attributed to the 4 kcal/mol difference in BDE between the cyclic and acyclic allylic 
hydrogens (cyclic ~ 82 kcal/mol, acyclic ~ 86 kcal/mol).9
Additional studies focused on other substituted cyclopentenes. Table 2.7 
outlines the allylic oxidation reaction of the ester-substituted quaternary 
cyclopentenes 172 to the corresponding enones 186/187.
Table 2.7 Scope of C02Me-Substituted Quaternary Cyclopentenes 172.a
M Cu{l)-NHC 183 (5 mol %)
2 fBuOOH (5 eq)
NaHCOg (1 eq)
MeCN (0.5 M), rt,18h
172
Entry R
186
186:187b
187
Yield" (%)
1 Me 172a 10:1 77
2 Allyl 172b 14:1 74
3 n-Propyl 172c 16:1 80
4 jy-OMe-Ph 172d >19:1 82
5 Ph 172e >19:1 84
6 jr^-F-Ph 172f >19:1 84
"Reactions were performed on 0.25 mmol scale with syringe pump 
addition of 'BuOOH at 0.3 eq/h. bDetermined by ^-NMR on crude 
mixtures, isolated yields.
The copper(I)-NHC-catalysed allylic oxidation reactions of the electron- 
deficient ester-substituted cyclopentenes 172 proceeded with lower regioselectivities, 
albeit in excellent yields. This study illustrates the same trend in selectivity with 
substrates bearing bulkier alkyl groups undergoing more selective oxidation (Table
R .COoMe R. C02Me
6 * 5-°
R CO
5
97
2.7, entries 1-3). Substrates bearing aryl substituents once again undergo completely 
regioselective oxidation (entries 4-6).
Table 2.8 outlines the resulting allylic oxidation of the ter/-butyldimethylsilyl 
protected hydroxy-substituted quaternary cyclopentenes 174. The copper(I)-NHC- 
catalysed allylic oxidation reaction furnished the enones 188/189 with excellent 
yields (Table 2.8, entries 1-6). Interestingly, the methyl-substituted derivative 174a, 
which provided lower selectivity for 172a and 173a, underwent oxidation with 
excellent results in this case (entry 1).
Table 2.8 Scope of OTBS-Substituted Quaternary Cyclopentenes 174.a
R OTBS 6
Cu(l)-NHC 183 (5 mol %) 
'BuOOH (5 eq)
NaHC03 (1 eq)
R OTBS
A *
R OTBSa-0
MeCN (0.5 M), rt, 18 h
174 188 189
Entry R 188:189b Yield" (%)
1 Me 174a >19:1 72
2 Allyl 174b >19:1 70
3 n-Propyl 174c >19:1 75
4 /?-OMe-Ph 174d >19:1 81
5 Ph 174e >19:1 81
6 jo-F-Ph 174f >19:1 83
“Reactions were performed on 0.25 mmol scale with syringe pump 
addition of 'BuOOH at 0.3 eq/h. ^Determined by ^-NMR on crude 
mixtures, isolated yields.
The hydroxyl-substituted enones provide valuable motifs for further 
derivatisation, which are not normally prepared via the metal-catalysed allylic 
oxidation (Scheme 2.43). For example, the tertiary alcohol 190, where Ri = H, can be 
prepared from the enone 191 using stoichiometric selenium dioxide.107 Alternatively, 
the tertiary silyl ether 192, where R\ — TMS, is available from the tertiary alcohol 
193 through a five-step sequence (Scheme 2.43).108 These reactions validate the 
synthetic value of the copper(I)-NHC-catalysed allylic oxidation reaction of
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homoallylic alcohols to the corresponding enones, which circumvents the necessity 
for toxic reagents and multi-step transformations.
X.O
193
5 steps
/.......—
where Ri = TMS, 
R2 = Alkyl
R2. ,OR-|
'o
190 or 192
Se02
where Ri = H, 
r2 = Alkyl
191
Scheme 2.43 Traditional Syntheses ofEnone 190 or 192.
Based on the data, mechanistic pathways are proposed for the fonnation of 
the enones 195 and 196 from the cyclopentene 194 (Figure 2,13). Analogous to the
proposed mechanism for the tertiary-substituted cyclopentenes, the cyclopentene 194 
undergo allylic hydrogen abstraction to afford the allyl radical 1941 (Fig. 2.13). The 
termination of the 'BuOO* 59 with 1941 would favour path A over path B due to 
steric encumbrance of the quaternary centre, leading to the highly regioselective 
formation of enone 195 over 196.
Figure 2.13 Proposed Pathways for Regioselectivity of Quaternary-Substituted 
Cyclopentenes 194.
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2.2.3. Total Synthesis of (±)-Untenone A 
2.2.3.I. Background and Significance
Untenone A 197, a marine natural product, derived from the biosynthetic 
pathway of manzamenones, was isolated from the Okinawan marine sponges of the 
genus Plakortis by Kobayashi et al in 1993. It provides a dienophile in the 
biosynthesis of manzamenones, more specifically, manzamenone A 198.109
o
.i'GOjMs
v CH2(CH2)14CH; 
OH
(±)-untenone A (197)
Untenone A 198 is reported to inhibit the cell proliferation of L1210 cells and the 
activity of DNA polymerases. Scheme 2.44 highlights the proposed biosynthetic 
pathway of manzamenones and the role of untenone A 197. Manzamenone A 198 is 
thought to be derived from the intennolecular [4+2] cycloaddition between the 
dienophile 200 (dehydrated 199) and the diene 201 (dehydrated precursor of 199) 
(Scheme 2.44). The isolation of 199 therefore provides compelling evidence for this 
biosynthesis proposal.109
O OMe Q c16H33 COOH
HOOC
,COOH
200
198
Scheme 2.44 Proposed Biosynthesis of Manzamenone A 198.
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There have been a plethora of racemic and asymmetric total syntheses of 
untenone A 197. In 1994, Takeda el ah described the first racemic total synthesis of
(±)-untenone A 197 in 5 steps (Scheme 2.45). 
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Scheme 2.45 First Reported Racemic Total Synthesis of (±)-Untenone A 197,
Treatment of /?-(phenylthio)acryloyl fe/7-butyldimethylsilane 202 with the 
lithium enolate 203 afforded the cyclopentenols 204/205 in 56% yield as 1:7 mixture 
of diastereomers (Scheme 2.45).110 Cyclopentenols 204/205 were individually 
subjected to deprotection under TBAF conditions to famish the cyclopentenol 206 in 
88% yield. MOM protection of 206 provided the ether 207, which was subjected to 
methoxycarbonylation with LDA and Mander’s reagent provided a 2:1 epimeric 
mixture of the |3-keto esters 208 in 50% yield. Treatment of the /?-keto esters 208 
with AcOH/HCl (50:1) afforded (±)-untenone A 197 in 54% yield along with its 
isomer 209 in 10% yield. The expedient 5-step synthesis provides (±)-untenone A 
197 in 10.9% overall yield.110
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Scheme 2.46 First Reported Asymmetric Total Syntheses of (+)- and (-)-Untenone A 
197,
In 1995, Yamada et al. described the first asymmetric total synthesis of (+)- 
and (—)-untenone A 197 in 13 steps from D-tartaric acid 210 (Scheme 2.46).111 
Treatment of the cyclopentenone 211 (prepared in 7 steps from D-tartaric acid 210) 
with the alkylsamarium(III) reagent afforded a diastereomeric mixture of 212/213 in 
98% yield (Scheme 2.46).112 Methoxy methyl protection of the alcohol 212 and 
subsequent TBAF deprotection/Jones oxidation furnished the enone 214 in 89% 
yield.111 Acylation of the enone 214 provided a mixture of /Tketo esters in a 3:2 
diastereomeric mixture. Acid-mediated MOM deprotection of 214 to provided (+)- 
untenone A 197 in 26% overall yield from 211, and 13 steps from D-tartaric acid 
210. (-)-Untenone A 197 was prepared from the diastereomeric alcohol 213 in a 
comparable 26% overall yield from 211, and 13 steps from D-tartaric acid 210.111,112
The asymmetric syntheses of (+)- and (-)-untenone A 197 were important 
because the two enantiomers exhibit a Cotton effect, whilst natural untenone A 197 
did not exert this effect, demonstrating that the natural product is actually racemic.111
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2.2.3.2. Total Synthesis of (±)-Untenone A
We envisaged that (±)-untenone A 197 would be derived from the 
acylation/deprotection of enone 217 (Scheme 2.47). Enone 217 is a common 
intermediate reported in previous total syntheses and a product that can be accessed 
from the regioselective copper(I)-NHC-catalysed allylic oxidation of the 
cyclopentene 218.110,111 The cyclopentene 218 is readily prepared via the ring-closing 
metathesis of the known Zhs-allyl tertiary alcohol 219.113
(±)'Untenone A (197) 216 217
Cu(l)-NHC
oxidation
Scheme 2.47 Retroanalysis of (±)-Untenone A 197.
The total synthesis of (±)“Untenone A 197 commenced with the treatment of 
methyl heptadecanoate 220 with allylmagnesium bromide to afford the tertiary 
alcohol 219 in 98% yield (Scheme 2.48).113 Hoveyda-Grubbs II ring-closing 
metathesis of alcohol 219 followed by the TMS protection provided the cyclopentene 
218 in 91% yield. This set up the key copper(I)-NHC-catalysed allylic oxidation.102 
Gratifyingly, exposure of the cyclopentene 218 to the modified allylic oxidation 
conditions furnished the cyclopentenone 217 in 69% yield as a single regioisomer. 
Due to the lipophilic nature of the cyclopentene 218, the solvent was changed to 
propionitrile for the dissolution of the substrate under the reaction conditions, which 
allowed for complete conversion after 48 hours. Treatment of the enolate generated 
from ketone 217 with Mander’s reagent and concomitant acid deprotection afforded 
(±)-untenone A 197 in 70% yield.114 This represents the most efficient (43% overall
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yield) and highly expedient (4 steps from methyl heptadecanoate 220 or 3 steps from
known alcohol 219) total synthesis of (±)-untenone A 197 developed to date.
H3C(H2C)14H2C
220
o
A
Allylmagnesium 
bromide (2.5 eq)
OMe THF, 0 °C - rt 
98%
4 steps from 220 
or
3 steps from 221 
43% overall yield
H3C(H2C)14H2C^OH 
219 V
i. HG-II 
(2.5 mol %) 
DCM, 2 h
O
/\.t,*C02Me
^-4-CH2(CH2)14CH3
OH
(±)-untenone A (197)
ii. TMSOTf (1.2 eq)
DIPEA (1.5 eq)
DCM, 1 h 
91%
Cu(l)-NHC 183 
(5 mol %) 
teuOOH (5 eq) 
NaHCOg (1 eq)
I. LDA, HMPA 
NCC02Me (3 eq)
THF, -78 °C, 3 h
HgCfHaCJuHaC^/OTMS
5
218
EtCN 
rt, 48 h 
69%
II. c-HCI, MeOH 
rt, 1 h 
70%
-CH2(CH2)14CH3 
OTMS 
217
Scheme 2.48 Highly Expedient and Efficient Total Synthesis of (±)-Untenone A 197.
2.3. Regioselective Copper (I)-NHC-Catalysed Ally lie Oxidation of Cyclohexenes 
2.3.1. Preliminary Results and Optimisation of Reaction Conditions
Having established that copper(I)-NHC catalysis provides highly 
regioselective and efficient allylic oxidations of prochiral quaternary-substituted 
cyclopentenes, we elected to examine related cycloalkene systems.102
Ri
O'"-
222I 222
O'
222II
O'o
223
HiJO'
224
Ri
225
Figure 2.14 Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of Ternaiy- 
Substituted Cyclohexene Concept.
We envisioned that the temary-substituted cyclohexene 222 would undergo a 
regioselective hydrogen abstraction to afford the allyl radical 222i (Path A) rather
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than 222ii (Path B) depending on the steric environment (Fig. 2.14). Cyclohexene 
222 could theoretically lead to three oxidation products, the enones 223, 224 and 
225.
The preparation of the alkoxy substituted-cyclohexenes 227 was achieved via 
the epoxidation/ring-opening of commercially available 1,4-cyclohexadiene to 
famish the cyclohexenol 226, which can be further derivatised with an array of 
electrophiles (Scheme 2.49).115
o mCPBA (1 eq) NaHC03(1 eq)DCM/H20 (1:1) 
0°C, 12 h 
70%
O LiAIH4 (1.5 eq)Et20 
0 0C, 2h
95%
Cr" R-X80-95% cr
226 227
Scheme 2.49 Synthesis of Oxygen Ternary-Cyclohexenes 227.
Treatment of the pivalate ester substituted-cyclohexene 227a with the 
copper(I)-NHC conditions afforded a mixture of the enones 228a/229a in 83% yield 
as a 1:1 mixture of constitutional isomers (Scheme 2.50).92 This result indicates that 
hydrogens at both allylic sites are capable of equal abstraction to generate the allyl 
radicals 222i and 222ii, which undergoes free-radical termination (Fig. 2.11).
H Cu(l)-NHC 183 (5 mol %)
teuOOH (5 eq)
T —►
O
227a
NaHC03 (1 eq) 
MeCN, rt, 24 h 
83%
0y'Bu +
° 0
228a 229a
Scheme 2.50 Initial Investigation into the Regioselective Copper(I)-NEC-Catalysed 
Allylic Oxidation of OPiv-Substituted Cyclohexene 227a.
The selectivity for the formation of 229a is interesting, since there are two 
inequivalent positions in 222ii, whereas 222i provides a prochiral intennediate that 
leads to the same constitutional isomer. We envisaged that other groups might 
influence regioselective allylic hydrogen abstraction.
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Table 2.9 Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of OPiv- 
Substituted Cyclohexene 227a Optimisation.0
H 227a
Cu(l)~NHC (5 mol %) 
feuOOH (5 eq)
Additive 
Solvent, rt
O^/Bu
T
O Xr VO O^'BuTo
228a 229a 230a
Entry Cu(I)-NHC Additive Solvent 
(1 eq)
Conv.
(%)
228a:229a:230ab Yieldc
(%)
ld 183 NaHCOs MeCN 100 1:1:0 83
2e 183 MeCN 79 1:1:0 55
3e 183 Na2C03 MeCN 16 1:1:0 45
4e 183 K2CO3 MeCN 75 1:1:0 41
5s 183 NaHCOs MeCN 74 1:1:0 59
6e 184 NaHC03 MeCN 62 1:1:0 47
T 185 NaHCOs MeCN 65 1:1:0 47
8e 183 NaHCOs DCM 52 1:1:0 26
9e 183 NaHCOs PhH 41 1:1:0 19
10e,f 183 NaHCOs MeCN 52 1:1:0 42
“Reactions were performed on 0.25 mmol scale under air for 48 hours. '’Determined by ^l-NMR
on crude mixtures, isolated yields. dSyringe pump addition of oxidant at 0.3 eq/h and stirred for 
24 hours. eOxidant added in one portion. Performed at 60 °C.
Table 2.09 outlines the optimisation of this transformation. Treatment of 
227a under the standard conditions afforded a 1:1:0 mixture of the enones 
228a/229a/230a in 83% yield using copper(I)-NHC catalyst 183, sodium bicarbonate 
and syringe-pump addition of fe/Y-butyl hydroperoxide (Table 2.09, entry 1). The 
addition of the hydroperoxide in one portion in the absence of base provided the 
same selectivity, albeit with lower yield (entiy 2). Other inorganic bases provided
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lower yields with comparable levels of regioselectivity, as did various copper(I)- 
NHC catalysts, solvents and elevated reaction temperatures (entries 3-10).
2.3.2. Scope and Limitations
Additional studies focused on the examination of substituents to control 
regioselectivity using the optimised conditions summarised in Table 2.10. 
Interestingly, the phenyl carbonate 227b and carbamate 227c provided a 2:1 mixture 
of 228b/229b and 228c/229c, whereas the tosyl carbamate 227d furnished a 10:1 
mixture of 228d/229d (entries 2-4). This result was intriguing since the former have 
sp2 attachment, whereas the latter is sp3. Hence, the SO2 linker is more flexible and 
may lead to 7i-7r-stacking with the alkene to shield the hydrogen from subsequent 
abstraction (Fig 2.15).
Figure 2,15 Proposed Tv-Stacking Model for Phenyl Carbamate 227c vs. Tosyl 
Carbamate 227d.
Additionally, the TBS ether 227e and TBDPS ether 227f provided a 6:1 and 
11:1 mixture of 228e/229e and 228f/229f, respectively (Table 2.10, entries 5-6). This 
observation is somewhat surprising as silyl ethers generally have decreasing A- 
values as the silyl group increases in size (OTMS = 1.31, OTBS = 1.06, OTBDPS = 
0.56 kcal/mol) compared to the alkyl ethers (OMe = 0.75, OEt = 0.90 kcal/mol), 
owing to the longer O-Si bond,120 Hence, although the A-value predicts the TBS 
ether should provide enhanced selectivity compared to the TBDPS ether, this is not 
the case. Gratifyingly, the methyoxy ethyl ether 227h afforded a >19:1 mixture of
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228h/229h in 75% yield. Interestingly, the methoxy methyl ether 227g, which should 
be similar in size to the methoxy ethyl ether 227h provided a 6:1 mixture of 
228g/229g, which suggests that this is the result of a conformational bias rather than 
a steric preference (entry 7 vs. entiy 8).
Table 2.10 Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of O- 
Substituted Cyclohexenes 227 Scope.0
Cu(l)-NHC 183 (5 mol %) 
R teuOOH {5 eq)
227
NaHCOg {1 eq) 
MeCN, rt, 24 h O
228
+
O
229
Entry R 228:229b Yield" (%)
1 OCO'Bu 227a 1:1 83
2 0C02Ph 227b 2:1 83
3 OCONHPh 227c 2:1 82
4 OCONHTs 227d 10:1 81
5 OTB S 227e 6:1 75
6 OTBDPS 227f 11:1 74
7 OCH2OMe 227g 6:1 73
gd 0(CH2)20Me 227h >19:1 75
“Reactions were performed on 0.25 mmol scale with syringe pump 
addition of 'BuOOH at 0.3 eq/h. determined by ‘H-NMR on crude 
mixtures, isolated yields. dAfter 48 hours.
Table 2.11 outlines the study of the oxidation of C-substituted cyclohexenes 
under the optimal conditions. Primary alcohols with varying protecting groups: 
electron deficient (pivalate ester 231a) and electron rich (te/Y-butyldiphenyl silyl 
ether 231b) all provided similar selectivity for the enones 232a/233a and 232b/233b
(Table 2.11, entries 1-2). From these observations, it was postulated that electronic 
factors did not govern the regioselectivity, either in the allylic hydrogen abstraction 
or the termination processes. The size of the substituent does not seem to influence
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the regioselectivity, since substitutions with a methylene linker have comparable A- 
values [CH2CH3 = 1.75, CH2C(CH3)3 = 2.0 kcal/mol].121 
Table 2.11 Regioselective Copper(I)-NHC-Catalysed Ally lie Oxidation of C- 
Substituted Cyclohexenes 231 Scope.a
Cu(l)-NHC 183 (5 mol %) 
'BuOOH (5 eq)
NaHC03 (1 eq) 
MeCN, rt, 24 h
233
Entry R 232:233l1 Yieldc (%)
1 CH2OCO'Bu 231a 3:1 78
2 ch2otbdps 231b 3:1 83
3 CH(CH3)OTBS 231c 7:1 74
4 CH(CH3)OTBDPS 231d 9:1 81
5 C(CH3)2OTBS 231e 12:1 S3
"Reactions were performed on 0.25 mmol scale with syringe pump 
addition of 'BuOOH at 0.3 eq/h. bDetermined by ^-NMR on crude 
mixtures, isolated yields.
Reaction of the secondary TBS ether 231c under the optimal conditions 
afforded a 7:1 mixture of 232c/233c in 74% yield, which is further improved when 
the TBDPS ether 231d is used as a substrate (Table 2.11, entries 3 and 4). 
Interestingly, the secondary substituent provided a significant improvement (entries 3 
vs. 5), which was predicted as the A-values rise for increasing carbon substitution (Et 
= 1.75, 'Pr = 2.15, rBu = >4.5 kcal/mol).121 With this trend in mind, it was logical to 
prepare the ternary TBS ether 23le. Gratifyingly, the ternary TBS ether 23le 
furnished a 12:1 mixture of 232e/233e in 83% yield, indicating that for carbon 
substituents the steric parameter is critical (entry 5).
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Table 2.12 Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation ofN- 
Substituted Cyclohexenes 234 Scope.0
Cu(i)-NHC 183 (5 mol %) 
R 'BuOOH (5 eq)
234
NaHC03 (1 eq) 
MeCN, rt, 24 h
Entry R 235:236b Yield" (%)
1 NPhth 234a 10:1 83
2d NHTs 234b 10:1 83
3d NHBoc 234c 14:1 72
4d NHTFA 234d 14:1 74
5d N(CH3)Boc 234e 16:1 69
6 NBocOBoc 234f >19:1 75
“Reactions were performed on 0.25 mmol scale with syringe pump 
addition of 'BuOOH at 0.3 eq/h. bDetermined by ^-NMR on crude 
mixtures, isolated yields. dAfter 48 hours.
A^-substituted cyclohexenes provided excellent regioselectivities in all cases 
with a plethora of protecting groups, with both secondary and tertiary nitrogen 
examples demonstrating exceptional reactivity (Table 2.12). Treatment of the 
phthalimide substituted cyclohexene 234a under the optimal conditions furnished a 
10:1 mixture of 235a/236a in 83% yield after 24 hours (Table 2.12, entry 1). The 
allylic oxidation of compounds containing a nitrogen substituent can be troublesome 
because of chelation to metal catalysts.122,123 Interestingly, the sulfmamide 234b, 
carbamate 234c and amide 234d reacted in good yield and with excellent selectivity 
(entries 2-4). The incorporation of the labile Boc and TFA protecting groups allows 
for the facile removal using acid (trifluoroacetic acid for the Boc group) or base 
(potassium carbonate/methanol for the TFA group) to access the free amine.124 The 
tertiary carbamate 234e provided a 16:1 mixture of 235e/236e in 69% yield, 
compared to the analogous secondary Boc carbamate 234c which afforded a 14:1
mixture, demonstrating that the additional substitution enhances the regioselectivity
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(entry 5 vs. entry 3). This is shown to great effect with the employment of the 
sterically demanding iV-Boc hydroxylamine 234f, which furnished a >19:1 mixture 
of 235f/236f in 75% yield.
The concept of copper(I)-NHC-catalysed allylic oxidation of temary- 
substituted cyclohexenes provides good regioselectivity for the oxygen, carbon and 
nitrogen substitutions. The regiocontrol for the carbon and nitrogen substrates is 
related to the steric bulk of the substituent (estimated from A-values), whereas the 
oxygen substituent is related to the conformation.
It was proposed that the electronic aspects could override steric factors in the 
case of the oxygen substitution, with hyperconjugation potentially playing a key role 
in this transformation.125 This is highlighted for the methoxy methyl ether 227g and 
methoxy ethyl ether 227h.126 In these two systems, the two oxygen groups prefer to 
be in the Gauche confonner, owing to the dipole interactions of the oxygen lone 
pairs. This Gauche interaction impedes bond rotation, effectively making the 
system more rigid.128
Cu(l)-NHC 183 (5 mol %)
'\/\^Phth teuOOH (5 eq) .NPhth
237
NaHCOg (1 eq) 
MeCN, rt, 24 h 
85% 238
OCONHTs
239
Cu(l)-NHC 183 (5 mol %) 
teuOOH (5 eq)
NaHC03 (1 eq) 
MeCN, rt, 24 h
79%
OCONHTs
240
Scheme 2.51 Highly Regioselective Copper(I)-NHC-Catalysed Allylic Oxidation of 
Tri-Snbstituted Alkenes 237 and239.
It has been reported that tri-substituted cycloalkenes provide exclusively one 
regioisomer in the metal-catalysed allylic oxidation using /er/-butyl hydroperoxide, 
with the oxidation favouring the least hindered tenninus of the alkene.77,89,97 It was
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envisaged that the combination of ring substituents and alkene substitution would 
provide enhanced regioselectivity.
Treatment of the phthalimide 237 and the tosyl sulfinamide 239 under the 
optimal conditions afforded the enones 238 and 240 in 85% and 79% yield, 
respectively with excellent selectivities of >19:1 (Scheme 2.51). Figure 2.16 
highlights the proposed model for the increased regioselectivity with the tri- 
substituted alkene providing supplemental steric hindrance for the a-hydrogen to the 
R group.
fBuOO*
H
237 or 239
H 'H
<
6
\o
 
<
6
\o
^ 'T _
Figure 2.16 Proposed Model for The Enhanced Regioselectivity of Tri-Substituted 
Alkenes 237 and 239.
Interestingly, when the methyl group is placed on the other end of the alkene, 
e.g. phthalimide 241, the major oxidation product is that where reaction has occurred 
at the hindered side of the alkene (Scheme 2.52). Phthalimide 241 provides 
competitive hydrogen abstraction, with the methyl and phthalimide groups offering 
differentiating steric hindrance to generate the enones 242 and 243.
H Cu(l)-NHC 183 (5 mol %)
NPhth teiiOOH (5 eq)
241
NaHC03 (1 eq) 
MeCN, rt, 24 h 
78%
Scheme 2.52 Substitution Competition Experiment of 241.
These motifs are synthetically useful building blocks, with the cyclohexenone 
242, essentially a a-substituted-amino enone, whereas cyclohexenone 243 would 
generally be prepared by a selenium dioxide oxidation.54 We envisage that increased
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regiocontrol can be achieved with careful manipulation of the substituents (type and 
position) to access either enones. Enantiopure phthalimide (/?)-237 was prepared by 
the Maruoka asymmetric allylation, 2nd Generation Hoveyda-Grubbs ring closing
metathesis and Mitsunobu reaction sequence in 95% enantiomeric 
Treatment of the enantiopure phthalimide (/?)-237 under the optimal 
furnished the enone (S)-238 in 85% yield as a single regioisomer, 
importantly, with preservation of enantiopurity (Scheme 2.53).
"O
Cu(l)-NHC 183 (5 mol %)
,NPhth 'BuOOH (5 eq) ^NPhth
(fl)-237
95% ee
NaHC03 (1 eq) 
MeCN, rt, 24 h
85%
V6 (S)‘238
92% ee
129excess, 
conditions 
and more
Scheme 2.53 Stereospecific Copper(I)-NHC-Catalysed Allylic Oxidation of 
Enantiopure Phthalimide (R)-237.
2.3.3. Mechanistic Insights
To investigate the reaction mechanism, the enantiopure phthalimide (/?)-234a 
was prepared in 99% ee using similar sequence outlined for the tri-substituted 
phthalimide (R)-237, and subjected to the optimal oxidation conditions.12g Treatment 
of the enantiopure phthalimide (/?)-234a afforded a racemic mixture of enone 235a 
in 82% yield (Scheme 2.54). Baldwin had previously suggested a prochiral allyl 
radical in the rhodium-catalysed autoxidation of (+)-carvomenthene 44.11 Hence, the 
symmetrisation of the phthalimide (/?)-234a also provides the prochiral allyl radical 
245, which consequently affords the racemic enone 235a.
Cu(l)-NHC 183 (5 mol %) 
y.NPhth 'BuOOH (5 eq)
NaHC03 (1 eq) 
MeCN, rt, 24 h 
82%
99% ee
Scheme 2.54 Mechanistic Study to Probe the Prochiral Intermediate.
/^NPhthQ
245
Prochiral
NPhth
O 235a
10:1, 0%ee
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A free radical pathway has been widely accepted for the mechanism of the 
metal-catalysed allylic oxidation reaction, and there have been many reports
involving rhodium.^ ’ ’ Generally, the use of a radical scavenger, e.g. 
hydroquinone, is utilised to inhibit the formation of free radicals. Table 2.13 outlines 
the investigation of the use of the free radical scavenger, hydroquinone in the 
copper(I)-NHC-catalysed allylic oxidation of the phthalimide 234a. Treatment of 
234a under the optimal conditions with catalytic amount of hydroquinone and 
butylated hydroxytoluene (BHT) afforded the enone 235a in 75% and 72% yield, 
respectively (entries 2 and 3). Although the copper(I)-NHC-catalysed allylic 
oxidation was suppressed when a stoichiometric amount of hydroquinone was added, 
this could result from the poisoning of the catalyst (entry 4).79 
Table 2.13 Free Radical Scavenger Effect.0
Cu(l)-NHC 183 (5 mol %)
a
NPhth 'BuOOH (5 eq)
234a
NaHC03 (1 eq)
Hydroquinone
MeCN, rt, 24 h
NPhth \0NPhth
O 235a 236a
Entry Hydroquinone (mol %) 235a:236ab Yield' (%)
2
2
100
10:1
10:1
10:1
83
75
72
"Reactions were performed on 0.25 mmol scale with syringe pump 
addition of 'BuOOH at 0.3 eq/h. bDetermined by 'H-NMR on crude 
mixtures, isolated yields. dBHT was used.
2.3.4. Enantioselective Copper(I)-Catalysed Allylic Oxidation
The enantioselective copper-catalysed allylic oxidation reaction of the 
racemic phthalimide 234a via the desymmetrisation of the prochiral allyl radical 
intermediate 245 to afford the enantiopure enone 235a was investigated. Treatment
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of racemic phthalimide 234a with the copper(I)-NHC catalysts 246-248 and 
copper(I) chloride/ligand complexes 249-250 with /er/-butyl hydroperoxide 
furnished the enone 235a in up to 84% yield, but the product was racemic in all cases 
(Scheme 2.55).130 These results were disappointing and demonstrates that the copper 
complex is not involved in the enantio-detenuining step of the oxidation reaction.
Cu(l)-NHC 246-248 (5 mol %)
NPhth or CuCI/L,! 249-250 (5 mol %)
'BuOOH (5 eq) 
NaHC03 (1 eq) 
MeCN, rt
70-84%
Scheme 2.55 Efforts Towards the Enantioselective Copper-Catalysed Ally lie 
Oxidation of Phthalimide 234a.
2.4 Conclusions
In conclusion, it has been demonstrated that copper(I)-NHC catalysts can be 
employed in the regioselective allylic oxidation of quaternary-substituted 
cyclopentenes and ternary-substituted cyclohexenes to give oxidised products in 
excellent yields and with good selectivities.92,131 These processes require the slow 
addition of ter/-butyl hydroperoxide to supress decomposition, allowing clean 
conversions and superior efficiencies. The quaternary-substituted cyclopentenes with 
an array of functional groups reacted in good regioselectivity.92 The synthetic utility 
of this transformation was exhibited in the most efficient and expedient total
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synthesis of (±)-untenone A reported to date.92 The copper(I)-NHC-catalysed allylic 
oxidation of the ternary-substituted cyclohexenes provided an insight into the nature 
of the steric environment for optimal regiocontrol with oxygen, carbon and nitrogen 
substituents.131 In the case of the cyclohexenes, steric influences were not necessarily 
the governing factor for high regioselectivity, with stereoelectronics playing an 
equally important role. Enhanced regioselectivities were observed for tri-substituted 
cyclohexenes, providing a stereospecific allylic oxidation route to synthetically 
useful enantiopure cyclohexenones.131 The intennediacy of the prochiral allyl radical 
was confirmed, which was used unsuccessfully in an enantioselective version of the 
oxidation reaction.
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2.5 Experimental
2.5.1. Experimental Procedures
OTIPS (Cyclopent-3-en-l-ylmethoxy)triisopropylsilane 171.143
Colour and state: Colorless oil. R/- 0.8 (Hexane 100%).
Representative Experimental Procedure: Methyl cyclopent-3-enecarboxylate 170 
(0.63 g, 5 mmol) was added dropwise to a suspension of lithium aluminium hydride 
(0.28 g, 7.5 mmol) in diethyl ether (50 mL) at 0 °C and stirred for 1 hour. The 
reaction was slowly quenched at 0 °C with saturated aqueous potassium sodium 
tartrate (50 mL) and extracted three times with diethyl ether (50 mL). The organics 
were dried (MgSCL), filtered and concentrated in vacuo to yield the crude alcohol as 
a colourless oil. The crude alcohol was added to a mixture of DMAP (0.06 g, 0.5 
mmol), imidazole (0.85 g, 12.5 mmol) in dichloromethane (50 mL) at 0 °C. To the 
reaction mixture was added chlorotriisopropylsilane (1.28 mL, 6 mmol) slowly and 
stirred for 2 hours, allowing warming up to room temperature. The reaction was 
quenched with water (50 mL), extracted three times with diethyl ether (50 mL) and 
washed with brine (100 mL). The organics were dried (MgS04), filtered and 
concentmted in vacuo to yield a crude oil. Purification by flash chromatography 
(silica, eluting with hexane) furnished 1.18 g (93%) of 171.
'H NMR (500 MHz, CDCI3) 8 5.65-5.61 (m, 2H), 3.56 (d,./ = 6.8 Hz, 2H), 2.53-
2.36 (ra, 3H), 2.16-2.10 (m, 2H), 1.06-1.03 (m, 21H).
IR (Neat) 3055 (w), 2943 (in), 2866 (in), 1617 (w), 1461 (m), 1103 (vs) cm'1.
‘"lOjMe Methyl l-methylcyclopent-3-enecarboxylate 172a.132
Colour and state: Pale yellow oil. R/ = 0.5 (Hexane:Ethyl acetate =
95:5).
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Representative Experimental Procedure'. To a solution of LDA, prepared from 
diisopropylamine (1.05 mL, 7.5 mmol) and «-butyllithium (2.5 M in hexanes, 3 mL, 
7.5 mmol) in tetrahydrofuran (50 mL) at -78 °C was added dropwise methyl 
cyclopent-3-enecarboxylate 170 (0.63 g, 5 mmol). The reaction was maintained at - 
78 °C for 1 hour to which iodomethane (0.47 mL, 7.5 mmol) was added. The reaction 
mixture was slowly wanned to room temperature over 4 hour's and stined overnight. 
The reaction was quenched with saturated aqueous ammonium chloride (50 mL), 
extracted three times with diethyl ether (50 mL) and washed with brine (150 mL). 
The organics were dried (MgSCL), filtered and concentrated in vacuo to yield a crude 
oil. Purification by flash chromatography (silica, 5-10% ethyl acetate/hexane) 
furnished the cyclopentene 172a in 85%.
‘H NMR (500 MHz, CDC13) 5 5.60 (bs, 2H), 3.69 (s, 3H), 2.92-2.89 (m, 2H), 2.24- 
2.21 (m, 2H), 1.30 (s, 3H).
IR (Neat) 2926 (w), 2853 (w), 1731 (vs), 1435 (w), 1274 (m), 1204 (s), 1119 (s) cm'
1
C02Me Methyl 1-allylcy clop ent-3-enecarboxy late 172b.
\_/ Colour and state: Pale yellow oil. R/= 0.5 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: Prepared in accordance to 172a using 
allylbromide (0.65 mL, 7.5 mmol) in 95%.
^ NMR (500 MHz, CDC13) 5 5.74-5.66 (m, 1H), 5.66 (s, 2H), 5.05 (dd, J- 16.0 
Hz, 1H), 5.05 (dd, /= 11.1 Hz, 1H), 3.69 (s, 3H), 2.85 (d, J= 14.3 Hz, 2H), 2.40 (d, 
J= 7.7 Hz, 2H), 2.34 (d, 14.6 Hz, 2H).
13C NMR (125 MHz, CDC13) 5 177.71 (e), 134.40 (0), 128.47 (0), 117.99 (e), 52.05 
(o), 51.96 (e), 43.48 (e), 42.10 (e).
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IR (Neat) 3060 (w), 2925 (w), 2853 (w), 1731 (vs), 1640 (w), 1435 (m), 1260 (m), 
1201 (s), 1135 (m), 916 (s) cm"1.
HRMS (Cl, [M+H]+) calcd for C10H17O2 167.1023, found 169.1019.
C02Me Methyl l-propylcyclopent-3-enecarboxylate 172c.
\—/ Colour and state: Colorless oil. R/= 0.5 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: Prepared in accordance to 172a using 
iodopropane (0.73 mL, 7.5 mmol) in 80%.
*H NMR (500 MHz, CDC13) 8 5.62 (s, 2H), 3.71 (s, 3H), 2.91 (d, J = 14.5 Hz, 2H), 
2.32 (d, J= 14.3 Hz, 2H), 1.69-1.65 (in, 2H), 1.29-1.21 (m, 2H), 0.91 (t, J= 7.2 Hz, 
3H).
13C NMR (125 MHz, CDCI3) 8 178.32 (e), 128.62 (o), 52.72 (e), 51.97 (0), 42.47 
(e), 42.10 (e), 18.78 (e), 14.61 (0).
IR (Neat) 3058 (w), 2957 (w), 2874 (w), 1732 (vs), 1622 (w), 1435 (m), 1298 (w), 
1268 (w), 1205 (s), 1137 (m) cm'1.
HRMS (Cl, [M+H]+) calcd for CioH|702169.1223, found 169.1219.
MeC) Methyl I-(4-methoxyphenyl)cyclopent-3-enecarboxylate
\Jl c02Ue 172d.
\—/ Colour and state: Colorless solid. R/ = 0.5 (Hexane:Ethyl
acetate = 90:10). mp = 31-33 °C.
Representative Experimental Procedure: To a solution of EDA, prepared from 
diisopropylamine (2.10 mL, 15 mmol) and /?-butyllithium (2.5 M in hexanes, 6 mL, 
15 mmol) in tetrahydrofuran (100 mL) at -78 °C was added dropwise methyl 2-(4- 
methoxyphenyl)acetate (1.80 g, 10 mmol). The reaction was maintained at -78 °C for
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1 hour to which allyl bromide (1.30 mL, 15 mmol) was added. The reaction mixture 
was slowly warmed to room temperature over 4 hours. The reaction was quenched 
with saturated aqueous ammonium chloride (100 mL), extracted three times with 
diethyl ether (100 mL) and washed with brine (200 mL). The organics were dried 
(MgSO^, filtered and concentrated in vacuo to yield the monoalkylated ester. The 
above alkylation step was repeated to afford the dialkylated ester, where it added to a 
solution of 2nd Generation Grubb’s catalyst (0.21 g, 2.5 mol %) in dichloromethane 
(100 mL). The reaction mixture was stirred for 2 hours, followed by the addition of 
dimethylsulfoxide (1.78 mL, 25 mmol), and then stirred for 12 horns. The mixture 
was concentrated in vacuo and purification by flash chromatography (silica, 5-10% 
ethyl acetate/hexane) furnished the cyclopentene 172d in 86%.
'H NMR (500 MHz, CDCI3) 5 7.24 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 
5.75 (s, 2H), 3.79 (s, 3H), 3.63 (s, 3H), 3.39 (d, J= 14.5 Hz, 2H), 2.72 (d, J= 14.8 
Hz, 2H).
13C NMR (125 MHz, CDC13) 8 176.88 (e), 158.41 (e), 135.85 (e), 129.29 (o), 127.77 
(o), 113.80 (o), 57.79 (e), 55.30 (o), 52.56 (o), 42.90 (e).
IR (Neat) 2952 (w), 2838 (w), 1728 (vs), 1611 (m), 1512 (vs), 1442 (m), 1295 (in), 
1249 (s), 1224 (s), 1183 (s), 1164 (s), 1037 (m), 831 (m) cm'1.
HRMS (Cl, [M+H]') calcd for Ci4Hi703 233.1172, found 233.1172.
Methyl l-phenylcyclopent-3-eiiecarboxylate 172e. 133
,C02Me
Colour and state: Colorless solid. R/= 0.5 (Hexane:Ethyl acetate = 
90:10). mp = 28-30 °C.
Representative Experimental Procedure: Prepared in accordance to 172d using 
methyl 2-phenylacetate (1.50 g, 10 mmol) in 87%.
‘H NMR (500 MHz, CDC13) 8 7.32-7.31 (m, 4H), 7.25-7.22 (m, 1H), 5.77 (s, 2H),
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3.64 (s, 3H), 3.43-3.40 (m, 2H), 2.78-2.75 (m, 2H).
IR (Neat) 3059 (w), 2951 (w), 1729 (vs), 1495 (w), 1447 (w), 1260 (m), 1222 (s), 
1164 (s) cm"1.
F\ ___ Methyl l-(4-fhioropheiiyl)cyclopeiit-3-enecarboxylate 172f.
C02Me Colour and state: Colorless oil. R/= 0.3 (Hexane:Ethyl acetate = 
W/ 95:5).
Representative Experimental Procedure'. Prepared in accordance to 172d using 
methyl 2-(4-fluorophenyl)acetate (1.68 g, 10 mmol) in 85%.
NMR (500 MHz, CDC13) 5 7.30-7.27 (m, 2H), 6.99 (t, 8.8 Hz, 2H), 5.76 (s,
2H), 3.64 (s, 3H), 3.40 (d, J= 14.5 Hz, 2H), 2.72 (d, 14.8 Hz, 2H).
13C NMR (125 MHz, CDC13) 5 176.41 (e), 161.68 (e, d, JC-f = 245.6Hz, CF), 139.42 
(e, d, Jc-f — 3.3 Hz, CCCCF), 129.16 (o), 128.26 (o, d,yC-F= 8.2 Hz, CCCF), 115.18 
(0, d, Jc-F = 21.3 Hz, CCF), 57.85 (e), 52.59 (o), 42.89 (e).
IR (Neat) 3060 (w), 2953 (w), 1730 (vs), 1606 (w), 1509 (vs), 1435 (m), 1261 (m), 
1224 (s), 1193 (m), 1159 (s), 1056 (m), 835 (m) cm"1.
HRMS (Cl, [M+H]+) calcd for Q3H14O2F221.0972, found 221.0973.
\/~~-OPiv (l-Methylcyclopent-3-enyl)methyl pivalate 173a.
Colour and state: Colorless oil. R/= 0.5 (Hexane:Ethyl acetate = 95:5). 
Representative Experimental Procedure: Methyl l-methylcyclopent-3-
enecarboxylate 172a (1.40 g, 10 mmol) was added dropwise to a suspension of 
lithium aluminium hydride (0.57 g, 15 mmol) in diethyl ether (100 mL) at 0 °C and 
stirred for 1 horn*. The reaction was slowly quenched at 0 °C with saturated aqueous 
potassium sodium tartrate (100 mL) and extracted three times with diethyl ether (50 
mL). The organics were dried (MgSC>4), filtered and concentrated in vacuo to yield a
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crude alcohol as a colourless oil. The crude alcohol was added to a mixture of
DMAP (0.12 g, 1 mmol), triethylamine (2.09 mL, 15 mmol) in dichloromethane (50 
mL) at 0 °C. To the reaction mixture was added trimethylacetyl chloride (1.85 mL, 
15 mmol) slowly and stirred for 2 horns, allowing wanning up to room temperature. 
The reaction was quenched with saturated aqueous ammonium chloride (50 mL), 
extracted three times with diethyl ether (50 mL) and washed with brine (100 mL). 
The organics were dried (MgSCL), filtered and concentrated in vacuo to yield a crude 
oil. Purification by flash chromatography (silica, 5-10% ethyl acetate/hexane) 
furnished cyclopentene 173a in 93%.
'H NMR (500 MHz, CDCI3) 8 5.59 (s, 2H), 3.90 (s, 2H), 2.31 (d, J= 13.9 Hz, 2H), 
2.08 (d, J= 14.6 Hz, 2H), 1.23 (s, 3H), 1.20 (s, 9H).
13C NMR (125 MHz, CDC13) 5 178.81 (e), 129.00 (o), 71.81 (e), 43.43 (e), 41.66 (e), 
39.06(e), 27.33 (o), 25.37 (o).
IR (Neat) 3057 (w), 2962 (w), 2848 (w), 1730 (vs), 1702 (m), 1481 (m), 1283 (s), 
1149 (vs) cm"1.
HRMS (Cl, [M+H]+) calcd for C12H2i02197.1536, found 197.1530.
—QPiv (l-AIIylcyclopent-3-enyl)methyl pivalate 173b.
\_/ Colour and state: Pale yellow oil. R/= 0.5 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: Prepared in accordance to 173a using
methyl l-allylcyclopent-3-enecarboxylate 172b (1.66 g, 10 mmol) in 90%.
lJi NMR (500 MHz, CDC13) 5 5.77-5.72 (m, 1H), 5.59 (s, 2H), 5.07-5.04 (m, 2H),
3.91 (s, 2H), 2.25-2.22 (m, 6H), 1.21 (s, 9H).
13C NMR (125 MHz, CDC13) 5 178.63 (e), 134.87 (o), 128.96 (o), 117.69 (e), 69.76 
(e), 44.59 (e), 42.21 (e), 41.28 (e), 39.03 (e), 27.32 (o).
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IR (Neat) 3078 (w), 2976 (w), 2906 (w), 2848 (w), 1730 (vs), 1640 (w), 1480 (m), 
1282 (s), 1157 (vs), 1034 (w), 992 (w), 914 (s), 734 (s) cm'1.
HRMS (Cl, [M+H]+) calcd for C14H23O2223.1693, found 223.1691.
QPiv (l-Propylcyclopent-3-enyl)methyl pivalate 173c.
\—/ Colour and state: Colorless oil. R/= 0.5 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: Prepared in accordance to 173a using 
methyl l-propylcyclopent-3-enecarboxylate 172c (1.68 g, 10 mmol) in 91%.
‘H NMR (500 MHz, CDC13) 8 5.58 (s, 2H), 3.89 (s, 2H), 2.22 (d, A of AB, JAB = 
15.1 Hz, 2H), 2.16 (d, B of AB, J^= 15.2 Hz, 2H), 1.46-1.43 (m, 2H), 1.26 (s, 2H), 
1.20 (s, 9H), 0.90 (t, J= 7.2 Hz, 3H).
19C NMR (125 MHz, CDC13) 8 178.73 (e), 129.03 (o), 69.84 (e), 44.66 (e), 41.75 (e), 
40.58 (e), 39.02 (e), 27.28 (o), 17.92 (e), 15.02 (o).
IR (Neat) 3057 (w), 2974 (w), 2907 (w), 2848 (w), 1730 (vs), 1639 (w), 1480 (m), 
1282 (s), 1156 (vs), 914 (m) cm'1.
HRMS (Cl, [M+Hf) calcd for CmHjsOj 225.1849, found 225.1844.
(l-(4-Methoxypheiiyl)cyclopent-3-enyI)methyl pivalate 
•OPiv 173d.
Colour and state: Colorless solid. R/ = 0.4 (Hexane:Ethyl 
acetate = 90:10). mp = 36-38 °C.
Representative Experimental Procedure: Prepared in accordance to 173a using 
methyl l“(4-methoxyphenyl)cyclopent-3-enecarboxylate 172d (2.32 g, 10 mmol) in
92%.
'H NMR (500 MHz, CDCI3) 5 7.19 (d, J= 8.8 Hz, 2H), 6.84 (d, /= 8.8 Hz, 2H),
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5.74 (s, 2H), 4.05 (s, 2H), 3.79 (s, 3H), 2.74-2.66 (m, 4H), 1.10 (s, 9H).
13C NMR (125 MHz, CDC13) 8 178.57 (e), 157.88 (e), 139.04 (e), 129.26 (o), 128.18 
(o), 113.46 (o), 71.43 (e), 55.32 (o), 49.37 (e), 42.60 (e), 38.91 (e), 27.23 (o).
IR (Neat) 3054 (w), 2957 (w), 2933 (w), 2910 (w), 2835 (w), 1723 (s), 1610 (m), 
1513 (s), 1478 (m), 1459 (m), 1268 (m), 1246 (s), 1184 (s), 1144 (vs), 1033 (s), 835 
(s) cm'1.
HRMS (ESI, [M+Na]4) calcd for CiaH^OsNa 311.1623, found 311.1629.
(l-Phenylcyclopent-3-enyl)methyl pivalate 173e.
Colour and state: Colorless oil. R/= 0.5 (Hexane:Ethyl acetate - 
95:5).
Representative Experimental Procedure: Prepared in accordance to 173a using 
methyl l-phenylcyclopent-3-enecarboxylate 172e (2.02 g, 10 mmol) in 93%.
‘H NMR (500 MHz, CDCI3) 8 7.32-7.27 (m, 4H), 7.20 (t, J= 8.8 Hz, 1H), 5.75 (s, 
2H), 4.08 (s, 2H), 2.77 (d, A of AB, JAB= 14.7 Hz, 2H), 2.70 (d, B of AB, .IAb= 14.6 
Hz, 2H), 1.09 (s, 9H).
i3C NMR (125 MHz, CDCI3) 5 178.53 (e), 146.88 (e), 129.23 (o), 128.15 (o), 127.22 
(o), 126.17 (0), 71.34 (e), 50.02 (e), 42.45 (e), 38.92 (e), 27.15 (0).
IR (Neat) 3059 (w), 2972 (w), 1727 (vs), 1602 (w), 1480 (m), 1283 (m), 1150 (vs), 
1034 (m) cm '.
HRMS (ESI, [M+Na]4) calcd for Ci7H2202Na281.1517, found 281.1522.
(l-(4-Fluorophenyl)cyclopent-3-enyl)methyI pivalate 173f.
OPiv Colour and state: Colorless oil. R/= 0.3 (Hexane:Ethyl acetate = 
95:5).
Representative Experimental Procedure: Prepared in accordance to 173a using
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methyl l-(4-fluorophenyl)cyclopent-3-enecarboxylate 172f (2.20 g, 10 mmol) in 
90%.
'H NMR (500 MHz, CDCb) 8 7.24-7.20 (m, 2H), 7.01-6.96 (m, J = 8.8 Hz, 2H), 
5.75 (s, 2H), 4.05 (s, 2H), 2.74-2.67 (m, 4H), 1.09 (s, 9H).
13C NMR (125 MHz, CDC13) 8 178.46 (e), 161.36 (e, d, JC-r= 244.3 Hz, CF), 142.58 
(e, d, JC-f= 3.5 Hz, CCCCF), 129.24 (o), 128.72 (o, d, JC-f = 7.9 Hz, CCCF), 114.84 
(o, d, Jc-F “21.1 Hz, CCF), 71.24 (e), 49.65 (e), 42.53 (e), 38.92 (e), 27.22 (o).
IR (Neat) 3059 (w), 2972 (w), 1727 (vs), 1604 (w), 1512 (s), 1480 (m), 1283 (s), 
1232 (m), 1153 (s), 835 (m) cm-1.
HRMS (ESI, [M+Na]') calcd for CnHjiChNa 299.1423, found 299.1429.
sOTBS fcrt-Butyldimethyl(l-methylcyclopent-3-enyIoxy)silane 174a.134
\=j Colour and state: Colorless oil. R/= 0.8 (100% Hexane).
Representative Experimental Procedure'. Ethyl acetate (0.98 mL, 10 mmol) was 
added dropwise to a solution of allylmagnesium bromide (1.0 M in diethyl ether, 25 
mL, 25 mmol) in tetrahydrofuran (50 mL) at 0 °C. The reaction was slowly wanned 
to room temperature over 4 horns, and quenched carefully with water (50 mL). The 
biphasic mixture was extracted three times with diethyl ether (75 mL) and washed 
with brine (150 mL). The organics were dried (MgS04), filtered and concentrated in 
vacuo to yield a crude oil. The crude alcohol was added to a solution of 2nd 
Generation Grubb’s catalyst (0.21 g, 2.5 mol %) in dichloromethane (100 mL). The 
reaction mixture was stined for 2 hours, followed by the addition of 
dimethylsulfoxide (1.78 mL, 25 mmol), and then stined for 12 hours. The crude 
mixture was concentrated in vacuo and purification by flash chromatography (silica, 
10-20% ethyl acetate/hexane) furnished the cyclopentenol. The cyclopentenol was 
added to a solution of diisopropylethylamine (3.48 mL, 20 mmol) in
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dichloromethane (50 mL) at 0 °C. fcr/-Butyldimethylsilyl trifluoromethanesulfonate 
(3.44 mL, 15 mmol) was added dropwise to the resulting mixture and stirred for 2 
hour’s at 0 °C. The reaction was quenched with water (100 mL), extracted three times 
with diethyl ether (75 mL) and washed with brine (100 mL), The organics were dried 
(MgS04), filtered and concentrated in vacuo to yield a crude oil. Purification by flash 
chromatography (silica, eluting with hexane) furnished cyclopentene 174a in 65%.
'H NMR (500 MHz, CDCI3) 8 5.61 (s, 2H), 2.49 (d, A of AB, Jab = 15.1 Hz, 2H), 
2.32 (d, B of AB, JAB = 14.8 Hz, 2H), 1.36 (s, 3H), 0.85 (s, 9H), 0.06 (s, 6H).
IR (Neat) 3060 (w), 2957 (w), 2857 (w), 2929 (m), 1473 (w), 1463 (w), 1370 (w), 
1308 (w), 1250 (s), 1155 (m), 1085 (m), 1027 (s), 834 (s), 772 (s) cm’1.
OTBS (l-Allylcyclopent-3-enyloxy)((erf-butyl)dimethylsilane 174b.
\_/ Colour and state: Colorless oil. R/= 0.8 (100% Hexane).
Representative Experimental Procedure: Prepared in accordance to 174a using 
methyl but-3-enoate (1.00 g, 10 mmol) in 60%.
‘if NMR (500 MHz, CDCI3) 5 5.92-5.84 (m, 1H), 5.62 (s, 2H), 5.05-5.02 (m, 2H), 
2.45-2.37 (m, 4H), 2.35 (d, J= 7.4 Hz, 2H), 0.85 (s, 9H), 0.04 (s, 6H).
13C NMR (125 MHz, CDCI3) 5 135.69 (0), 128.88 (0), 116.99 (e), 83.21 (e), 47.77 
(e), 46.61 (e), 25.98 (o), 18.32 (e), -2.66 (o).
IR (Neat) 3060 (w), 2955 (w), 2929 (m), 2897 (w), 2857 (m), 1640 (w), 1472 (w), 
1251 (s), 1081 (s), 913 (m), 833 (s), 772 (s) cm’1.
HRMS (Cl, [M+]) calcd for Cnf^OSi 238.1747, found 238.1744.
OTBS tert-Butyl(l-butylcyclopent-3-enyloxy)dimethylsilane 174c.
\—/ Colour and state: Colorless oil. R/= 0.8 (100% Hexane).
Representative Experimental Procedure: Prepared in accordance to 174a using
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methyl pentanoate (1.16 g, 10 mmol) in 64%.
'H NMR (500 MHz, CDCI3) 5 5.63 (s, 2H), 2.38-2.40 (m, 4H), 1.59-1.56 (m, 2H), 
1.39-1.26 (m, 4H), 0.90 (t, ./= 7.3 Hz, 3H), 0.86 (s, 9H), 0.01 (s, 6H).
13C NMR (125 MHz, CDC13) 5 128.95 (o), 83.85 (e), 47.06 (e), 43.15 (e), 26.99 (e), 
25.86 (o), 23.41 (e), 18.37 (e), 14.33 (o), -2.73 (o).
IR (Neat) 2955 (m), 2929 (m), 2857 (m), 1472 (m), 1361 (w), 1252 (s), 1053 (s), 
1005 (m), 835 (s), 780 (s) cm'1.
HRMS (Cl, [M+]) calcd for CuHjoOSi 254.2055, found 254.2060.
/e/'Mtiityl(l-(4-m ethoxy phenyl)cydo[H'nf-3-enyloxy)
S...I OTBS dimetliylsilane 174d.
\—/ Colour and state: Colorless oil. R/^ 0.4 (100% Hexane).
Representative Experimental Procedure: Prepared in accordance to 174a using 
methyl 4-methoxybenzoate (1.66 g, 10 mmol) in 69%.
‘H NMR (500 MHz, CDCI3) 5 7.37 (d, J= 8.9 Hz, 2H), 6.84 (d, 7 = 8.8 Hz, 2H), 
5.75 (s, 2H), 3.80 (s, 3H), 2.84-2.76 (m, 4H), 0.89 (s, 9H), -0.05 (s, 6H).
13C NMR (125 MHz, CDCI3) 5 158.22 (e), 141.52 (e), 128.85 (o), 126.54 (0), 113.21 
(0), 84.22 (e), 55.37 (o), 50.18 (e), 26.10 (0), 18.49 (e), -2.93 (0).
IR (Neat) 3059 (w), 2953 (m), 2929 (m), 2855 (m), 1612 (m), 1582 (w), 1512 (s), 
1463 (m) 1311 (w), 1247 (vs), 1179 (m), 1085 (s), 1041 (m), 996 (m), 834 (s), 774 
(s) cm'1.
HRMS (Cl, [M+Na]1) calcd for Ci8H2802NaSi327.1756, found 327.1764.
OTBS
terr-Butyldimethyl(l-phenylcyclopeiit-3-enyloxy)silane 174e.
Colour and state: Colorless oil. R/= 0.8 (100% Hexane). 
Representative Experimental Procedure: Prepared in accordance to
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174a using methyl benzoate (1.36 g, 10 mmol) in 68%,
^ NMR (500 MHz, CDC13) 5 7.46 (d, J = 7.2 Hz, 2H), 7.30 (t, J = 7.5 Hz, 2H), 
7.21 (t, /= 7.2 Hz, 1H), 5.77 (s, 2H), 2.86 (d, A of AB, JAB= 16,1 Hz, 2H), 2.81 (d, 
B of AB, JAB = 16.6 Hz, 2H), 0.91 (s, 9H), -0.02 (s, 6H).
13C NMR (125 MHz, CDC13) 5 149.53 (e), 128.81 (o), 127.94 (o), 126.42 (o), 125.22 
(o), 84.39 (e), 50.59 (e), 26.11 (o), 18.54 (e), -2.92 (o).
IR (Neat) 3059 (w), 2954 (m), 2928 (m), 2856 (m), 1601 (w), 1462 (w), 1254 (s), 
1072 (s), 995 (m), 833 (s), 773 (s), 699 (s) cm4.
HRMS (Cl, [M+]) calcd for Cn^OiSi 274.1747, found 274.1746.
fc/7-Butyl(l-(4-tliiorophenyl)cyclopent-3-enyloxy)dimethyl 
silane 173f.
Colour and state: Colorless oil. R/= 0.6 (100% Hexane). 
Representative Experimental Procedure: Prepared in accordance to 174a using 
methyl 4-fluorobenzoate (1.54 g, 10 mmol) in 66%.
^ NMR (500 MHz, CDC13) 6 7.43-7.39 (m, 2H), 7.00-6.95 (m, J - 8.8 Hz, 2H),
5.76 (s, 2H), 2.80 (s, 4H), 0.90 (s, 9H), -0.02 (s, 6H).
13C NMR (125 MHz, CDC13) 5 161.60 (e, d, Jc-f = 244.4 Hz, CF), 145.30 (e, d, JC-f 
= 2.8 Hz, CCCCF), 128.83 (o), 126.83 (o, d, JC-f = 7.6 Hz, CCCF), 114.58 (o, d, JC-f 
= 21.1 Hz, CCF), 84.09 (e), 50.43 (e), 26.08 (o), 18.49 (e), -2.92 (o).
IR (Neat) 3060 (w), 2955 (m), 2929 (m), 2856 (m), 1602 (w), 1508 (s), 1472 (w), 
1231 (s), 1253 (m), 1157 (m), 1085 (s), 995 (m), 832 (s), 774 (s) cm'1.
General Procedure for the Copper(I)-NHC-Catalyzed Allylic Oxidation of 
Cyclopentenes:
Copper(I)-NHC catalyst 183 (5.04 mg, 0.013 mmol) and sodium bicarbonate
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(21 mg, 0.25 mmol) were added to a 10 mL round bottom flask under air. The septa 
contained a needle to allow gas to escape during the course of the reaction. 
Acetonitrile (0.50 mL) was added to reaction flask, followed by the cyclopentene 
171, 172a-f, 173a-f, 174a-f or 218 (0.25 mmol) and stirred for ca. 10 minutes, tert- 
Butylhydroperoxide (5.5 M in decane, 0.23 mL, 1.25 mmol) was added to the 
reaction solution via syringe-pump (rate of ca. 0.3 eq/h) at room temperature and 
stirred until completion (tl.c. control). The solution was filtered through a short plug 
of silica using ethyl acetate and concentrated in vacuo. The crude oils were purified 
by flash chromatography (silica, eluting with ethyl acetate/hexanes) to afford the 
cyclop entenones.
^OTIPS 4-(((Triisopropylsilyl)oxy)methyl)cyclopent-2-enone 179.144
Colour and state: Colorless oil. Regioselectivity: 179/150 = 3:1.
O Ry= 0.4 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
171 (0.064 g, 0.25 mmol) in 59%.
'H NMR (500 MHz, CDC13) 5 7.69 (dd, J= 5.7, 2.5 Hz, 1H), 6.19 (dd, 5.7, 2.0 
Hz, 1H), 3.83 (dd, A of ABX, JAB = 9.6 Hz, JAX= 5.7 Hz, 1H), 3.68 (dd, B of ABX, 
Jab = 9.6 Hz, JBx = 6.8 Hz, 1H), 3.16-3.10 (m, 1H), 2.42 (dd, A of ABX, JAB = 18.7 
Hz, JAX= 6.6 Hz, 1H), 2.13 (dd, B of ABX, JAB = 18.8 Hz, JBX = 2.3 Hz, 1H), 1.05- 
1,00 (m, 21H).
IR (Neat) 2943 (w), 2866 (m), 1718 (vs), 1464 (w), 1097 (s) cm'1.
^02Me Methyl l-methyl-4-oxocyclopeiit-2-enecarboxylate 186a.
O
Colour and state: Colorless oil; Regioselectivity: 186a/187a = 10:1.
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R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
172a (0.035 g, 0.25 mmol) in 77%.
"H NMR (500 MHz, CDCI3) 5 7.58 (d, J = 5.7 Hz, 1H), 6.15 (d, J = 5.7 Hz, 1H), 
3.73 (s, 3H), 2.98 (d, A of AB, Jab = 18.9 Hz, 1H), 2.25 (d, B of AB, Jab = 18.8 Hz, 
1H), 1.51 (s, 3H).
13C NMR (125 MHz, CDC13) 8 207.75 (e), 174.10 (e), 165.97 (o), 133.18 (o), 52.88 
(o), 45.80 (e), 42.80 (e), 24.82 (o).
IR (Neat) 2918 (m), 2850 (w), 1719 (s), 1591 (w), 1458 (w), 1280 (m), 1195 (m), 
1171 (m), 808 (m) cm'1.
HRMS (Cl, [M+NH4]+) calcd for CsHmC^N 172.0968, found 172.0970.
rC02Me Methyl l-allyl-4-oxocyclopent-2-enecarboxylate 186b.
Colour and state: Colorless oil; Regioselectivity: 186b/187b = 
14:1.
R/= 0.5 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
172b (0.042 g, 0.25 mmol) in 74%.
‘H NMR (500 MHz, CDCI3) 8 7.58 (d, 7= 5.7 Hz, 1H), 6.17 (d, 7= 5.7 Hz, 1H),
5.63 (ddt, 7= 17.3, 10.0, 7.2 Hz, 1H), 5.14-5.10 (m, 2H), 3.73 (s, 3H), 2.90 (d, A of 
AB, Jab - 18.8 Hz, 1H), 2.60 (dd, A of ABX, JAB = 13.8 Hz, JAx~ 7.8 Hz, 1H), 2.52 
(dd, B of ABX, JAB = 13.8 Hz, Jux = 6.9 Hz, 1H), 2.34 (d, B of AB, Jab = 18.9 Hz, 
1H).
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13C NMR (125 MHz, CDCI3) 5 207.27 (e), 164.33 (0), 134.11 (o), 131.93 (0), 120.12 
(e), 55.60 (e), 52.84 (0), 42.94 (e), 42.13 (e).
IR (Neat) 2955 (w), 1717 (vs), 1591 (w), 1436 (m), 1218 (m), 1192 (m), 926 (m), 
807 (m) cm"1.
HRMS (Cl, [M+H]+) calcd for CioHnOa 181.0859, found 181.0855.
C02Me Methyl 4-oxo-l-propylcyclopeiit-2-enecarboxylate 186c.
\\_/ Colour and state: Colorless oil; Regioselectivity: 186c/187c =
O
16:1.
R/= 0.5 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
172c (0.042 g, 0.25 mmol) in 80%.
^ NMR (500 MHz, CDCI3) 6 7.60 (d, 5.7 Hz, 1H), 6.14 (d, J = 5.7 Hz, 1H),
3.73 (s, 3H), 2.95 (d, A of AB, JAb = 18.8 Hz, 1H), 2.30 (d, B of AB, Jab= 18.8 Hz, 
1H), 1.90-1.84 (m, 1H), 1.72-1.66 (m, 1H), 1.31-1.23 (m, 2H), 0.92 (t, J= 7.3 Hz, 
3H).
13C NMR (125 MHz, CDC13) 5 207.65 (e), 173.57 (e), 165.22 (0), 133.40 (0), 56.07 
(e), 52.72 (o), 43.58 (e), 40.59 (e), 18.76 (e), 14.29 (o).
IR (Neat) 2959 (w), 2875 (w), 1717 (vs), 1591 (w), 1435 (w), 1224 (m), 1192 (m), 
1163 (s), 806 (m) cm"1.
HRMS (Cl, [M+H]+) calcd for C10H15O3183.1016, found 183.1011.
MeO iviptiivi i-M_mpthftYvphenyl)-4-oxocyclopent-2-ene
O
Colorless solid; Regioselectivity:
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186d/187d>\9\\. R/= 0.3 (Hexane:Ethyl acetate = 80:20). mp = 47-49 °C. 
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
172d (0.058 g, 0.25 mmol) in 82%.
*H NMR (500 MHz, CDCI3) 5 7.94 (d, J = 5.7 Hz, 1H), 7.13 (d, J = 8.8 Hz, 2H), 
6.87 (d, J = 8.8 Hz, 2H), 6.30 (d, J= 5.7 Hz, 1H), 3.79 (s, 3H), 3.74 (s, 3H), 3.47 (d, 
A of AB, JAB = 18.9 Hz, 1H), 2.58 (d, B of AB, = 18.8 Hz, 1H).
13C NMR (125 MHz, CDC13) S 207.30 (e), 172.68 (e), 163.33 (o), 159.16 (e), 133.95 
(0), 132.97 (e), 127.19 (0), 114.53 (0), 59.34 (e), 55.44 (0), 53.20 (o), 47.00 (e).
IR (Neat) 3074 (w), 2959 (w), 1715 (vs), 1508 (s), 1436 (m), 1247 (vs), 1153 (s), 
1031 (s), 821 (s) cm-1.
HRMS (Cl, [M+Hf) calcd for C14H15O4 247.0965, found 247.0965.
Methyl 4-oxO“l-phenylcyclopent-2-enecarboxylate 186e.
Colour and state: Colorless oil; Regioselectivity: 186e/187e >19:1. 
R/= 0.5 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
172e (0.050 g, 0.25 mmol) in 84%.
'H NMR (500 MHz, CDC13) 5 7.96 (d,./ = 5.6 Hz, 1H), 7.37 (t,./ - 7.1 Hz, 2H),
7.30 (t, J= 7.1 Hz, 1H), 7.20 (d, 7.1 Hz, 1H), 6.33 (d, ,/= 5.7 Hz, 1H), 3.75 (s,
3H), 3.51 (d, A of AB, JAB= 18.8 Hz, 1H), 2.59 (d, B of AB, JAB = 18.9 Hz, 1H).
13C NMR (125 MHz, CDCI3) 8 207.12 (e), 172.46 (e), 163.09 (o), 140.96 (e), 134.25 
(o), 129.23 (0), 127.96 (o), 126.01 (o), 60.07 (e), 53.27 (o), 46.92 (e).
IR (Neat) 3073 (w), 3013 (w), 2961 (w), 1710 (vs), 1591 (m), 1429 (s), 1239 (s), 
1144 (s), 1041 (s), 817 (s) cm"1.
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HRMS (Cl, [M+Hf) calcd for C13H13O3 217.0859, found 217.0860.
Methyl l-(4-fluorophenyl)-4-oxocyclopent-2-enecarboxylate 
C02Me 186f.
V_/ Colour and state: Colorless oil; Regioselectivity: 186f/187f
O
>19:1.
R/= 0.3 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
172f (0.055 g, 0.25 mmol) in 84%.
'H NMR (500 MHz, CDCI3) 8 7.93 (d, 7= 5.7 Hz, 1H), 7.20-7.16 (m, 2H), 7.04 (t, J 
= 8.7 Hz, 2H), 6.33 (d, J= 5.6 Hz, 1H), 3.74 (s, 3H), 3.49 (d, A of AB, JAB = 18.9 
Hz, 1H), 2.54 (d, B of AB, JAB= 18.8 Hz, 1H).
13C NMR (125 MHz, CDC13) 8 206.74 (e), 172.29 (e), 162.65 (o), 162.22 (e, d, JC-f 
= 248.0 Hz, CF), 136.78 (e, d, JC-f = 3.5 Hz, CCCCF), 134.42 (o), 127.82 (o, d, Jc-f 
= 8.2 Hz, CCCF), 116.12 (o, d, JC-f = 21.3 Hz, CCF), 59.40 (e), 53.34 (o), 46.97 (e). 
IR (Neat) 2956 (w), 1718 (vs), 1601 (w), 1509 (s), 1435 (w), 1235 (s), 1151 (m), 
1039 (m), 837 (m).
HRMS (Cl, [M+H]+) calcd for CnH^OsF 235.0765, found 235.0766.
OPiv (l-Methyl-4-oxocyclopent-2-enyl)methyl pivalate 181a.
Colour and state: Colorless oil; Regioselectivity: 181 a/182a — 18:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
173a (0.049 g, 0.25 mmol) in 80%.
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^ NMR (500 MHz, CDCI3) 5 7.39 (d,J~ 5.7 Hz, 1H), 6.11 (d, J = 5.5 Hz, 1H), 
4.14 (d, A of AB, Jab = 10.8 Hz, 1H), 3.92 (d, B of AB, JAB= 10.6 Hz, 1H), 2.41 (d, 
A of AB, JAb = 18.5 Hz, 1H), 2.14 (d, B of AB, = 18.3 Hz, 1H), 1.25 (s, 3H), 1.14 
(s, 9H).
13C NMR (125 MHz, CDC13) 6 208.58 (e), 178.23 (e), 168.68 (0), 133.73 (o), 68.73 
(e), 45.67 (e), 45.39 (e), 39.00 (e), 27.20 (0), 23.02 (0).
IR (Neat) 2971 (w), 2875 (w), 1714 (vs), 1588 (w), 1481 (w), 1282 (m), 1144 (s), 
798 (m) cm"1.
HRMS (Cl, [M+H]+) calcd for C12H19O3 211.1329, found 211.1328,
OPiv (l-Allyl“4“Oxocyclopeiit-2-enyl)methyl pivalate 181b.
Colour and state: Colorless oil; Regioselectivity: 181b/182b 
>19:1.
R/= 0.5 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
173b (0.056 g, 0.25 mmol) in 77%.
lH NMR (500 MHz, CDC13) 6 7.42 (d,J= 5.1 Hz, 1H), 6.18 (d, 7 = 5.6 Hz, 1H), 
5.66 (ddt, J = 16.9, 10.0, 7.5 Hz, 1H), 5.16-5.11 (m, 2H), 4.19 (d, A of AB, JAb = 
10.9 Hz, 1H), 3.97 (d, B of AB, = 11.1 Hz, 1H), 2.35-2.32 (m, 2H), 2.30-2.27 (m, 
2H), 1.16 (s, 9H).
I3C NMR (125 MHz, CDC13) 5 208.14 (e), 178.23 (e), 167.09 (0), 134.84 (0), 132.07 
(o), 120.07 (e), 67.64 (e), 49.04 (e), 42.86 (e), 40.23 (e), 39.09 (e), 27.24 (0).
IR (Neat) 2975 (w), 1717 (vs), 1590 (w), 1481 (w), 1281 (m), 1148 (s), 1035 (w), 
994 (w), 922 (w) cm"1.
HRMS (Cl, [M+Hf) calcd for C14H21O3 237.1485, found 237.1486.
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OPjV (4-Oxo-l-propyIcyclopent-2-enyl)methyl pivalate 181c.
V_/ Colour and state: Colorless oil; Regioselectivity: 181 c/182c >19:1.
O
R/= 0.5 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
173c (0.056 g, 0.25 mmol) in 81%.
*H NMR (500 MHz, CDCls) 5 7.39 (d, /= 5.7 Hz, 1H), 6.13 (d, /= 5.7 Hz, 1H), 
4.18 (d, A of AB, Jab - 11.0 Hz, 1H), 3.94 (d, B of AB,Jab = 11.1 Hz, 1H), 2.31 (d, 
A of AB, JAB = 18.9 Hz, 1H), 2.22 (d, B of AB, JAB = 18.5 Hz, 1H), 1.60-1.48 (m, 
2H), 1.35-1.10 (m, 2H), 0.93 (s, 9H), 0.92 (t, J= 7.3 Hz, 3H).
13C NMR (125 MHz, CDC13) 6 208.66 (e), 178.29 (e), 167.99 (o), 134.26 (0), 67.80 
(e), 49.36 (e), 43.29 (e), 39.02 (e), 38.01 (e), 27.21 (0), 17.75 (e), 14.69 (0).
XR (Neat) 2960 (m), 2934 (w), 2874 (w), 1715 (vs), 1590 (w), 1481 (m), 1281 (s), 
1144 (vs), 1035 (w), 796 (m) cm'1.
HRMS (Cl, [M+Hf) calcd for C14H23O3 239.1642, found 239.1641.
OPiv
(l-(4-MethoxyphenyI)-4-oxocyclopent-2-enyl)methyI 
pivalate 181d.
Colour and state: Colorless oil; Regioselectivity: 181d/182d
>19:1. R/= 0.3 (Hexane:Ethyl acetate = 80:20). 
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
173d (0.072 g, 0.25 mmol) in 85%.
'H NMR (500 MHz, CDC13) 5 7.76 (d, /= 6.0 Hz, 1H), 7.17 (d, 7 = 8.8 Hz, 1H),
6.89 (d, J= 8.8 Hz, 1H), 6.30 (d, 7= 5.7 Hz, 1H), 4.47 (d, A of AB, JAB =11.0 Hz,
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1H), 4.21 (d, B of AB, JM = 11.0 Hz, 1H), 3.79 (s, 3H), 2.74 (d, A of AB, J,w = 18.5 
Hz, 1H), 2.59 (d, B of AB, Jm = 18.6 Hz, 1H), 1.11 (s, 9H).
13C NMR (125 MHz, CDC13) 8 208.07 (e), 178.18 (e), 165.91 (o), 158.91 (e), 134.34 
(o), 133.38 (e), 127.50 (o), 114.41 (o), 68.30 (e), 55.42 (o), 52.32 (e), 46.72 (e), 
38.98 (e), 27.16(0).
IR (Neat) 2971 (w), 1717 (vs), 1610 (w), 1514 (s), 1480 (w), 1280 (m), 1252 (s), 
1141 (s), 1035 (m), 969 (w), 832 (m) era'1.
HRMS (ESI, [M+Na]1) ealed for Ci8H2204Na325.1416, found 325.1425.
(4-Oxo-l-phenylcyclopent-2-enyI)methyl pivalate 181e.
Colour and state: Colorless oil; Regioselectivity: 181e/182e >\9:l. 
R/= 0.5 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
173e (0.065 g, 0.25 mmol) in 84%.
lH NMR (500 MHz, CDC13) 5 7.82 (d, J= 5.7 Hz, 1H), 7.39-7.26 (m, 5H), 6.34 (d, J 
= 5.6 Hz, 1H), 4.54 (d, A of AB, JAb = 10.9 Hz, 1H), 4.26 (d, B of AB, JAB = 11.1 
Hz, 1H), 2.78 (d, A of AB, JAB = 18.2 Hz, 1H), 2.64 (d, B of AB, JAB = 18.6 Hz, 1H), 
1.12 (s, 9H).
13C NMR (125 MHz, CDC13) 5 207.83 (e), 178.15 (e), 165.64 (o), 141.43 (e), 134.56 
(o), 129.10 (o), 127.67 (o), 126.43 (o), 68.28 (e), 52.93 (e), 46.60 (e), 38.97 (e), 
27.14 (o).
IR (Neat) 2972 (w), 1717 (vs), 1593 (w), 1480 (w), 1281 (m), 1141 (s), 1036 (w), 
969 (w), 762 (m), 700 (m) cm'1.
HRMS (ESI, [M+Na]*) ealed for Ci7H2o03Na295.1310, found 295.1319.
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(l-(4-Fliioropheiiyl)-4-oxocyclopent-2-eiiyl)methyl pivalate 
181f.
Colour and state: Colorless oil; Regioselectivity: 181f/182f 
>19:1.
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
173f (0.069 g, 0.25 mmol) in 85%.
'H NMR (500 MHz, CDCls) 8 7.77 (d, J= 6.0 Hz, 1H), 7.24-7.20 (m, 2H), 7.05 (t, J 
= 8.5 Hz, 2H), 6.33 (d, J= 5.7 Hz, 1H), 4.48 (d, A of AB, JAB = 11.1 Hz, 1H), 4.21 
(d, B of AB, JAB = 11.0 Hz, 1H), 2.75 (d, A of AB, Jab = 18.1 Hz, 1H), 2.57 (d, B of 
AB>^= 18.5 Hz, 1H), 1.10 (s, 9H).
13C NMR (125 MHz, CDC13) 5 207.40 (e), 178.07 (e), 165.22 (o), 162.02 (e, d, JC-f 
= 247.4 Hz, CF), 137.30 (e, d, JC-f = 3.0 Hz, CCCCF), 134.72 (o), 128.11 (o, d, JC-f 
= 8.2 Hz, CCCF), 115.98 (o, d, Jc.f = 21.6 Hz, CCF), 68.27 (e), 52.40 (e), 46.69 (e), 
38.97(e), 27.13 (o).
IR (Neat) 2974 (w), 1717 (vs), 1604 (w), 1511 (s), 1480 (m), 1280 (in), 1230 (m), 
1138 (s), 971 (w), 835 (m) cm"1.
HRMS (ESI, (M+Na]+) calcd for Ci7Hi903FNa313.1216, found 313.1226.
OTBS 4-(ter£-ButyIdimethylsilyloxy)“4-methylcyclopent-2-enone 188a.
Colour and state: Colorless oil; Regioselectivity: 188a/189a >19:1.
O
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
174a (0.053 g, 0.25 mmol) in 72%.
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'H NMR (500 MHz, CDCI3) 5 7.41 (d, J = 5.7 Hz, 1H), 6.04 (d, J = 5.4 Hz, 1H), 
2.54 (d, A of AB, Jab = 18.2 Hz, 1H), 2.46 (d, B of AB, Jab = 18.2 Hz, 1H), 1.49 (s, 
3H), 0.85 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H).
"C NMR (125 MHz, CDC13) 5 207.36 (e), 167.90 (o), 132.00 (0), 78.42 (e), 51.61 
(e), 29.13 (0), 25.69 (0), 17.98 (e), -2.28 (0), -2.35 (o).
IR (Neat) 2956 (w), 2930 (w), 2888 (w), 2858 (w), 1721 (vs), 1592 (w), 1473 (w), 
1253 (s), 1202 (m), 1077 (s), 1018 (m), 844 (vs), 774 (s) cm'1.
HRMS (ESI, [M-l-Na]1) calcd for Cn^CWaSt 249.1287, found 249.1291.
x OTBS 4-Allyl-4-(fert-butyldimethylsilyloxy)cyclopent-2-enone 188b.
\\_J Colour and state: Colorless oil; Regioselectivity: 188b/l89b >19:1.
O
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
174b (0.060 g, 0.25 mmol) in 70%.
‘H NMR (500 MHz, CDC13) S 7.42 (d, J= 5.7 Hz, 1H), 6.12 (d, J = 5.7 Hz, 1H), 
5.78 (ddt, J = 17.3, 10.1, 7.1 Hz, 1H), 5.13-5.07 (m, 2H), 2.55 (d, A of AB, JAB = 
18.5 Hz, 1H), 2.46-2.44 (m, 2H), 2.42 (d, B of AB, Jab = 18.6 Hz, 1H), 0.86 (s, 9H), 
0.06 (s, 3H), 0.04 (s, 3H).
,3C NMR (125 MHz, CDCI3) 8 206.72 (e), 166.47 (o), 133.38 (o), 132.95 (0), 119.18 
(e), 80.64 (e), 48.91 (e), 46.57 (e), 25.71 (o), 18.15 (e), -2.21 (0), -2.49 (0).
IR (Neat) 2955 (w), 2930 (w), 2897 (w), 2858 (w), 1723 (vs), 1641 (w), 1473 (w), 
1253 (m), 1188 (m), 1075 (s), 833 (vs), 805 (s), 774 (s) cm'1.
HRMS (ESI, [M+Naf) calcd for Ci^OzNaSi 275.1443, found 275.1454.
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,OTBS 4-Butyl-4-(tert-butyldimethylsilyloxy)cyclopent-2-eiione X88c.
V_/ Colour and state: Colorless oil; Regioselectivity: 188c/189c
O
>19:1.
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
174c (0.060 g, 0.25 mmol) in 75%.
'H NMR (500 MHz, CDCI3) 8 7.42 (d, J= 5.7 Hz, 1H), 6.10 (d, J= 6.0 Hz, 1H), 
2.51 (d, A of AB, JAB = 18.3 Hz, 1H), 2.44 (d, B of AB, Jab = 18.5 Hz, 1H), 1.73- 
1.59 (m, 2H), 1.37-1.18 (m, 4H), 0.94-0.82 (m, 12H), 0.05 (s, 3H), 0.04 (s, 3H).
I3C NMR (125 MHz, CDC13) 8 207.21 (e), 167.22 (o), 132.89 (o), 81.14 (e), 49.62 
(e), 41.87 (e), 26.59 (e), 25.75 (o), 23.09 (e), 18.17 (e), 14.14 (o), -2.21 (o), -2.45 (o). 
IR (Neat) 2956 (m), 2930 (m), 2858 (w), 1723 (vs), 1463 (w), 1252 (m), 1190 (m), 
1077 (s), 835 (vs), 806 (s), 774 (vs) cm'1.
HRMS (ESI, [M+Na]’) calcd for Cis^sOiNaSi 291.1756, found 291.1757.
4-(fc/7‘-Butyldiniethylsilyloxy)-4-(4-methoxyphenyl) 
cyclopent-2-enone 188d.
Colour and state: Colorless oil; Regioselectivity: 188d/189d 
>19:1.
R/= 0.4 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
174d (0.076 g, 0.25 mmol) in 81%.
'H NMR (500 MHz, CDCI3) 5 7.50 (d, J= 5.6 Hz, 1H), 7.28 (d, J = 8.8 Hz, 1H), 
6.87 (d, J- 8.8 Hz, 1H), 6.24 (d, J= 5.6 Hz, 1H), 3.80 (s, 3H) 2.83 (d, A of AB, Jab
OTBS
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- 18.8 Hz, 1H), 2.78 (d, B of AB, JAB = 18.9 Hz, 1H), 0.93 (s, 9H), 0.04 (s, 3H), 0.02 
(s, 3H).
13C NMR (125 MHz, CDC13) 5 207.58 (e), 166.24 (o), 159.04 (e), 136.71 (e), 132.65 
(o), 126.20 (o), 113.95 (o), 81.74 (e), 55.43 (o), 53.29 (e), 25.90 (o), 18.38 (e), -2.27 
(o), -2.44 (o).
IR (Neat) 2955 (w), 2930 (w), 2857 (w), 1720 (vs), 1610 (w), 1509 (s), 1463 (w), 
1249 (s), 1176 (m), 1079 (m), 932 (m), 831 (s), 806 (s), 775 (s) cm'1.
HRMS (ESI, [M+Na]*) calcd for Ci^OsNaSi 341.1549, found 341.1550.
4-(ter/-Butyldiiiiethylsilyl()xy)-4-phenylcyclopent-2-enone 188e.
Colour and state: Colorless oil; Regioselectivity: 188e/189e >19:1. 
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
174e (0.069 g, 0.25 mmol) in 81%.
^ NMR (500 MHz, CDC13) 5 7.51 (d, J= 5.7 Hz, 1H), 7.38-7.26 (m, 5H), 6.28 (d, J
= 5.6 Hz, 1H), 2.84 (d, A of AB, JAB = 18.8 Hz, 1H), 2.80 (d, B of AB, JAB = 18.9 
Hz, 1H), 0.95 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H).
13C NMR (125 MHz, CDC13) 5 207.51 (e), 166.09 (o), 144.67 (e), 133.04 (o), 128.64 
(o), 127.57 (o), 124.89 (o), 82.02 (e), 53.33 (e), 25.90 (o), 18.40 (e), -2.24 (o), -2.43 
(o).
IR (Neat) 2956 (w), 2930 (w), 2887 (w), 2857 (w), 1720 (vs), 1590 (w), 1472 (w), 
1253 (m), 1153 (m), 1069 (s), 934 (m), 834 (s), 775 (s) 699 (s) cm'1.
HRMS (ESI, [M+Na]*) calcd for CnHi^NaSi 311.1443, found 311.1443.
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OTBS
4-(fcr^Butyldimethylsilyloxy)-4-(4-fluoropheiiyl)cyclopent-2- 
enone 188f.
Colour and state: Colorless oil; Regioselectivity: 188f/189f >19 :1.
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes using 
174f (0.073 g, 0.25 mmol) in 83%.
^ NMR (500 MHz, CDC13) 6 7.48 (d, J= 5.7 Hz, 1H), 7.34-7.31 (m, 2H), 7.03 (t, J
= 8.6 Hz, 2H), 6.28 (d, J= 5.7 Hz, 1H), 2.83 (d, A of AB, JAB = 18.9 Hz, 1H), 2.75 
(d, B of AB, JAB = 18.6 Hz, 1H), 0.94 (s, 9H), 0.06 (s, 3H), 0.04 (s, 3H).
13C NMR (125 MHz, CDC13) 6 207.06 (e), 165.68 (o), 162.18 (e, d, JC-f= 246.3 Hz,
CF), 140.58 (e), 133.25 (o), 126.64 (o, d, 8.2 Hz, CCCF), 115.46 (o, d, JC-f = 
21.3 Hz, CCF), 81.74 (e), 53.34 (e), 25.89 (o), 18.37 (e), -2.23 (o), -2.42 (o).
IR (Neat) 2956 (w), 2931 (w), 2858 (w), 1721 (vs), 1602 (w), 1508 (s), 1254 (m), 
1227 (s), 1156 (m), 1080 (s), 931 (m), 834 (vs), 775 (s) cm'1.
HRMS (ESI, [M+Na]+) calcd for Cn^C^FNaSi 329.1349, found 329.1364.
TMSO,
95:5).
(CH ) (l-Heptadecylcyclopent-3-enyloxy)trimethylsilane 218.
Colour and state: Colorless oil. R/= 0.5 (Hexane:Ethyl acetate =
Hoveyda-Gmbbs 2 catalyst (0.16 g, 2.5 mol %) was added to anhydrous 
dichloromethane (100 mL) under nitrogen atmosphere at room temperature. Alcohol 
219 (2.92 g, 10 mmol) was added to the resultant solution dropwise and stirred until 
completion (t.l.c. control). Diisopropylethylamine (2.61 mL, 15 mmol) was added to 
the crude reaction at 0 °C and stirred for ca. 10 minutes. Trimethylsilyl 
trifhioromethanesulfonate (2.17 mL, 12 mmol) was added dropwise to the reaction
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dropwise and stirred at 0 °C for 1 hour. The reaction was quenched with water (100 
inL) and extracted three times with diethyl ether (100 mL). The organic extracts were 
washed with sat. aqueous ammonium chloride (200 mL) and brine (200 mL), dried 
(MgS04), filtered and concentrated in vacuo to afford a crude oil. Purification by 
flash chromatography (silica, eluting with hexanes) afforded the cyclopentene 218 in 
91%.
lH NMR (500 MHz, CDC13) 5 5.64 (s, 2H), 2.44 (d, A of AB, JAB = 15.7 Hz, 1H), 
2.37 (d, B of AB, JAB = 15.7 Hz, 1H), 1.59-1.54 (m, 2H), 1.20-140 (m, 30H), 0.88 (t, 
J= 6.9 Hz, 3H), 0.08 (s, 9H).
I3C NMR (125 MHz, CDC13) 5 128.95 (o), 47.03 (e), 43.18 (e), 32.09 (e), 30.33 (e), 
29.86 (e), 29.83 (e), 29.53 (e), 24.77 (e), 22.85 (e), 14.28 (o), 2.22 (o).
IR (Neat) 2922 (s), 2853 (m), 1466 (w), 1316 (w), 1249 (s), 1063 (m), 837 (s), 752 
(m) cm'1.
HRMS (ESI, [M+Na]^ calcd for C24H48ONaSi403.3372, found 403.3392.
135TMSO x-(ch2)14 4-Heptadecyl-4-(trimethylsilyloxy)cyclopent-2-enone 217.
^ 7 Colour and state: Colorless oil. Regioselectivity >19:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 95:5).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclopentenes, 
modified with propionitrile (10 mL, 0.1 M) using 218 (0.38 g, 1 mmol) in 69%.
^ NMR (500 MHz, CDC13) 5 7.43 (d, J= 5.7 Hz, 1H), 6.10 (d, /= 5.7 Hz, 1H),
2.49 (m, 2H), 2.43-2.35 (m, 2H), 1.70-1.53 (m, 4 H), 1.25 (m, 26H), 0.87 (t, J= 7.0 
Hz, 3H), 0.10 (s, 9H).
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13C NMR (125 MHz, CDCI3) 5 207.07 (e), 167.02 (o), 132.99 (o), 81.42 (e), 49.71 
(e), 42.06 (e), 32.07 (e), 30.00 (e), 29.84 (e), 29.80 (e), 29.77 (e), 29.70 (e), 29.66 (e), 
29.51 (e), 24.45 (e), 22.84 (e), 14.27 (o), 2.29 (o).
IR (Neat) 2923 (s), 2853 (m), 1725 (s), 1466 (w), 1340 (w), 1251(s), 1198 (w), 1075 
(m), 839 (s), 753 (m) cm'1.
HRMS (ESI, [M+Na]^ calcd for C24H4602NaSi417.3165, found 417.3160.
(±)-Untenone A 197.135
Colour and state: Colorless solid.
R/ - 0.3 (Hexane:Ethyl acetate = 
80:20).
Diisopropylamine (0.09 mL, 0,70 mmol) was added to anhydrous tetrahydrofui*an 
(2.50 mL) at 0 °C and stirred for ca. 10 minutes. «-Butyllithium (2.5 M in hexane, 
0.28 mL, 0.70 mmol) was added to the resultant solution dropwise and stirred at 0 °C 
for 15 minutes. The solution was cooled to -78 °C and the cyclopentenone 2X7 (0.099 
g, 0.25 mmol) in tetrahydrofuran (1 mL) was added dropwise. The reaction mixture 
was stirred at -78 °C for 1 hour and methyl cyanofonnate (0.05 mL, 0.60 mmol) in 
HMPA (0.25 mL) was added dropwise. The reaction was stirred at -78 °C for 1 hour 
and slowly warmed to room temperature. The reaction was carefully quenched with 
methanol (5 mL) at 0 °C and stirred vigorously for ca. 1 hour followed by cone, 
hydrochloride acid (1 drop). Water (20 mL) was added to the reaction mixture and 
extracted three times with ethyl acetate (100 mL). The organics were dried (MgSCL), 
filtered and concentrated in vacuo to afford a crude oil. Purification by flash 
chromatography (silica, eluting with ethyl acetate/hexanes 5:1) afforded (±)- 
untenone A 197 in 70%.
COoMe
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^ NMR (500 MHz, CDC13) 5 7.52 (d, J= 5.6 Hz, 1H), 6.19 (d, J = 5.7 Hz, 1H), 
3.79 (s, 3H), 3.61 (s, 1H), 3.47 (s, 1H), 1.84-1.78 (m, 1H), 1.72-1.66 (m, 1H), 1.25 
(m, 3OH), 0.88 (t, J= 7.0 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 200.10 (e), 169.24 (e), 167.29 (o), 132.50 (o), 80.03 
(e), 60.99 (o), 53.11 (o), 40.52 (e), 32.08 (e), 29.91 (e), 29.85 (e), 29.81 (e), 29.79 
(e), 29.76 (e), 29.68 (e), 29.59 (e), 29.52 (e), 28.60 (o), 24.01 (e), 22.85 (e), 14.28 
(o).
IR (Neat) 3458 (b), 2917 (vs), 2850 (s), 1736 (s), 1709 (s), 1467 (w), 1436 (w), 1320 
(m), 1247 (m), 1154 (m), 1002 (w), 818 (w), 766 (w), 721 (w) cm'1.
HRMS (ESI, [M+Na]+) calcd for C23403O4Na403.2824, found 403.2812.
Cyclohex-3-en-l-yl pivalate 227a.136
Colour and state: Colorless oil. R/ = 0.5 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure'. Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a solution of DMAP (0.06 g, 0.5 mmol) and triethylamine (1.04 mL, 7.5 
mmol) in dichloromethane (50 mL) at 0 °C. To the reaction mixture was added 
trimethylacetyl chloride (0.92 mL, 7.5 mmol) slowly and stirred for 2 hours, 
allowing warming up to room temperature. The reaction was quenched with 
saturated aqueous ammonium chloride (50 mL), extracted three times with diethyl 
ether (50 mL) and washed with brine (150 mL). The organics were dried (MgS04), 
filtered and concentrated in vacuo to yield a crude oil. Purification by flash 
chromatography (silica, 2% ethyl acetate/hexane) furnished cyclohexene 227a in 
95%.
iH NMR (500 MHz, CDC13) 8 5.69-5.65 (m, 1H), 5.58-5.54 (m, 1H), 4.50-4.95 (m, 
1H), 2.37-2.31 (m, IH), 2.20-2.01 (m, 3H), 1.85-1.79 (m, IH), 1.75-1.68 (m, IH),
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1.17 (s, 9H).
IR (Neat) 2972 (w), 1725 (vs), 1480 (w), 1282 (s), 1157 (vs) cm1.
^\^0C02Ph Cyclohex-3-en-l-yl phenyl carbonate 227b.
Colour and state: Colorless solid. R/= 0.5 (Hexane:Ethyl acetate = 
95:5). mp = 28-30 °C.
Representative Experimental Procedure: Prepared in accordance to 227a using 
phenyl chloroformate (1.17 g, 7.5 mmol) in 82%.
‘H NMR (500 MHz, CDCI3) 5 7.44-7.36 (m, 2H), 7.29-7.22 (m, 1H), 7.20-7.18 (m, 
2H), 5.74-5.70 (m, 1H), 5.63-5.59 (m, 1H), 5.02-4.97 (m, 1H), 2.54-2.48 (m, 1H), 
2.31-2.13 (3H), 2.06-2.01 (m, 1H), 1.92-1.85 (m, 1H).
13C NMR (125 MHz, CDClj) S 153.35 (e), 151.26 (e), 129.56 (0), 126.94 (0), 126.03 
(o), 123.30 (o), 121.21 (o), 74.91 (0), 30.66 (e), 27.27 (e), 23.28 (e).
IR (Neat) 3031 (w), 2931 (w), 2848 (w), 1752 (vs), 1592 (w), 1494 (m), 1204 (vs), 
1180 (vs), 1160 (vs), 994 (m) cm"1.
HRMS (Cl, [M+NH4f) calcd for C13H18O3N 236.1281, found 236.1280.
OCONHPh CycIohex-3-en-l-yl phenylcarbamate 227c.
Colour and state: Colorless solid. R/= 0.6 (Hexane:Ethyl acetate 
= 90:10). mp = 78-80 °C.
Representative Experimental Procedure: Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a solution of phenyl isocyanate (0.57 mL, 5.25 mmol) in tetrahydrofuran 
(25 mL) at 0 °C. The reaction was stirred for 16 hour's at room temperature and 
concentrated in vacuo. Purification by flash chromatography (silica, 5% ethyl 
acetate/hexane) furnished cyclohexene 227c in 95%.
‘H NMR (500 MHz, CDC13) 8 7.40-7.38 (m, 2H), 7.32-7.29 (m, 2H), 7.07-7.04 (m,
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1H), 6.65 (bs, 1H), 5.73-5.71 (m, IE), 5.63-5.60 (m, 1H), 5.08-5.03 (m, 1H), 2.47- 
2.44 (m, 1H), 2.24-2.15 (m, 3H), 1.98-1.93 (m, 1H), 1.84-1.77 (m, 1H).
13C NMR (125 MHz, CDC13) 5 138.15 (e), 129.15 (o), 126.95 (o), 123.77 (o), 123.39 
(o), 118.66 (o), 70.65 (o), 31.05 (e), 27.51 (e), 23.21 (e).
IR (Neat) 3313 (w), 2948 (w), 2918 (w), 1689 (vs), 1599 (s), 1531 (vs), 1444 (vs), 
1315 (s), 1232 (vs), 1053 (s) cm'1.
HRMS (Cl, [M+NH4]+) calcd for Ci3Hi602N218.1176, found 218.1176.
OCONHTs Cyclohex-3-en-l-yl tosylcarbamate 227d.
Colour and state: Colorless solid. R/= 0.5 (Hexane:Ethyl acetate 
= 90:10). mp = 80-82 °C.
Representative Experimental Procedure: Prepared in accordance to 227c using tosyl 
isocyanate in 95%.
'H NMR (500 MHz, CDC13) 8 7.92-7.90 (m, 2H), 7.33-7.32 (in, 2H), 5.67-5.63 (m, 
1H), 5.53-5.49 (m, 1H), 4.96-4.91 (m, 1H), 2.44 (s, 3H), 2.33-2.29 (m, 1H), 2.14- 
1.99 (m, 3H), 1.83-1.77 (m, 1H), 1.73-1.66 (m, 1H).
I3C NMR (125 MHz, CDCI3) 8 150.37 (e), 145.06 (e), 135.64 (e), 129.63 (0), 128.48 
(0), 126.90 (0), 123.09 (0), 73.25 (o), 30.40 (e), 26.90 (e), 22.75 (e), 21.79 (0).
IR (Neat) 3196 (w), 2937 (w), 2918 (w), 1748 (vs), 1595 (w), 1437 (s), 1339 (s), 
1228 (s), 1153 (vs), 1089 (m), 1044 (m) cm'1.
HRMS (ESI, [M+Na]*) calcd for Ci^HnNOjNaS 318.0776, found 318.0773.
a
OTBS tertf-Biityl(cyclohex-3-en-l-yloxy)dimethylsilane 227e.
Colour and state: Colorless oil. R/= 0.8 (100% Hexane). 
Representative Experimental Procedure: Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a mixture of DMAP (0.06 g, 0.5 mmol), imidazole (0.85 g, 12.5 mmol) in
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dichloromethane (50 inL) at 0 °C. To the reaction mixture was added TBSC1 (0.90 g, 
6 mmol) slowly and stirred for 2 hours, allowing wanning up to room temperature. 
The reaction was quenched with water (50 mL), extracted three times with diethyl 
ether (50 mL) and washed with brine (100 mL). The organics were dried (MgSO^, 
filtered and concentrated in vacuo to yield a crude oil. Purification by flash 
chromatography (silica, eluting with hexane) furnished cyclohexene 227e in 87%.
*H NMR (500 MHz, CDCI3) 8 5.63-5.60 (m, 1H), 5.57-5.53 (m, 1H), 3.88 (dddd, J= 
10.1, 8.2, 5.2, 3.1 Hz, 1H), 2.27-2.22 (m, 1H), 2.19-2.14 (m, 1H), 2.10-1.95 (m, 2H), 
1.83-1.78 (m, 1H), 1.61-1.53 (m, 1H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H).
13C NMR (125 MHz, CDCI3) 8 126.76 (0), 124.85 (0), 68.18 (o), 35.33 (e), 31.94 
(e), 26.05 (o), 24.60 (e), 18.36 (e), -4.50 (o).
IR (Neat) 2928 (m), 2857 (m), 1472 (w), 1251 (m), 1104 (vs) cm1.
HRMS (Cl, [M+H]+) calcd for Ci2H25OSi213.1669, found 213.1664.
/\.''OTBDps ter/-Butyl(cyclohex-3-en-l-yloxy)diphenylsilane 227f.
Colour and state: Colorless oil. R/= 0.8 (100% Hexane). 
Representative Experimental Procedure: Prepared in accordance to 227e using 
TBDPSC1 in 85%.
“H NMR (500 MHz, CDC13) S 7.72-7.69 (m, 4H), 7.45-7.37 (m, 6H), 5.60-5.57 (m, 
1H), 5.52-5.48 (m, 1H), 3.98-3.93 (m, 1H), 2.19-2.05 (m, 3H), 1.95-1.88 (m, 1H), 
1.79-1.75 (m, 1H), 1.68-1.61 (m, 1H), 1.08 (s, 9H).
13C NMR (125 MHz, CDCI3) 8 135.91 (0), 134.79 (e), 129.61 (o), 127.63 (o), 126.72 
(o), 124.69 (o), 68.73 (o), 34.92 (e), 31.44 (e), 27.10 (o), 24.18 (e), 19.34 (e).
IR (Neat) 2929 (w), 2894 (w), 2857 (w), 1472 (w), 1427 (m), 1104 (vs) cm4.
HRMS (ESI, [M+Na]+) calcd for C22H28ONaSi359.1807, found 359.1810.
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,OMOM 4-(Methoxymethoxy)cyclohex-l-ene 227g.
Colour and state: Colorless oil. R/ = 0.5 (Pentane:Diethyl ether =
90:10).
Representative Experimental Procedure'. Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a mixture of diisopropylethylamine (2.61 mL, 15 mmol) at 0 °C. To the 
reaction mixture was added freshly distilled MOMC1 (1.14 mL, 15 mmol) slowly and 
stirred for 6 hours at 0 °C. The reaction was quenched with water (10 mL), extracted 
three times with diethyl ether (20 mL) and washed with brine (50 mL). The organics 
were dried (MgSC>4), filtered and concentrated in vacuo to yield a crude oil. 
Purification by flash chromatography (silica, eluting with 5% diethyl ether/pentane) 
furnished cyclohexene 227g in 70%.
^ NMR (500 MHz, CDC13) 6 5.68-5.64 (m, 1H), 5.61-5.56 (m, 1H), 4.73 (d, A of 
AB, JAB= 6.8 Hz, 1H), 4.70 (d, B of AB, JAb=6.9 Hz, 1H), 3.86-3.81 (m, 1H), 3.38 
(s, 3H), 2.39-2.34 (m, 1H), 2.21-2.16 (m, 1H), 2.12-2.04 (m, 2H), 1.94-1.89 (m, 1H), 
1.69-1.62 (m, 1H).
I3C NMR (125 MHz, CDC13) 6 126.94 (o), 124.29 (o), 94.78 (e), 72.16 (o), 55.27 
(o), 32.09 (e), 28.31 (e), 23.95 (e).
IR (Neat) 2927 (w), 2886 (w), 1439 (w), 1148 (m), 1101 (m), 1034 (vs), 915 (m) cm'
HRMS (Cl, [M+H]+) calcd for C8H1502143.1021, found 143.1023.
4-(2-Methoxyethoxy)cyclohex-l-ene 227h.
Colour and state: Colorless oil. R/= 0.4 (Hexane:Ethyl acetate
= 90:10).
Representative Experimental Procedure'. Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a suspension of sodium hydride (60%, 0.40 g, 10 mmol) in N,N-
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dimethylformamide (25 mL) at 0 °C and stin'ed for 1 hour. To the reaction mixture 
was added bromoethyl methyl ether (1.41 mL, 15 mmol) and stin’ed for 24 hours at 
room temperature. The reaction was quenched with water (50 mL), extracted three 
times with diethyl ether (50 mL) and washed with brine (100 mL). The organics were 
dried (MgSO^, filtered and concentrated in vacuo to yield a crude oil. Purification 
by flash chromatography (silica, eluting with 10% diethyl ether/pentane) furnished 
cyclohexene 227h in 46%.
NMR (500 MHz, CDC13) 8 5.64-5.60 (m, 1H), 5.58-5.54 (m, 1H), 3.68-3.60 (m, 
2H), 3.54 (t, 4.9 Hz, 2H), 3.38 (s, 3H), 2.41-2.34 (m, 1H), 2.20-2.12 (m, 1H),
2.09-1.93 (m, 3H), 1.58(dtd, 13.4, 10.1,5.9 Hz, 1H).
13C NMR (125 MHz, CDC13) 8 126.94 (o), 124.44 (o), 75.19 (o), 72.42 (e), 67.40 
(e), 59.22 (o), 31.81 (e), 28.02 (e), 24.37 (e).
IR (Neat) 2920 (m), 1456 (w), 1358 (w), 1199 (w), 1102 (vs), 1039 (m) cm"1.
HRMS (Cl, [M+H]+) calcd for C9H17O2 157.1023, found 157.1027.
OPiv Cyclohex-3-en-l-ylmethyl pivalate 231a.140
Colour and state: Colorless oil. R/ = 0.5 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: 3-Cyclohexene-1-carboxylic acid (0.58 mL, 
5 mmol) was added dropwise to a suspension of lithium aluminium hydride (0.28 g, 
7.5 mmol) in diethyl ether (50 mL) at 0 °C and stirred for 1 hour. The reaction was 
slowly quenched at 0 °C with saturated aqueous potassium sodium tartrate (50 mL) 
and extracted three times with diethyl ether (50 mL). The organics were dried 
(MgS04), filtered and concentrated in vacuo to yield a crude alcohol as a colourless 
oil. The crude alcohol was added to a solution of DMAP (0.06 g, 0.5 mmol) and 
triethylamine (1.39 mL, 10 mmol) in dichloromethane (50 mL) at 0 °C. To the
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reaction mixture was added trimethylacetyl chloride (0.92 mL, 7.5 mmol) slowly and 
stirred for 2 hours, allowing wanning up to room temperature. The reaction was 
quenched with saturated aqueous ammonium chloride (50 mL), extracted three times 
with diethyl ether (50 mL) and washed with brine (100 mL). The organics were dried 
(MgSCU), filtered and concentrated in vacuo to yield a crude oil. Purification by flash 
chromatography (silica, eluting with 2% ethyl acetate/hexane) furnished cyclohexene 
231a in 78%.
'll NMR (500 MHz, CDCl,) 6 5.68-5.62 (m, 2H), 3.97-3.92 (m, 2H), 2.10-2.04 (m, 
3H), 1.94-1.93 (m, 1H), 1.78-1.74 (m, 2H), 1.34-1.26 (m, 1H), 1.83 (s, 9H).
IR (Neat) 2972 (w), 2919(w), 1729 (vs), 1480 (m), 1285 (m), 1152 (vs) cm'1.
' OTB D P S tert-Butyl(cyclohex-3-en-l-yImethoxy)diphenylsilane 231b.
Colour and state: Colorless oil. R/= 0.8 (100% Hexane). 
Representative Experimental Procedure: 3-Cyclohexene-1-carboxylic acid (0.58 mL, 
5 mmol) was added dropwise to a suspension of lithium aluminium hydride (0.28 g, 
7.5 mmol) in diethyl ether (50 mL) at 0 °C and stirred for 1 hour. The reaction was 
slowly quenched at 0 °C with saturated aqueous potassium sodium tartrate (50 mL) 
and extracted three times with diethyl ether (50 mL). The organics were dried 
(MgSO^, filtered and concentrated in vacuo to yield a crude alcohol as a colourless 
oil. The crude alcohol was added to a solution of DMAP (0.06 g, 0.5 mmol) and 
imidazole (0.85 g, 12.5 mmol) in dichloromethane (50 mL) at 0 °C. To the reaction 
mixture was added TBDPSC1 (1.95 ml, 7.5 mmol) slowly and stirred for 2 horns, 
allowing warming up to room temperature. The reaction was quenched with water 
(50 mL), extracted three times with diethyl ether (50 mL) and washed with brine 
(100 mL). The organics were dried (MgS04), filtered and concentrated in vacuo to 
yield a crude oil. Purification by flash chromatography (silica, eluting with hexane)
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fui'nished cyclohexene 231b in 80%.
‘H NMR (500 MHz, CDCh) 8 7.70-7.68 (m, 4H), 7.45-7.38 (m, 6H), 5.69-5.68 (m, 
2H), 3.57 (d, J= 6.1 Hz, 2H), 2.15-2.06 (m, 3H), 1.91-1.76 (m, 3H), 1.36-1.28 (m, 
1H), 1.07 (s, 9H).
13C NMR (125 MHz, CDC13) 8 135.76 (o), 134.20 (e), 129.65 (o), 127.73 (o), 127.21 
(o), 126.44 (o), 68.72 (e), 36.50 (o), 28.41 (e), 27.02 (o), 25.51 (e), 24.97 (e), 19.48 
(o).
IR (Neat) 2929 (w), 2857 (w), 1472 (w), 1427 (in), 1111 (vs), 1074 (s) cm'1.
HRMS (ESI, [M+Na]1) calcd for C23H3oONaSi373.1964, found 373.1978.
fert-Butyl(l-(cyclohex-3-en-l-yl)ethoxy)dimethylsilane 231 c.
OTBS
Colour and state: Colorless oil. R/= 0.8 (100% Hexane). 
Representative Experimental Procedure: 3-Cyclohexene-1-carboxylic acid (0.58 mL, 
5 mmol) was added dropwise to a suspension of lithium aluminium hydride (0.28 g, 
7.5 mmol) in diethyl ether (50 mL) at 0 °C and stirred for 1 hour. The reaction was 
slowly quenched at 0 °C with saturated aqueous potassium sodium tartrate (50 mL) 
and extracted three times with diethyl ether (50 mL). The organics were dried 
(MgSCL), filtered and concentrated in vacuo to yield a crude alcohol as a colourless 
oil. The crude alcohol was added to PDC (2.82 g, 7.5 mmol) and celite (3 g) in 
dichloromethane (50 mL), and stirred for 12 hours. The reaction mixture was passed 
through a plug of silica, washing with diethyl ether (100 mL), and concentrated in 
vacuo. The crude aldehyde was stirred in diethyl ether (50 mL) at 0 °C and 
methylmagnesium bromide (3 M in diethyl ether, 3.33 mL, 10 mmol) was added. 
The reaction was slowly wanned to room temperature over 2 hours, quenched with 
water (50 mL), extracted three times with diethyl ether (50 mL), and washed with 
brine (100 mL). The organics were dried (MgSCL), filtered and concentrated in
151
vacuo to yield a crude oil. Purification by flash chromatography (silica, eluting with 
20% ethyl acetate/hexane) furnished the secondary alcohol in 75%. The alcohol (3 
mmol) was added to a solution of DMAP (0.04 g, 0.3 mmol) and imidazole (0.51 g, 
7.5 mmol) in dichloromethane (30 mL) at 0 °C. To the reaction mixture was added 
TBSC1 (0.68 g, 4.5 mmol) slowly and stined for 2 horns, allowing wanning up to 
room temperature. The reaction was quenched with water (30 ml), extracted three 
times with diethyl ether (50 ml) and washed with brine (100 ml). The organics were 
dried (MgS04), filtered and concentrated in vacuo to yield a crude oil. Purification 
by flash chromatography (silica, eluting with hexane) furnished cyclohexene 231c in 
87%.
'H NMR (500 MHz, CDCh) 5 5.71-5.63 (m, 2H), 3.69-3.64 (m, 1H), 2.09-1.99 (m, 
3H), 1.89-1.81 (m, 1H), 1.56-1.49 (m, 1H), 1.37-1.29 (m, 1H), 1.12 (d, J - 6.3 Hz, 
3H), 0.88 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H).
13C NMR (125 MHz, CDC13) 5 127.07 (0), 126.92 (o), 71.99 (o), 41.67 (o), 26.91 
(e), 26.06 (o), 25.70 (e), 21.25 (o), 18.25 (e), -4.10 (o), -4.64 (0).
IR (Neat) 2929 (m), 2857 (m), 1463 (w), 1373 (w), 1252 (m), 1141 (m), 1080 (s) cm'
1
HRMS (Cl, [M+H]+) calcd for Ci4H29OSi241.1904, found 241.1905.
terf-Butyl(l-(cyclohex-3-en-l-yl)ethoxy)diphenylsilane 231d.
OTBDPS
Colour and state: Colorless oil. R/= 0.8 (100% Hexane). 
Representative Experimental Procedure: 3-Cyclohexene-1-carboxylic acid (0.58 mL, 
5 mmol) was added dropwise to a suspension of lithium aluminium hydride (0.28 g, 
7.5 mmol) in diethyl ether (50 mL) at 0 °C and stirred for 1 hour. The reaction was 
slowly quenched at 0 °C with saturated aqueous potassium sodium tartrate (50 mL) 
and extracted three times with diethyl ether (50 mL). The organics were dried
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(MgSC^), filtered and concentrated in vacuo to yield a crude alcohol as a colourless 
oil. The crude alcohol was added to PDC (2.82 g, 7.5 mmol) and celite (3 g) in 
dichloromethane (50 mL), and stirred for 12 hours. The reaction mixture was passed 
through a plug of silica, washing with diethyl ether (100 mL), and concentrated in 
vacuo. The crude aldehyde was stirred in diethyl ether (50 mL) at 0 °C and 
methylmagnesium bromide (3 M in diethyl ether, 3.33 mL, 10 mmol) was added. 
The reaction was slowly wanned to room temperature over 2 horns, quenched with 
water (50 mL), extracted three times with diethyl ether (50 mL), and washed with 
brine (100 mL). The organics were dried (MgS04), filtered and concentrated in 
vacuo to yield a crude oil. Purification by flash chromatography (silica, eluting with 
20% ethyl acetate/hexane) furnished the secondary alcohol in 75%. The alcohol (3 
mmol) was added to a solution of DMAP (0.04 g, 0.3 mmol) and imidazole (0.51 g, 
7.5 mmol) in dichloromethane (30 mL) at 0 °C. To the reaction mixture was added 
TBDPC1 (1.17 mL, 4.5 mmol) slowly and stirred for 2 horns, allowing warming up 
to room temperature. The reaction was quenched with water (30 ml), extracted three 
times with diethyl ether (50 ml) and washed with brine (100 ml). The organics were 
dried (MgS04), filtered and concentrated in vacuo to yield a crude oil. Purification 
by flash chromatography (silica, eluting with hexane) furnished cyclohexene 23Id in 
89%.
'H NMR (500 MHz, CDC13) 5 7.70-7.68 (m, 4H), 7.43-7.40 (m, 2H), 7.38-7.35 (m, 
4H), 5.69-5.64 (m, 2H), 3.79-3.71 (m, 1H), 2.08-1.96 (m, 3H), 1.93-1.81 (m, 1H), 
1.73-1.61 (m, 1H), 1.43-1.34 (m, 1H), 1.25-1.17 (m, 1H), 1.04 (s, 9H), 0.99 (d, J = 
6.3 Hz, 3H).
13C NMR (125 MHz, CDC13) 5 136.10 (o), 134.51 (e), 129.61 (o), 127.63 (0), 127.48 
(o), 126.93 (0), 73.10 (o), 41.58 (0), 27.22 (o), 27.09 (e), 25.85 (e), 24.95 (e), 20.31 
(o), 19.61 (e).
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IR (Neat) 2930 (w), 2857 (w), 1427 (m), 1109 (s), 1088 (m) cm'1.
HRMS (ESI, [M+Na]1) calcd for C24H320NaSi 387.1964, found 387.1978.
^^-Butyl((2-(cyclohex-3-eii-l-yl)propan-2-yl)oxy)dimethyl
OTBS
silane 231e.
Colour and state: Colorless oil. R/= 0.8 (100% Hexane).
Representative Experimental Procedure: 3-Cyclohexene-1-carboxylic acid (0.58 mL, 
5 mmol) was stirred in diethyl ether (25 mL) at 0 °C and methylmagnesium bromide 
(3 M in diethyl ether, 5 mL, 15 mmol) was added. The reaction was slowly wanned 
to room temperature over 2 hours, quenched with water (30 mL), extracted three 
times with diethyl ether (50 mL), and washed with brine (100 mL). The organics 
were dried (MgS04), filtered and concentrated in vacuo to yield a crude oil. 
Purification by flash chromatography (silica, eluting with 15% ethyl acetate/hexane) 
furnished the tertiary alcohol in 90%. The alcohol was added to a solution of 
diisopropylethylamine (1.74 mL, 10 mmol) in dichloromethane (50 mL) at 0 °C. tert- 
Butyldimethylsilyl trifluoromethanesulfonate (1.72 mL, 7.5 mmol) was added 
dropwise to the resulting mixture and stirred for 2 hours at 0 °C. The reaction was 
quenched with water (50 mL), extracted three times with diethyl ether (75 mL) and 
washed with brine (150 mL). The organics were dried (MgS04), filtered and 
concentmted in vacuo to yield a crude oil. Purification by flash chromatography 
(silica, eluting with hexane) furnished cyclohexene 231e in 85%.
^ NMR (500 MHz, CDC13) 5 5.71-5.65 (m, 2H), 2.11-1.98 (m, 3H), 1.88-1.82 (m, 
2H), 1.51-1.45 (m, 1H), 1.28-1.21 (m, 1H), 1.18 (s, 3H), 1.16 (s, 3H), 0.86 (s, 9H), 
0.07 (s, 6H).
13C NMR (125 MHz, CDC13) 6 127.37 (o), 127.00 (o), 75.29 (e), 46.19 (o), 27.78 
(o), 27.27 (o), 26.93 (e), 26.50 (e), 26.03 (o), 23.77 (e), 18.40 (e), -1.90 (o), -2.80 (o).
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IR (Neat) 2955 (w), 2928 (w), 2857 (w), 1471 (w), 1365 (w), 1255 (m), 1162 (s), 
1033 (vs) cm'1.
HRMS (Cl, [M+H]+) calcd for Ci5H3iOSi255,2121, found 255.2121.
2-(Cyclohex-3-en-l-yl)isomdoline-l,3-dione 234a.137
Colour and state: Colorless solid. R/^ 0.4 (Hexane:Ethyl acetate 
= 90:10).
Representative Experimental Procedure: Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a solution of triphenylphosphine (1.97 g, 7.5 mmol) and phthalknide (1.10 
g, 7.5 mmol) in tetrahydrofuran (50 mL) at room temperature. The reaction mixture 
was cooled to 0 °C and DIAD (1.48 mL, 7.5 mmol) was added dropwise over 5 
minutes. The reaction was stirred for 12 horns at room temperature and concentrated 
in vacuo onto silica. Purification by flash chromatography (silica, eluting with 5% 
ethyl acetate/hexane) furnished cyclohexene 234a in 61%.
^ NMR (500 MHz, CDC13) 5 7.83-7.82 (m, 2H), 7.71-7.70 (m, 2H), 5.73-5.66 (m, 
2H), 4.41 (ddt, J= 12.0, 5.5, 3.2 Hz, 1H), 2.92 (m, 1H), 2.53 (ddt, /= 12.5, 9.7, 7.9 
Hz, 1H), 2.30-2.12 (m, 3H), 1.81-1.77 (m, 1H).
13C NMR (125 MHz, CDC13) 5 168.52 (e), 133.95 (o), 132.10 (e), 126.67 (o), 125.10 
(o), 123.17 (o), 47.56 (o), 28.75 (e), 26.37 (e), 25.84 (e).
IR (Neat) 3033 (w), 2947 (w), 2854 (w), 1704 (vs), 1471 (w), 1397 (m), 1373 (vs), 
1330 (m), 1109 (s), 923 (m) cm'1.
^\.NHTs Ar-(Cyclohex-3-en-l-yl)-4-methylbenzenesulfonamide 234b.
Colour and state: Colorless oil. R/ = 0.5 (Hexane:Ethyl acetate =
80:20).
Representative Experimental Procedure: Cyclohexenol 226 (0.49 g, 5 mmol) was
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added to a solution of triphenylphosphine (1.97 g, 7.5 mmol) and fert-butyl 
tosylcarbamate (2.03 g, 7.5 mmol) in tetrahydrofuran (50 mL) at room temperature. 
The reaction mixture was cooled to 0 °C and DIAD (1.48 mL, 7.5 mmol) was added 
dropwise over 5 minutes. The reaction was stirred for 12 hours at room temperature 
and concentrated in vacuo onto silica. Purification by flash chromatography (silica, 
eluting with 5% ethyl acetate/hexane) furnished the te/Y-butyl tosylcarbamate 
cyclohexene. The cyclohexene was stirred in dichloromethane (50 mL) at 0 °C and 
trifluoroacetic acid (7.66 mL, 100 mmol) was added dropwise. The reaction was 
stirred for 4 hours, quenched with saturated aqueous sodium bicarbonate (100 mL), 
extracted three times with diethyl ether (75 mL) and washed with brine (150 mL). 
The organics were dried (MgS04), filtered and concentrated in vacuo to yield a crude 
oil. Purification by flash chromatography (silica, eluting with 15% ethyl 
acetate/hexane) furnished cyclohexene 234b in 45%.
‘H NMR (500 MHz, CDCI3) 5 7,78-7.76 (m, 2H), 7.31-7.29 (m, 2H), 5.66-5.61 (m, 
1H), 5.51-5.47 (m, 1H), 4.50-4.49 (m, 1H), 3.52-3.45 (m, 1H), 2.43 (s, 3H), 2.22- 
2.18 (m, 1H), 2.10-2.00 (m, 2H), 1.86-1.79 (in, 1H), 1.76-1.71 (m, 1H), 1.55-1.49 
(m, 1H).
13C NMR (125 MHz, CDC13) 6 143.22 (e), 138.28 (e), 129.70 (o), 127.00 (o), 126.95 
(o), 123.98 (o), 49.04 (o), 32.37 (e), 28.87 (e), 23.54 (e), 21.55 (o).
IR (Neat) 3270 (m), 2921 (w), 1599 (w), 1438 (m), 1322 (s), 1157 (vs), 1094 (m) 
cm'1.
HRMS (ESI, [M+Naf) calcd for Ci3H17N02Na 274.0878, found 274.0881.
^..NHBoc terf-Butyl cycloliex-3-en-l-ylcarbamate 234c.138
Colour and state: Colorless solid. R/= 0.4 (Hexane:Ethyl acetate =
95:5).
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Representative Experimental Procedure: Prepared in accordance to literature.
‘H NMR (500 MHz, CDCls) 8 5.67-5.62 (m, 1H), 5.59-5.55 (m, 1H), 4.57 (bs, 1H), 
3.79-3.73 (m, 1H), 2.36-2.33 (m, 1H), 2.15-2.06 (m, 2H), 1.86-1.80 (m, 2H), 1.54- 
1.47 (m, 1H), 1.42 (s, 9H).
IR (Neat) 3312 (m), 2947 (w), 1674 (vs), 1520 (vs), 1363 (s), 1314 (s), 1239 (s), 
1167 (vs), 1022 (s) cm'1.
. '  blHTFA lV-(Cyclohex-3-en-l-yl)-2,2,2-trifluoroacetamide 234d.138
Colour and state: Colorless solid. R/= 0.4 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: Prepared in accordance to literature.
'll NMR (500 MHz, CDC13) 8 6.32 (bs, 1H), 5.74-5.72 (m, 1H), 5.64-5.60 (m, 1H), 
4.21-4.13 (m, 1H), 2.46-2.43 (m, 1H), 2.25-2.09 (m, 2H), 2.01-1.96 (m, 1H), 1.93- 
1.88 (m, 1H), 1.73-1.67 (m, 1H).
IR (Neat) 3292 (m), 2937 (w), 1698 (s), 1558 (m), 1180 (s), 1151 (vs) cm'1.
/^.NMeBoc terf-Butyl cyclohex-3-en-l-yl(methyl)carbamate 234e.139
Colour and state: Colorless oil. R/ = 0.6 (Hexane:Ethyl acetate =
95:5).
Representative Experimental Procedure: /er/-Butyl cyclohex-3-en-l-ylcarbamate 
234c (0.59 g, 3 mmol) was added to a suspension of sodium hydride (0.18 g, 4.5 
mmol) in A(vV-dimethylformamide (30 mL) at 0 °C and stirred for 1 hour. To the 
reaction mixture was added iodomethane (0.28 mL, 4.5 mmol) and stirred for a 
further 2 hours. The reaction was quenched with water (50 mL), extracted three times 
with diethyl ether (50 mL) and washed with brine (100 mL). The organics were dried 
(MgSCU), filtered and concentrated in vacuo to yield a crude oil. Purification by flash
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chromatography (silica, eluting with 3% ethyl acetate/hexane) furnished cyclohexene 
234e in 88%.
‘H NMR (500 MHz, CDCU) 5 5.65-5.61 (m, 2H), 4.26-4.05 (m, 1H), 2.74 (s, 3H), 
2.17-2.05 (m, 4H), 1.70-1.62 (m, 2H), 1.46 (s, 9H).
IR (Neat) 2973 (w), 2922 (w), 1687 (vs), 1363 (s), 1311 (s), 1139 (vs) cm'1.
NBocOBoc fert-Butyl (tert-butoxycarbonyI)oxy(cyclohex-3-en-l-yl) 
carbamate 234f.
Colour and state: Colorless solid. R/= 0.6 (Hexane:Ethyl acetate = 95:5). mp = 68- 
71 °C.
Representative Experimental Procedure: Cyclohexenol 226 (0.49 g, 5 mmol) was 
added to a solution of triphenylphosphine (1.97 g, 7.5 mmol) and te/Y-butyl {tert- 
butoxycarbonyl)oxycarbamate (1.75 g, 7.5 mmol) in tetrahydrofuran (50 mL) at 
room temperature. The reaction mixture was cooled to 0 °C and DIAD (1.48 mL, 7.5 
mmol) was added dropwise over 5 minutes. The reaction was stirred for 12 hours at 
room temperature and concentrated in vacuo onto silica. Purification by flash 
chromatography (silica, eluting with 3% ethyl acetate/hexane) furnished cyclohexene 
234f in 53%.
’H NMR (500 MHz, CDCI3) S 5.61-5.60 (m, 2H), 4.29-4.21 (m, 1H), 2.34-2.08 (m, 
4H), 1.97-1.95 (m, 1H), 1.81-1.80 (m, 1H), 1.51 (s, 9H), 1.47 (s, 9H).
13C NMR (125 MHz, CDC13) 8 154.88 (e), 152.76 (e), 126.50 (o), 125.06 (0), 84.44 
(e), 82.39 (e), 55.48 (o), 28.23 (o), 28.10 (e), 27.69 (o), 27.24 (e), 25.54 (e).
IR (Neat) 2976 (w), 2936 (w), 1786 (vs), 1703 (vs), 1370 (s), 1354 (vs), 1300 (m), 
1240 (vs), 1146 (vs), 1083 (s) cm'1.
HRMS (ESI, [M+Na]+) calcd for C1(iH27N05Na 336.1787, found 336.1791.
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General Procedure for the Copper(I)-NHC-CataIyzed Allylic Oxidation of 
Cyclohexenes:
Copper(I)-NHC catalyst 183 (5.04 mg, 0.013 mmol) and sodium bicarbonate 
(21 mg, 0.25 mmol) were added to a 10 mL round bottom flask under air. The septa 
contained a needle to allow gas to escape during the course of the reaction. 
Acetonitrile (0.50 mL) was added to reaction flask, followed by the cyclohexene 
227a-h, 231a-e, 234a-f, (JR)-234a, 237, (i?)-237, 239 or 241 (0.25 mmol) and stirred 
for ca. 10 minutes. te/y-ButyIhydroperoxide (5.5 M in decane, 0.23 mL, 1.250 mmol) 
was added to the reaction solution via syringe-pump (rate of ca. 0.3 eq/h) at room 
temperature and stirred until completion (t.l.c. control). The solution was filtered 
through a short plug of silica using ethyl acetate and concentrated in vacuo. The 
crude oils were purified by flash chromatography (silica, eluting with ethyl 
acetate/hexanes) to afford the cyclohexenones.
OPiv 5-Oxocyclohex-3-en-l-yl pivalate 228a.
Colour and state: Yellow oil. Regioselectivity: 228a/229a =1:1.
O
R/= 0.3 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227a (0.046 g, 0.25 mmol) in 83%.
‘H NMR (500 MHz, CDCI3) 8 6.88 (dt, J= 10.1, 4.1 Hz, 1H), 6.12 (dt, J= 10.2, 2.0
Hz, 1H), 5.35-5.31 (m, 1H), 2.76-2.73 (m, 1H), 2.73 (dd, A of ABX, JAB = 16.6 Hz,
Jax = 6.5 Hz, 1H), 2.63 (dd, B of ABX, Jab = 16.6 Hz, JBX = 7.2 Hz, 1H), 2.54-2.50 
(in, 1H), 1.16 (s, 9H).
,3C NMR (125 MHz, CDC13) 5 196.50 (e), 177.85 (e), 145.76 (o), 130.26 (o), 68.57 
(o), 43.16 (e), 38.87 (e), 31.00 (e), 27.22 (o).
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IR (Neat) 2973 (m), 1725 (vs), 1683 (vs), 1480 (m), 1281 (s), 1153 (vs), 1033 (s) 
cm"1.
HRMS (Cl, [M+NH4]+) calcd for CiiH2o03N214.1438, found 214.1440.
oj0-'OPiv 4-Oxocyclohex-2-en-l-yI pivalate 229a.
Colour and state: Yellow oil. Regioselectivity: 228a/229a =1:1. 
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227a (0.046 g, 0.25 mmol) in 83%.
'B. NMR (500 MHz, CDCls) 5 6.83 (ddd, /= 10.3, 2.8, 1.4 Hz, 1H), 6.06 (d, J =
10.3 Hz, 1H), 5.56-5.52 (m, 1H), 2.62 (dt, J= 17.0, 5.2 Hz, 1H), 2.46 (ddd, J= 16.9, 
11.7, 5.0 Hz, 1H), 2.37-2.31 (m, 1H), 2.08 (dddd, 13.1, 11.7, 8.7, 4.5 Hz, 1H), 
1.22 (s, 9H).
13C NMR (125 MHz, CDC13) 5 198.19 (e), 177.95 (e), 148.00 (o), 130.97 (o), 67.55 
(o), 40.92 (e), 35.10 (e), 28.76 (e), 27.22 (o).
IR (Neat) 2973 (w), 1727 (vs), 1686 (vs), 1481 (w), 1278 (m), 1146 (vs), 1034 (s) 
cm'1.
HRMS (Cl, [M+H]+) calcd for CnHnChs 197.1172, found 197.1171.
OC02Ph 5-Oxocyclohex-3-en-l-yl phenyl carbonate 228b.
Colour and state: Yellow oil. Regioselectivity: 228b/229b = 2:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227b (0.055 g, 0.25 mmol) in 83%.
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'H NMR (500 MHz, CDCI3) 8 7.43-7.40 (m, 2H), 7.30-7.27 (m, 1H), 7.21-7.19 (m,
2H), 6.96 (dt, J = 10.2, 4.1 Hz, 1H), 6.20 (dt, 7= 10.2, 1.9 Hz, 1H), 5.36-5.32 (m,
1H), 2.92-2.86 (m, 1H), 2.90 (dd, A of ABX, JAB = 16.8 Hz, JAX= 7.9 Hz, 1H), 2.84
(dd, B of ABX, JAB = 16.7 Hz, Jbx = 7.6 Hz, 1H), 2.77-2.70 (m, 1H).
13C NMR (125 MHz, CDCI3) 5 195.67 (e), 152.96 (e), 150.91 (e), 145.42 (0), 130.49
(o), 129.68 (o), 126.36 (0), 121.05 (0), 73.40 (o), 43.10 (e), 30.89 (e).
IR (Neat) 2924 (w), 1760 (s), 1693 (s), 1488 (m), 1250 (vs), 1206 (vs) 1070 (m) cm' 
1
HRMS (ESI, [M+Na]+) calcd for CnHizC^Na255.0633, found 255.0629.
OCONHPh 5-Oxocyclohex-3-en-l-yI phenylcarbamate 228c.
Colour and state: Yellow oil. Regioselectivity: 228c/229c = 2:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 50:50).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)“NHC-catalyzed allylic oxidation of cyclohexenes using 
227c (0.054 g, 0.25 mmol) in 82%.
'H NMR (500 MHz, CDCI3) 8 7.32-7.29 (m, 2H), 7.18-7.16 (m, 2H), 7.09-7.05 (m, 
1H), 6.90 (dt, J= 10.3, 4.1 Hz, 1H), 6.64 (bs, 1H), 6.15 (dt, J= 10.2, 1.9 Hz, 1H), 
5.41-5.37 (m, 1H), 2.84-2.79 (m, 1H), 2.80 (dd, A of ABX, JAb = 16.6 Hz, JAX= 6.9 
Hz, 1H), 2.72 (dd, B of ABX, Jab = 16.6 Hz, JBx = 6.9 Hz, 1H), 2.68-2.62 (m, 1H). 
13C NMR (125 MHz, CDCI3) 8 196.68 (e), 146.05 (o), 137.62 (e), 130.25 (o), 129.23 
(0), 123.82 (0), 118.80 (o), 69.78 (0), 43.46 (e), 31.32 (e).
IR (Neat) 3309 (w), 2973 (w), 1713 (s), 1673 (vs), 1599 (s), 1535 (s), 1444 (s), 1314 
(m), 1209 (vs), 1050 (s) cm'1.
HRMS (ESI, [M+Na]+) calcd for CnH.sNOsNa 254.0793, found 254.0798.
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OCONHTs 5-Oxocyclohex-3-en-l-yl tosylcarbamate 228d.
O
10:1.
Colour and state: Brown gum. Regioselectivity: 228d/229d =
R/= 0.3 (Hexane:Ethyl acetate = 30:70). mp = 86-88 °C.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227d (0.074 g, 0.25 mmol) in 81%.
‘H NMR (500 MHz, CDCb) 5 7.88-7.86 (m, 2H), 7.35-7.33 (m, 2H), 6.83 (dt, J - 
10.1, 4.2 Hz, 1H), 6.09 (dt, 10.2, 1.9 Hz, 1H), 5.27-5.23 (m, 1H), 2.69-2.65 (m, 
2H), 2.60-2.54 (m, 2H), 2.45 (s, 3H).
,3C NMR (125 MHz, CDC13) 8 195.64 (e), 149.81 (e), 145.44 (o), 135.44 (e), 130.25 
(o), 129.83 (o), 128.49 (o), 71.95 (o), 42.84 (e), 30.75 (e), 21.85 (o).
IR (Neat) 3261 (w), 2923 (w), 1671 (s), 1326 (s), 1155 (vs) 1090 (s) cm'1.
HRMS (ESI, [M+Na]+) calcd for CwHuNOsNaS 332.0569, found 332.0578.
5-((/ert-Butyldimethylsilyl)oxy)cyclohex-2-enone 228e.141
Colour and state: Yellow oil. Regioselectivity: 228e/229e = 6:1.
O
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227e (0.053 g, 0.25 mmol) in 75%.
'H NMR (500 MHz, CDCI3) 8 6.87 (ddd,./ = 10.1, 5.2, 3.3 Hz, 1H), 6.05 (dt, J =
10.1, 1.9 Hz, 1H), 4.25-4.20(m, 1H), 2.66 (dd, A of ABX, Jab = 16.0 Hz, X,a--4.1 
Hz, 1H), 2.49 (dd, B of ABX, JAB = 16.0 Hz, JBx = 9.7 Hz, 1H), 2.62-2.56 (m, 1H), 
2.38 (tdd, 18.3, 7.7, 2.9 Hz, 1H), 0.87 (s, 9H), 0.07 (s, 6H).
IR (Neat) 2930 (m), 2858 (w), 1680 (s), 1472 (w), 1389 (w), 1251 (s), 1099 (vs) cm'
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1OTBDPS 5-((te/'^-ButyldiphenylsiIyI)oxy)cyclohex-2-enone 228f.
Colour and state: Yellow oil. Regioselectivity: 228f/229f= 11:1.
O
R/= 0.5 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227f (0.084 g, 0.25 mmol) in 74%.
‘H NMR (500 MHz, CDCU) 6 7.66-7.63 (m, 4H), 7.46-7.43 (m, 2H), 7.40-7.37 (m, 
4H), 6.79 (dt, J= 10.1, 4.9 Hz, 1H), 6.03 (dt, J = 10.1, 1.9 Hz, 1H), 4.26-4.21 (m, 
1H), 2.64-2.54 (m, 2H), 2.48-2.38 (m, 2H), 1.04 (s, 9H).
I3C NMR (125 MHz, CDClj) S 198.68 (e), 146.94 (o), 135.81 (o), 133.85 (e), 130.13 
(0), 130.06 (0), 127.85 (0), 68.38 (o), 47.61 (e), 35.14 (e), 26.94 (o), 19.22 (e).
IR (Neat) 2931 (w), 2858 (w), 1682 (s), 1472 (w), 1427 (m), 1105 (vs), 1073 (s) cm"
1
HRMS (ESI, [M+Naf) calcd for C22H2602NaSi373.1600, found 373.1608
OMOM 5-(Methoxymethoxy)cyclohex-2-enone 228g.142
Colour and state: Yellow oil. Regioselectivity: 228g/229g = 6:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227g (0.036 g, 0.25 mmol) in 73%.
‘H NMR (500 MHz, CDC13) S 6.89 (dt, J = 10.4, 4.2 Hz, 1H), 6.08 (d, 7= 10.1, 1.9
Hz, 1H), 4.67 (bs, 2H), 4.17 (tdd, J= 8.6, 7.0, 4.3 Hz, 1H), 3.36 (s, 3H), 2.74 (dd, A
of ABX, Jab = 16.3 Hz, JAx = 4.0 Hz, 1H), 2.60 (dd, B of ABX, Jab = 16.1 Hz, JBx =
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8.8 Hz, 1H), 2.71-2.67 (m, 1H), 2.53-2.47 (m, 1H).
IR (Neat) 2938 (w), 1676 (s), 1389 (w), 1148 (m), 1026 (vs), 916 (m) cm'1.
°'^/VvOMe
O
>19:1.
5-(2-Methoxyethoxy)cyclohex-2-enone 228h.
Colour and state: Yellow oil. Regioselectivity: 228h/229h
R/= 0.3 (Hexane:Ethyl acetate = 50:50).
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
227h (0.039 g, 0.25 mmol) in 75%.
ln NMR (500 MHz, CDC13) 6 6.89 (ddd, 10.1, 5.1, 3.4 Hz, 1H), 6.06 (dt, 7- 
10.1, 1.9 Hz, 1H), 3.96-3.91 (m, 1H), 3.67-3.59 (m, 1H), 3.52 (t, 4.8 Hz, 2H),
3.37 (s, 3H), 2.79 (dd, A of ABX, JAB = 16.1 Hz, 4.0 Hz, 1H), 2.55 (dd, B of 
ABX, JAB = 16.1 Hz, JBX = 9.7 Hz, 1H), 2.74-2.69 (m, 1H), 2.46 (tdd, /= 18.4, 7.7, 
2.9 Hz, 1H).
13C NMR (125 MHz, CDC13) 5 198.22 (e), 146.86 (o), 130.34 (o), 74.69 (o), 72.21 
(e), 68.05 (e), 59.27 (o), 44.51 (e), 32.31 (e).
IR (Neat) 2923 (m), 1677 (vs), 1391 (w), 1249 (m), 1092 (vs) 1033 (s) cm1.
HRMS (Cl, [M+H]+) calcd for C9H1503 171.1016, found 171.1015.
OPiv (5-Oxocyclohex-3-en-l-yl)methyl pivalate 232a.
Colour and state: Yellow oil. Regioselectivity: 232a/233a = 3:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure', Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
231a (0.049 g, 0.25 mmol) in 78%.
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‘II NMR (500 MHz, CDCI3) 8 6.98 (ddd, 7= 10.1, 5.5, 2.7 Hz, 1H), 6.06 (dd, J = 
10.1, 2.7 Hz, 1H), 4.07-4.01 (m, 2H), 2.57-2.43 (m, 2H), 2.30-2.17 (in, 2H), 1.27- 
1.23 (m, 1H), 1.21 (s, 9H).
I3C NMR (125 MHz, CDCI3) S 198.53 (e), 178.45 (e), 148.92 (o), 130.08 (o), 67.03 
(e), 40.95 (e), 34.81 (o), 29.85 (e), 28.81 (e), 27.35 (0).
IR (Neat) 2973 (w), 1728 (vs), 1683 (vs), 1481 (w), 1283 (m), 1154 (vs) cm'1.
HRMS (Cl, [M+Nfttf) calcd for C12H22O3N 228.1594, found 228.1594.
OTBDPS 5-(((fc/7-Biityldiphenylsilyl)oxy)methyI)cydohex-2-enone
232b.
O
Colour and state: Yellow oil. Regioselectivity: 232b/233b = 3:1.
R/= 0.4 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
231b (0.088 g, 0.25 mmol) in 83%.
‘H NMR (500 MHz, CDC13) 8 7.67-7.64 (m, 4H), 7.47-7.38 (m, 6H), 7.00-6.96 (m, 
1H), 6.03 (d, J= 10.0 Hz, 1H), 3.67-3.57 (m, 2H), 2.53-2.28 (m, 4H), 1.06 (s, 9H). 
13C NMR (125 MHz, CDCI3) 8 199.90 (e), 149.88 (o), 135.69 (o), 133.45 (e), 129.99 
(0), 129.84 (o), 127.92 (o), 66.95 (e), 41.07 (e), 37.85 (0), 28.82 (e), 26.97 (o), 19.44 
(e).
IR (Neat) 2931 (w), 2858 (w), 1681 (vs), 1427 (s), 1106 (vs) cm'1.
HRMS (ESI, [M+Naf) calcd for CzsHjgCWaSi 387.1756, found 387.1757.
5-(l-((te/7-Butyldimethylsilyl)oxy)ethyl)cyclohex-2-enone 232c.
OTBS
Colour and state: Yellow oil. Regioselectivity: 232c/233c = 7:1. 
R/= 0.4 (Hexane:Ethyl acetate = 90:10).
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Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
231c (0.060 g, 0.25 mmol) in 74%.
XH NMR (500 MHz, CDC13) 5 7.03-6.97 (m, 1H), 6.01 (dd, /= 10.0, 2.7 Hz, 1H), 
3.78-3.68 (m, 1H), 2.46-2.23 (m, 4H), 2.10-2.04 (m, 1H), 1.35 (d, /= 6.4 Hz, 3H), 
0.88 (s, 9H), 0.06 (s, 6H).
13C NMR (125 MHz, CDC13) 5 200.52 (e), 150.47 (o), 129.59 (o), 70.50 (o), 42.84 
(o), 41.93 (e), 29.05 (e), 25.98 (o), 21.28 (o), 18.18 (e), -4.04 (o).
IR (Neat) 2955 (w), 2929 (w), 2857 (w), 1683 (vs), 1388 (w), 1252 (s), 1076 (s) cm
i
HRMS (ESI, [M+Na]+) calcd for Ci^CbNaSi 277.1600, found 277.1604.
5-(l-((ter/-Butyldiphenylsilyl)oxy)ethyl)cyclohex-2-enone 
232d.
Colour and state: Yellow oil. Regioselectivity: 232d/233d = 9:1. 
R/= 0.4 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
231d (0.091 g, 0.25 mmol) in 81%.
'H NMR (500 MHz, CDC13) 8 7.68-7.66 (in, 4H), 7.45-7.42 (m, 2H), 7.40-7.37 (m, 
4H), 7.01-6.97 (m, 1H), 6.01 (d, 7= 10.0 Hz, 1H), 3.80 (tdd, 7= 26.7, 10.1, 6.3 Hz, 
1H), 2.48-2.23 (m, 4H), 2.16-2.09 (m, 1H), 1.05 (s, 9H), 1.03 (d, 7= 6.3 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 200.41 (e), 150.38 (o), 135.92 (o), 134.40 (e), 129.82
(o), 129.59 (0), 127.75 (o), 71.56 (o), 42.59 (0), 41.24 (e), 28.49 (e), 26.89 (0), 20.29 
(o), 19.47 (e).
IR (Neat) 2931 (w), 2858 (w), 1680 (vs), 1427 (m), 1110 (vs), 1076 (s) cm'1.
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HRMS (ESI, [M+Na]+) calcd for CwHsoCWaSi401.1913, found 401.1914.
5-(2-((^r/-ButyldimethylsiIyl)oxy)propan-2-yl)cyclohex-2-
OTBS
enone 232e.
Colour and state: Yellow oil. Regioselectivity: 232e/233e — 12:1. 
R/= 0.4 (Hexane:Ethyl acetate = 90:10).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
231e (0.064 g, 0.25 mmol) in 83%.
‘H NMR (500 MHz, CDCl,) 8 7.04-7.00 (m, 1H), 6.01 (d, J = 10.0 Hz, 1H), 2.58- 
2.54 (m, 1H), 2.48-2.42 (m, 1H), 2.35-2.26 (m, 2H), 2.01-1.94 (m, 1H), 1.24 (s, 3H), 
1.21 (s, 3H), 0.85 (s, 9H), 0.08 (s, 3H), 0.08 (s, 3H).
13C NMR (125 MHz, CDC13) 5 201.32 (e), 150.95 (o), 129.23 (o), 73.98 (e), 46.96 
(o), 39.58 (e), 28.02 (o), 27.66 (o), 27.05 (e), 25.98 (o), 18.36 (e), -2.00 (o).
IR (Neat) 2954 (w), 2929 (w), 2857 (w), 1682 (vs), 1386 (w), 1255 (m), 1149 (s), 
1033 (vs) cm'1.
HRMS (ESI, [M+Na]+) calcd for Ci5H2802NaSi29U756, found 291.1754.
2-(5-Oxocyclohex-3-en-l-yl)isomdoline-l,3-dione 235a.
Colour and state: Colorless solid. Regioselectivity: 235a/236a =
10:1.
R/= 0.3 (Hexane:Ethyl acetate = 80:20). mp = 166-168 °C.
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
234a (0.057 g, 0.25 mmol) in 83%.
'H NMR (500 MHz, CDCh) 8 7.86-7.84 (m, 2H), 7.76-7.73 (m, 2H), 7.05-7.02 (m,
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1H), 6.14 (dd,J= 10.2, 2.4 Hz, 1H), 4.83-4.76 (m, 1H), 3.44 (dd, 15.7, 14.3 Hz, 
1H), 3.32-3.26 (m, 1H), 2.59 (d, /= 16.1, 3.9 Hz, 1H), 2.51 (dt, 7 = 18.1, 5.3 Hz, 
1H).
13C NMR (125 MHz, CDC13) 6 197.49 (e), 168.05 (e), 148.19 (o), 134.46 (o), 131.71 
(e), 130.03 (o), 123.60 (o), 45.79 (o), 41.65 (e), 29.50 (e).
IR (Neat) 2923 (w), 1695 (vs), 1667 (vs), 1467 (w), 1375 (s), 1280 (m), 1107 (s) cm'
i
HRMS (ESI, [M+Na]^ calcd for Ci4HiiN03Na264.0637, found 264.0638.
O
NHTs 4-Methyl-Ar-(5-o\ocyclohex-3-eii-l-yl)benzeiiesull(mamide 235b.
Colour and state: Colorless solid. Regioselectivity: 235b/236b = 10:1. 
R/= 0.3 (Hexane:Ethyl acetate = 60:40). mp = 126-130 °C.
Representative Experimental Procedure’. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
234b (0.063 g, 0.25 mmol) in 83%.
lB. NMR (500 MHz, CDC13) 5 7.75-7.73 (m, 2H), 7.31-7.29 (m, 2H), 6.85 (ddd, J =
10.1, 5.2, 3.2 Hz, 1H), 6.03 (diJ= 10.1 Hz, 1H), 5.53 (d, J= 8.0 Hz, 1H), 3.80-3.73 
(m, 1H), 2.63 (dt, / - 18.5, 5.0 Hz, 1H), 2.51 (dd, A of ABX, JAB = 16.3 Hz, Jax = 
4.3 Hz, 1H), 2.55 (dd, B of ABX, JAB = 16.4 Hz, JBX « 5.5 Hz, 1H), 2.43 (s, 3H), 
2.39-2.34 (m, 1H).
13C NMR (125 MHz, CDC13) 6 196.94 (e), 147.54 (o), 143.95 (e), 137.57 (e), 130.05
(o), 128.63 (o), 127.02 (o), 49.39 (o), 44.86 (e), 33.34 (e), 21.70 (o).
IR (Neat) 3223 (w), 2923 (w), 1657 (vs), 1444 (w), 1330 (m), 1149 (vs), 1063 (s) 
cm'1.
HRMS (ESI, [M+Naf) calcd for Ci3Hi5N03NaS 288.0670, found 288.0676.
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NHBoc tert-Butyl (5--oxocyclohex-3-eii-l-yl)carbainate 235c.
Colour and state: Yellow solid. Regioselectivity: 235c/236c — 14:1.
O
R/= 0.3 (Hexane:Ethyl acetate = 80:20). mp = 54-57 °C.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
234c (0.049 g, 0.25 mmol) in 72%.
'H NMR (500 MHz, CDCI3) 5 6.93 (ddd, J = 10.2, 4.9, 3.4 Hz, 1H), 6.09 (dt, J =
10.2, 1.9 Hz, 1H), 4.68 (bs, 1H), 4.21-4.16 (m, 1H), 2.77-2.70 (m, 2H), 2.44 (d, J = 
16.1, 10.0Hz, 1H), 2.36-2.31 (m, 1H), 1.44(s, 9H).
13C NMR (125 MHz, CDC13) 8 197.66 (e), 154.97 (e), 147.78 (o), 130.31 (o), 79.97
(e), 46.60 (o), 44.56 (e), 32.66 (e), 28.43 (o).
IR (Neat) 3363 (w), 2975 (w), 1674 (vs), 1518 (vs), 1367 (s), 1247 (s), 1167 (vs) 
1050 (m) cm'1.
HRMS (Cl, [M+H]+) calcd for CnHisOsmami, found 212.1283.
NHTFA 2,2,2-Trifluoro-lV-(5-oxocyclohex-3-en-l-yl)acetamide 235d.
Colour and state: Yellow oil. Regioselectivity: 235d/236d- 14:1.
O
R/= 0.3 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
234d (0.048 g, 0.25 mmol) in 74%.
*H NMR (500 MHz, CDC13) 8 6.97 (ddd, J= 10.2, 4.9, 3.5 Hz, 1H), 6.57 (bs, 1H),
6.16 (dt, J= 10.2, 1.9 Hz, 1H), 4.58-4.51 (m, 1H), 2.85-2.79 (m, 1H), 2.79 (dd, A of
ABX, J,W - 16.5 Hz, Jax = 4.5 Hz, 1H), 2.57 (dd, B of ABX, Jab = 16.4 Hz, JBx = 
9.9 Hz, 1H), 2.48 (tdd, 7= 18.5, 7.9, 2.9 Hz, 1H).
13C NMR (125 MHz, CDCI3) 8 196.03 (e), 181.74 (e), 146.92 (o), 130.53 (0), 46.30
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(o), 43.16(e), 31.28 (e).
IR (Neat) 3291 (w), 2923 (w), 1706 (vs), 1683 (vs), 1554 (s), 1388 (m), 1156 (vs), 
1033 (m) cm'1.
HRMS (Cl, [M+NH4]+) calcd for C8H12O2N2F3 225.0845, found 225.0847.
terf-Butyl methyl(5-oxocyclohex-3-en-l-yl)carbamate 235e.
Colour and state: Yellow oil. Regioselectivity: 235e/236e = 16:1.
O
R/= 0.4 (Hexane:Ethyl acetate = 80:20).
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
234e (0.053 g, 0.25 mmol) in 69%.
‘H NMR (500 MHz, CDCI3) 8 6.98 (ddd, J = 10.1, 6.1, 2.4 Hz, 1H), 6.06 (d, J =
10.0 Hz, 1H), 4.61-4.45 (m, 1H), 2.80 (s, 3H), 2.64-2.50 (m, 3H), 2.43 (dt, J= 18.2, 
5.1 Hz, 1H), 1.45 (s, 9H).
13C NMR (125 MHz, CDClj) 8 198.61 (e), 148.67 (o), 129.99 (o), 28.55 (o).
IR (Neat) 2974 (w), 1679 (vs), 1480 (w), 1365 (s), 1146 (vs), 1033 (in) cm'1.
HRMS (ESI, [M+Na]'*) calcd for CijH^NOsNa 248.1263, found 248.1255.
. NBocOBoc te/tf-Butyl (tert-butoxycarbonyl)oxy(5-oxocyclohex-3-en-l- 
yl)carbamate 235f.
Colour and state: Pale yellow solid. Regioselectivity: 235f/236f >\9\\. R/= 0.4 
(Hexane:Ethyl acetate = 80:20). mp = 90-93 °C.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
234f (0.078 g, 0.25 mmol) in 75%.
]H NMR (500 MHz, CDCI3) 8 6.97 (m, 1H), 6.06 (d, J= 9.9 Hz, 1H), 4.72-4.65 (m,
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1H), 2.78-2,49 (m, 4H), 1.52 (s, 9H), 1.48 (s, 9H).
13C NMR (125 MHz, CDC13) 5 197.57 (e), 153.98 (e), 147.80 (o), 130.01 (o), 85.32
(e), 83.32 (e), 54.56 (o), 41.42 (e), 41.19 (e), 28.21 (o), 27.71 (o).
IR (Neat) 2974 (w), 1786 (vs), 1707 (vs), 1673 (vs), 1370 (s), 1237 (vs), 1147 (vs), 
1095 (s), 1003 (s) cm'1.
HRMS (ESI, [M+Na]+) calcd for Ci6H25N06Na 350.1580, found 350.1577.
(i?)-2-(Cyclohex-3-en-l-yl)isoindoline-l,3-dione (i?)-234a.
Colour and state: Colorless solid. R/= 0.4 (Hexane:Ethyl acetate 
= 90:10). [a]D20 =: +4.4 (c 1.00, CHCI3). 99% ee determination by
chiral HPLC: Chiralpak AD-H column, hexane/z-PrOH 95:5, 0.2 mL/min; retention 
times: 31.8 min {R). mp = 154-157 °C.
Representative Experimental Procedure: Bis(((iS)-binaphthoxy)(isopropoxy)titanium) 
oxide (10 mol %) and 4-pentenal (0.84 g, 10 mmol) was stirred in dichloromethane 
(100 mL) at -15 °C. To the reaction mixture was added allyltributyltin (3.41 mL, 11 
mmol) and stirred at 0 °C for 12 hours. The reaction was quenched with saturated 
aqueous sodium bicarbonate (100 mL), extracted three times with diethyl ether (100 
mL) and washed with brine (200 mL). The organics were dried (MgSCL), filtered and 
concentrated in vacuo to yield a crude oil. Purification by flash chromatography 
(silica, eluting with 15% ethyl acetate/hexane) fumished the homoallylic alcohol in 
70%. The alcohol (0.63 g, 5 mmol) was added to a solution of triphenylphosphine 
(1.97 g, 7.5 mmol) and phthalimide (1.10 g, 7.5 mmol) in tetrahydrofuran (50 mL) at 
room temperature. The reaction mixture was cooled to 0 °C and DIAD (1.48 mL, 7.5 
mmol) was added dropwise over 5 minutes. The reaction was stirred for 12 hours at 
room temperature and concentrated in vacuo onto silica. Purification by flash 
chromatography (silica, eluting with 5% ethyl acetate/hexane) furnished the
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phthalimide in 55%. The oil (0.51 g, 2 mmol) was added to a solution of 2nd 
Generation Grubb’s catalyst (0.04 g, 2.5 mol %) in dichloromethane (20 mL). The 
reaction mixture was stirred for 2 hours, followed by the addition of 
dimethylsulfoxide (0.36 mL, 5 mmol), and then stirred for 12 hours. The mixture 
was concentrated in vacuo and purification by flash chromatography (silica, 5% ethyl 
acetate/hexane) furnished the cyclohexene (Z?)-234a in 79%.
‘H NMR (500 MHz, CDCI3) 5 7.83-7.82 (m, 2H), 7.71-7.70 (m, 2H), 5.73-5.66 (m, 
2H), 4.41 (ddt, J = 12.0, 5.5, 3.2 Hz, 1H), 2.92 (in, 1H), 2.53 (ddt, 7 = 12.5, 9.7, 7.9 
Hz, 1H), 2.30-2.12 (m, 3H), 1.81-1.77 (m, 1H).
“c NMR (125 MHz, CDC13) 8 168.52 (e), 133.95 (o), 132.10 (e), 126.67 (o), 125.10 
(o), 123.17 (o), 47.56 (o), 28.75 (e), 26.37 (e), 25.84 (e).
IR (Neat) 3033 (w), 2947 (w), 2854 (w), 1704 (vs), 1471 (w), 1397 (m), 1373 (vs), 
1330 (m), 1109 (s), 923 (m) cm'1.
Ov / \ 2-(3-Methylcyclohex-3-en-l-yl)isoindoline-l,3-dione 237.Y\J
N-'v(/ Colour and state: Colorless solid. R/ = 0.4 (Hexane:Ethyl 
O
acetate = 90:10). mp - 156-158 °C.
Representative Experimental Procedure: Indium (1.26 g, 11 mmol) and 4-pentenal 
(0.84 g, 10 mmol) was stirred in water (100 mL) at 0 °C. To the reaction mixture was 
added 2-methylallyl bromide (1.51 mL, 15 mmol) and stirred at room temperature 
for 12 hours. The reaction was quenched with saturated aqueous sodium bicarbonate 
(100 mL), extracted three times with diethyl ether (100 mL) and washed with brine 
(150 mL). The organics were dried (MgS04), filtered and concentrated in vacuo to 
yield a crude oil. Purification by flash chromatography (silica, eluting with 15% 
ethyl acetate/hexane) furnished the homoallylic alcohol in 90%. The alcohol (0.70 g, 
5 mmol) was added to a solution of triphenylphosphine (1.97 g, 7.5 mmol) and
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phthalimide (1.10 g, 7.5 mmol) in tetrahydrofuran (50 mL) at room temperature. The 
reaction mixture was cooled to 0 °C and DIAD (1.48 mL, 7.5 mmol) was added 
dropwise over 5 minutes. The reaction was stirred for 12 horns at room temperature 
and concentrated in vacuo onto silica. Purification by flash chromatography (silica, 
eluting with 5% ethyl acetate/hexane) furnished the phthalimide in 52%, The oil 
(0.54 g, 2 mmol) was added to a solution of 2nd Generation Grubb’s catalyst (0.04 g, 
2.5 mol %) in dichloromethane (20 mL). The reaction mixture was stirred for 2 
hours, followed by the addition of dimethylsulfoxide (0.36 mL, 5 mmol), and then 
stirred for 12 hour's. The mixture was concentrated in vacuo and purification by flash 
chromatography (silica, 5% ethyl acetate/hexane) furnished the cyclohexene (JR)-237 
in 81%.
’H NMR (500 MHz, CDCI3) 8 7.83-7.82 (in, 2H), 7.71-7.69 (m, 2H), 5.42 (bs, 1H), 
4.44-4.37 (m, 1H), 2.86-2.80 (m, 1H), 2.48-2.40 (m, 1H), 2.19 (bs, 2H), 2.02-1.98 
(m, 1H), 1.77-1.74 (m, 1H), 1.68 (s, 3H).
13C NMR (125 MHz, CDC13) 8 168.56 (e), 133.93 (o), 132.41 (e), 132.17(e), 123.16 
(0), 120.60 (o), 47.99 (o), 33.45 (e), 26.06 (e), 25.53 (e), 23.44 (0).
IR (Neat) 2916 (w), 1768 (w), 1706 (vs), 1374 (m), 908 (vs) cm'1.
HRMS (ESI, [M+Naf) calcd for CisHisNOzNa 264.1000, found 264.0999.
Qv /=\ W-2-(3-Methylcyclohex-3-en-l-yl)isoindoline-l,3-dione
{ (l£)-237.
O
Colour and state: Colorless solid. R/ = 0.4 (Hexane:Ethyl 
acetate = 90:10). [ajo20 = -3.3 (c 1.00, CHCI3). 94.6% ee determination by chiral 
HPLC: Kromasil AmyCoat column, hexane/AcOH/z-PrOH 99:0.1:1, 1 mL/min; 
retention times: 12.3 min (major), 14.2 min (minor), mp = 157-159 °C.
Representative Experimental Procedure: Bis(((5)-binaphthoxy)(isopropoxy)titanium)
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oxide (10 mol %) and 4-pentenal (0.84 g, 10 mmol) was stirred in dichloromethane 
(100 mL) at -15 °C. To the reaction mixture was added 2-methylallyltributyltin 
(10.35 g, 30 mmol) and stirred at 0 °C for 12 hours. The reaction was quenched with 
saturated aqueous sodium bicarbonate (100 mL), extracted three times with diethyl 
ether (100 mL) and washed with brine (200 mL). The organics were dried (MgSCU), 
filtered and concentrated in vacuo to yield a crude oil. Purification by flash 
chromatography (silica, eluting with 15% ethyl acetate/hexane) furnished the 
homoallylic alcohol in 67%. The alcohol (0.70 g, 5 mmol) was added to a solution of 
triphenylphosphine (1.97 g, 7.5 mmol) and phthalimide (1.10 g, 7.5 mmol) in 
tetrahydrofiiran (50 mL) at room temperature. The reaction mixture was cooled to 0 
°C and DIAD (1.48 mL, 7.5 mmol) was added dropwise over 5 minutes. The reaction 
was stirred for 12 hours at room temperature and concentrated in vacuo onto silica. 
Purification by flash chromatography (silica, eluting with 5% ethyl acetate/hexane) 
furnished the phthalimide in 56%. The oil (0.54 g, 2 mmol) was added to a solution 
of 2nd Generation Grubb’s catalyst (0.04 g, 2.5 mol %) in dichloromethane (20 mL). 
The reaction mixture was stined for 2 horn's, followed by the addition of 
dimethylsulfoxide (0.36 mL, 5 mmol), and then stirred for 12 hours. The mixture 
was concentrated in vacuo and purification by flash chromatography (silica, eluting 
with 5% ethyl acetate/hexane) furnished the cyclohexene (f?)-237 in 80%.
‘H NMR (500 MHz, CDCI3) 8 7.83-7.82 (m, 2H), 7.71-7.69 (m, 2H), 5.42 (bs, 1H), 
4.44-4.37 (m, 1H), 2.86-2.80 (m, 1H), 2.48-2.40 (m, 1H), 2.19 (bs, 2H), 2.02-1.98 
(m, 1H), 1.77-1.74 (m, 1H), 1.68 (s, 3H).
IR (Neat) 2916 (w), 1768 (w), 1706 (vs), 1374 (m), 908 (vs) cm'1.
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Ov / \ 2-(3-Methyl-5-oxocyclohex-3-en-l-yl)isomdoline-l,3-dione
/ 238.
Colour and state: Colorless solid. Regioselectivity: >19:1.
R/= 0.3 (Hexane:Ethyl acetate = 70:30). mp = 168-170 °C.
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
237 (0.060 g, 0.25 mmol) in 85%.
"H NMR (500 MHz, CDCU) 5 7.86-7.85 (m, 2H), 7.75-7.74 (m, 2H), 6.00 (s, 1H), 
4.78 (tdd, J = 13.7, 11.5, 4.8 Hz, 1H), 3.37-3.31 (m, 1H), 3.32-3.28 (m, 1H), 2.53 
(dd, A of ABX, JAB - 16.1 Hz, JAx= 4.3 Hz, 1H), 2.36 (dd, B of ABX, Jab = 17.5 Hz,
Jbx = 4.4 Hz, 1H), 2.02 (s, 3H).
13C NMR (125 MHz, CDC13) 8 197.17 (e), 168.09 (e), 160.44 (e), 134.43 (o), 131.82 
(e), 126.90 (o), 123.58 (o), 45.83 (o), 40.44 (e), 34.58 (e), 24.43 (o).
IR (Neat) 2919 (w), 1770 (w), 1704 (vs), 1662 (s), 1371 (s), 1107 (m) cm''.
HRMS (ESI, [M-i-Na] ') calcd for Cl5Hi3N03Na 278.0793, found 278.0787.
C>)-2-(3-Methyl-5-oxoeyclohex-3-eii-l-yl)isoindoline-l,3- 
dione (5)-238.
Colour and state: Colorless solid. Regioselectivity: >19:1. R/= 
0.3 (Hexane:Ethyl acetate = 70:30). [(x]d20 = +7.5 (c 1.00, CHC13). 91.6% ee 
detennination by chiral HPLC: Chiralpak AD-H column, hexane//-PrOH 85:15, 1 
mL/min; retention times: 24.5 min (minor), 26.1 min (major), mp = 168-170 °C. 
Representative Experimental Procedure: Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
CR)-237 (0.060 g, 0.25 mmol) in 85%.
'll NMR (500 MHz, CDC13) 8 7.86-7.85 (m, 2H), 7.75-7.74 (m, 2H), 6.00 (s, 1H),
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4.78 (tdd, J = 13.7, 11.5, 4.8 Hz, 1H), 3.37-3.31 (m, 1H), 3.32-3.28 (m, 1H), 2.53
(dd, A of ABX, JAb =16.1 Hz, JAX= 4.3 Hz, 1H), 2.36 (dd, B of ABX, Jab = 17.5 Hz, 
Jbx = 4.4 Hz, 1H), 2.02 (s, 3H).
IR (Neat) 2919 (w), 1770 (w), 1704 (vs), 1662 (s), 1371 (s), 1107 (m) cm'1.
OCONHTs 3-Methylcyclohex-3-en-l-yl tosylcarbamate 239.
Colour and state: Colorless solid. R/ = 0.4 (Hexane:Ethyl 
acetate = 85:15). mp = 83-86 °C.
Representative Experimental Procedure: Indium (1.26 g, 11 mmol) and 4-pentenal 
(0.84 g, 10 mmol) was stirred in water (100 mL) at 0 °C. To the reaction mixture was 
added 2-methylallyl bromide (1.51 mL, 15 mmol) and stirred at room temperature 
for 12 hours. The reaction was quenched with saturated aqueous sodium bicarbonate 
(100 mL), extracted three times with diethyl ether (100 mL) and washed with brine 
(150 mL). The organics were dried (MgSCL*), filtered and concentrated in vacuo to 
yield a crude oil. Purification by flash chromatography (silica, eluting with 15% 
ethyl acetate/hexane) furnished the homoallylic alcohol in 90%. The oil (0.70 g, 5 
mmol) was added to a solution of 2nd Generation Grubb’s catalyst (0.11 g, 2.5 mol 
%) in dichloromethane (50 mL). The reaction mixture was stirred for 2 hours and 
was concentrated in vacuo. Purification by flash chromatography (silica, eluting with 
15% ethyl acetate/hexane) furnished the cyclohexenol in 70%. The cyclohexenol 
(0.22 g, 2 mmol) was added to a solution of tosyl isocyanate (0.34 mL, 2.2 mmol) in 
tetrahydrofuran (20 mL) at 0 °C. The reaction was stirred for 16 horns at room 
temperature and concentrated in vacuo. Purification by flash chromatography (silica, 
10% ethyl acetate/hexane) furnished cyclohexene 239 in 85%.
‘H NMR (500 MHz, CDCL) 5 7.92-7.90 (m, 2H), 7.34-7.33 (m, 2H), 5.37-5.36 (m,
1H), 4.98-4.93 (m, 1H), 2.45 (s, 3H), 2.24-2.21 (m, 1H), 2.09-1.92 (m, 3H), 1.76-
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1.71 (m, 1H), 1.69-1.64 (m, 1H), 1.62 (s, 3H).
13C NMR (125 MHz, CDC13) 6 150.31 (e), 145.06 (e), 135.75 (e), 130.41 (e), 129.67 
(o), 128.50 (o), 120.80 (o), 73.81 (o), 35.13 (e), 26.66 (e), 23.39 (o), 22.50 (e), 21.81 
(o).
IR (Neat) 3233 (w), 2920 (w), 1718 (s), 1441 (s), 1346 (s), 1226 (m), 1158 (vs), 
1090 (s) cm’1.
HRMS (ESI, [M+Na]+) calcd for CisHipNCWaS 332.0932, found 332.0931.
OCONHTs 3-Methyl“5-oxocyclohex-3-en-l-yl tosylcarbamate 240.
Colour and state: Brown solid. Regioselectivity: >19:1.
O
R/= 0.3 (Hexane:Ethyl acetate = 30:70). mp = 89-92 °C.
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
239 (0.077 g, 0.25 mmol) in 79%.
lK NMR (500 MHz, CDC13) 5 7.88-7.86 (m, 2H), 7.35-7.33 (m, 2H), 5.94 (bs, 1H),
5.26-5.22 (m, 1H), 2.67-2.62 (m, 1H), 2.57 (dd, A of ABX, JAb = 16.8 Hz, ^=4.1 
Hz, 1H), 2.36 (dd, B of ABX, JAb = 10.8 Hz, JBx = 4.8 Hz, 1H), 2.50-2.46 (m, 1H), 
2.45 (s, 3H), 1.96 (s, 3H).
13C NMR (125 MHz, CDC13) 5 195.59 (e), 157.98 (e), 149.90 (e), 145.38 (e), 135.46 
(e), 129.83 (o), 128.47 (o), 126.85 (o), 71.85 (o), 41.66 (e), 35.78 (e), 24.45 (o),
21.85 (o).
IR (Neat) 3070 (w), 1746 (s), 1658 (s), 1452 (m), 1346 (m), 1222 (m), 1161 (vs), 
1090 (m) cm'1.
HRMS (ESI, [M+Na]+) calcd for CisHnNOsNaS 346.0725, found 346,0737.
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o. 2-(4-Methylcyclohex-3-en-l-yl)isoindoline-l,3-dione 241.
^ //
o
Colour and state: Colorless solid. R/ = 0.4 (Hexane:Ethyl
acetate = 90:10). mp = 157-160 °C.
Representative Experimental Procedure: 4-Methylpent-4-enal (0.98 g, 10 mmol) was 
stirred in diethyl ether (100 mL) and allylmagnesium bromide (1 M in diethyl ether, 
15 mL, 15 mmol) was added at 0 °C. The reaction mixture was slowly wanned to 
room temperature over 2 hours. The reaction was quenched with saturated aqueous 
ammonium chloride (100 mL), extracted three times with diethyl ether (100 mL) and 
washed with brine (150 mL). The organics were dried (MgSCU), filtered and 
concentrated in vacuo to yield a crude oil. Purification by flash chromatography 
(silica, eluting with 15% ethyl acetate/hexane) furnished the homoallylic alcohol in 
85%. The alcohol (0.98 g, 7 mmol) was added to a solution of triphenylphosphine 
(2.75 g, 10.5 mmol) and phthalimide (1.54 g, 10.5 mmol) in tetrahydrofuran (70 mL) 
at room temperature. The reaction mixture was cooled to 0 °C and DIAD (2.07 mL, 
10.5 mmol) was added drop wise over 5 minutes. The reaction was stirred for 12 
hours at room temperature and concentrated in vacuo onto silica. Purification by 
flash chromatography (silica, eluting with 5% ethyl acetate/hexane) furnished the 
phthalimide in 55%. The oil (0.81 g, 3 mmol) was added to a solution of 2nd 
Generation Grubb’s catalyst (0.08 g, 2.5 mol %) in dichloromethane (30 mL). The 
reaction mixture was stirred for 2 hours, followed by the addition of 
dimethylsulfoxide (0.53 mL, 7.5 mmol), and then stirred for 12 hours. The mixture 
was concentrated in vacuo and purification by flash chromatography (silica, 5% ethyl 
acetate/hexane) furnished the cyclohexene 241 in 77%.
'H NMR (500 MHz, CDCI;,) 5 7.81-7.80 (m, 2H), 7.69-7.68 (m, 2H), 5.37 (bs, 1H),
4.38-4.32 (m, 1H), 2.86-2.78 (m, 1H), 2.55 (qd, J= 12.5, 5.9 Hz, 1H), 2.24-2.18 (m, 
1H), 2.11-2.04 (m, 2H), 1.80-1.75 (m, 1H), 1.68 (s, 3H).
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13C NMR (125 MHz, CDCb) 6 168.57 (e), 133.90 (o), 133.85 (e), 132.20 (e), 123.14 
(o), 119.35 (0), 47.78 (o), 30.62 (e), 28.67 (e), 26.56 (e), 23.42 (0).
IR (Neat) 2960 (w), 2914 (w), 1697 (vs), 1394 (m), 1378 (s), 1108 (m) cm'1.
HRMS (ESI, [M i-Na]1) calcd for CisH^NOzNa 264.1000, found 264.0996.
1:3.
2-(4-Methyl-5-oxocycLohex-3-en-l-yl)isoindolme-l,3-dione
243.
Colour and state: Colorless solid. Regioselectivity: 242/243 =
R/= 0.3 (Hexane:Ethyl acetate = 70:30). mp = 167-171 °C.
Representative Experimental Procedure'. Prepared in accordance to the general 
procedure for the copper(I)-NHC-catalyzed allylic oxidation of cyclohexenes using 
241 (0.060 g, 0.25 mmol) in 78%.
‘H NMR (500 MHz, CDC13) 6 7.86-7.84 (m, 2H), 7.75-7.73 (m, 2H), 6.79-6.78 (m, 
1H), 4.77 (qd, J = 13.9, 11.4, 4.7 Hz, 1H), 3.45 (dd, J= 16.0, 13.9 Hz, 1H), 3.32- 
3.25 (m, 1H), 2.63 (ddd, 7= 16.0,4.4, 1.6 Hz, 1H), 2.50-2.44 (m, 1H), 1.84 (s, 3H). 
13C NMR (125 MHz, CDCls) 5 197.41 (e), 168.12 (e), 142.94 (o), 136.26 (e), 134.40 
(o), 131.84 (e), 123.57 (o), 46.29 (0), 41.67 (e), 29.85 (e), 15.84 (o).
IR (Neat) 2924 (w), 1703 (vs), 1665 (vs), 1467 (w), 1371 (s), 1102 (s) cm1.
HRMS (ESI, [M+Na]*) calcd for CijHuNOjNa 278.0793, found 278.0796.
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Chapter 3
Studies Towards The Total Synthesis of Cephalimysin A
3.1. Introduction
3.1.1. Isolation, Activity and Background
Cephalimysin A 1 was first isolated in 2007 by Yamada et ah from a strain of 
Aspergillus fumigatus OUPS-T106B-5, derived from the marine fish Mitgil 
cephalus.1 This agent 1 exhibits cytotoxicity against the murine P388 and human 
HL-60 leukemia cell line, with significant activity of IC50 15.0 and 9.5 nM, 
respectively.
Cephalimysin A (1)
The strain 1 from Mugil cephalus fish was cultured at 27 °C for 6 weeks in a medium 
containing 1% soluble starch and 0.1% casein, buffered to pH 7.4, in 50% artificial 
seawater. The purification of cephalimysin A 1 was carried out by bioassay-directed 
fractionation, employing a stepwise combination of Sephadex LH-20, silica gel 
column chromatography and reverse phase HPLC to provide the natural product 1 as
CeCI3l NaBH4 
MeOH, rt, 2h
H RO O
+0.03 H
Id R = (R)-MTPA ester, 1e R = (S)-MTPA ester
HOMO
Scheme 3.1 Determination of Absolute Stereochemistiy of Cephalimysin A 1.
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The structural elucidation of 1 was based on detailed NMR studies (ID and 
2D NMR), although the relative stereochemistiy could not be determined using 
NOESY experiments. Cephalimysin A 1 was elaborated by the cerium(III) chloride 
mediated reduction to the triols la and lb, and subsequent acetonide formation to 
afford exclusively 1c (Scheme 3.1).1 NOESY studies were performed on 1c, which 
established the antf/antf-relationship between the C4-C5, H9 and 8-OMe, thus 
providing the desired relative stereochemistry. The absolute stereochemistry was 
identified via the modified Mosher’s method, where 1c was converted to the {R)~ and 
(5)-MTPA esters Id and le.2 The ^-NMR chemical shift differences were 
compared and the absolute stereo chemistiy was assigned with the IS, 3S, 47?, 57?, 8S, 
97? and 107? configurations.
Cephalimysin A (1) Pseurotin A (2): R = H 
Pseurotin B : R = OH
Pseurotin C : R = OH 
Pseurotin E (3): R = (=0)
OH OHn
Pseurotin D Pseurotin Fi : R-( = OH, R2 = COPh 
Pseurotin F2 (4): R-! = COPh, R2 = OH
Azaspirene (5)
Synerazol (6) FD-838 (7)
Figure 3.1 7-Oxa-7-azaspiro[4.4]non-2-ene-4,6-dione Containing Natural Products.
Cephalimysin A 1 contains a highly functionalised l-oxa“7“azaspiro[4.4]non- 
2-ene-4,6-dione skeleton, which is found in a plethora of other related natural
products, as outlined in Figure 3.1.3'8 The total synthesis of cephalimysin A 1 has not
been forthcoming, but other members of this family have been prepared, including
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pseurotin A 2, E 3, F2 4, azaspirene 5, synerazol 6 and FD-838 7.4'8 Due to the novel, 
highly substituted and oxygenated core of these natural products, their total syntheses 
provide a significant challenge.
In 2007, Turner et al identified a single hybrid polyketide synthase/non- 
ribosomal peptide synthetase (PKS/NRPS) gene required for the biosynthesis of 
pseurotin A 2 from the human pathogen Aspergillus fumigatus.9 It was revealed that 
the presence of a PKS/NRPS gene, within a cluster of five genes, was involved in the
secondary metabolism.
i) Epoxide hydrolysis 
ii) Methyiation
i) Methyiation
i) Epoxidation 
ii) Isomerisation 
iii) a-Hydroxylation
i) Isomerisation 
ii) Benzylic oxidation 
iii) Epoxidation Azaspirene (5)
Scheme 3.2 Proposed Biosynthesis of Pseurotin A 2 and Related Natural Products.
The pentaketide 9 was produced from the thioester 8 by five domain genes 
(KS: ketosynthase, AT: acyltransferase, DH: dehydratase, KR: ketoreductase and 
CMeT; C-methyltransferase) (Scheme 3.2).9 The condensation of polyketide 9 and 
adenylated L-phenylalanine afforded the PKS-NRPS-bound intennediate 10. The 
cyclisation and release of 10 provided the pyrrolidinone intermediate 11. Through a
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sequence of epoxidation, isomerisation and a-hydroxylation, by EAL85114 and 
EAL8511 (sequence similarities to hydrolase/dienelactone hydrolase and P450 
monooxygenase, respectively), the successful conversion of 11 to azaspirene 5 was 
achieved. Additional alkene isomerisation/benzylic oxidation and epoxidation of 
azaspirene 5, leads to the intermediate 12. It was suggested that some of these steps 
could take place elsewhere in the genome as only one P450 is present in the gene 
cluster. Synerazol 6 would arise from the 0-methylation of intennediate 12 by 
EAL85122 catalysis, and pseurotin A 2 from the epoxide hydrolysis of 12 by 
EAL85110 catalysis and EAL85122-catalysed O-methylation. This study identifies 
azaspirene 5 as the parent natural product, from which the other members of the 
family are prepared.
3.1.2. Syntheses of Other l-Oxa-7-azaspiro[4.4]non-2-ene-4,6-dione
Skeleton Natural Products
Pseurotin A 2, first isolated in 1976 by Bloch and Tamm from a culture broth 
of Pseudeurotium ovalis (strain S2269/F) demonstrates a variety of biological 
activities, including chitin synthase inhibition, induction of cell differentiation and 
the inhibition of immunoglobulin E (IgE) production.10 In 1990, Tamm et al 
reported the synthesis of a furan-3(2/7)-one core in an approach to pseurotin A 2 
(Scheme 3.3).11 The synthesis proceeded with the deprotonation of cyanohydrin 14 
with EDA and reaction with silyl ketone 13, which provided the alcohol 15. The 
THP protecting group was removed selectively with PTSA in methanol to afford diol 
16 in 61% yield over two steps. Ketone 17 was accessed through a retro cyanohydrin 
reaction with sodium hydroxide and subsequent silylation of the hydroxyl group, 
which proceeded in 81% yield. Condensation of ketone 17 with aldehyde 18 
(previously prepared in 5 steps from D-glucose)12 using EDA furnished
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hydroxyketone 19. This was immediately subjected to Swem oxidation to generate 
the diketone 20 in moderate yield. Treatment of 20 with acid afforded the cyclisation 
product, albeit with complete deprotection. This problem was solved by performing 
the cyclisation of 20 under basic conditions, followed by TBAF deprotection of the 
silyl groups to retain the cyclic acetal present and furnish the diol 21 in an excellent
94% yield. The diol 21 was converted into the key silyl ether 22 in 24% yield in four 
additional steps.11
TBSO^JL^OTBS
13
OTHP
LDA
THF/HMPA
THPO OH 9TBS
CN
OTBS
CN
14
OTMS LDA
OTBS THF/HMPA 
O OTBS
15
PTSA
MeOH
61%
over 2 steps
HO OH
CN
OTBS
OTBS
16
i) NaOH, THF 
ii) HMDS 
TMSCI, py
81%
TMSO pTBS
-OTBS
17
coci2j dmso
EtgN, DCM
47%
i) K2C03 
MeOH
OTMS
20 O
OTBS ii) TBAF 
THF
OTBS 94% 21 O
4 steps
24%
22 O
OTBS
Scheme 3.3 Synthesis of the Furan-3(2H)-one Core by Tamm et al.
With the key silyl ether 22 in hand, introduction of a methoxycarbonyl group 
was attempted by LiHMDS deprotonation of 22 and treatment with methyl 
chloroformate (Scheme 3.4). Unfortunately, (9-acylation occurred predominantly 
over the desired C-acylation and furan derivative 25 was obtained.11 The (9- 
alkylation is presumably the result of the formation of the highly stable enolate 23 
due to the aromatic nature of the pseudo-fm&n, which disfavours C-acylation.
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OTBS 
25 0C02Me
OTBS 
OCO2M6
26 O
Scheme 3.4 Failed Acylation Step of Furan-3(2H)-one Synthesis by Tamm et al.
Tamm and Su provided an alternative route for the syntheses of the 
functionalised y-lactone for pseurotin A 2 (Scheme 3.5).13 Vinylbromide 28 was 
converted into the vinyl lithium by treatment with 72-BuLi, and this was added to the 
aldehyde 27 to afford a 7:3 diastereomeric mixture of allylic alcohols 29/30 in 70% 
yield (Scheme 3.5). The minor diastereomer 30 was further functionalised in 7 steps 
to provide y-lactone 31, albeit possessing the opposite stereochemistry of pseurotin A 
2.13
r-Q
27
+ X
Br^XH(OEt)2
28
n-BuLi
70% oOl - F°-n^Y^OH(OB)2 ___
OH 29 (*3j
CH(OEt)2 
OH 30
O
HO
^ y^OMMTr 7 steps Xq
OBn
35
3 steps
co2h
O
HO OBn
34
7 steps
OBz
OBn
32
8 steps
AcO OBz
HXSHXO'
OBn
33
7 steps
0Xr°H
°VO OBn^ 3,
Scheme 3.5 Synthesis of y-Lactones by Tamm and Su.
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The major diastereomer 29 was transformed into a variety of highly 
substituted y-lactones via carboxylic acid 32 (Scheme 3.5). For example, the 
synthesis of the thioester 33 was accomplished in 8 steps, whereas the enol lactone 
34 was prepared in 7 steps from the carboxylic acid 32. Alternatively, the y-lactone 
35, which has the correct relative configuration of pseurotin A 2 was obtained in 
excellent overall yield via a 7 step sequence (10 total steps from aldehyde 27).13
It was not until 2002 that Hayashi reported the first total synthesis of (—)- 
azaspirene 5, which was the first synthesis of any member of this family.6 (-)- 
Azaspirene 5 was isolated in 1990 from the fungus Neosartoiya sp, and possessed 
inhibitory activity against angiogenesis-related diseases, for example, cancer and 
rheumatoid arthritis.14
The total synthesis of (-)-azaspirene 5 was accomplished as outlined in 
Scheme 3.6. Sharpless asymmetric dihydroxylation of methyl 2-pentenoate 40 
provided diol 41 in 88% yield, which was converted to the acetal 42 for the 
Mukaiyama aldol reaction to afford the sy/i-aldol 43 in 69% yield (Scheme 3.6).14 
The alcohol 43 was transformed to the key intermediate 49 via a 7 step sequence. 
Aldol condensation of 49 with heptadienal generated 50 in 50% yield as a 3.8:1 
mixture of diastereomers, which was inconsequential. The alcohol 50 was oxidised to 
the diketone 51, which was partially converted into the bicycle 52 in 94% yield as a 
1:1 mixture. When the mixture of diketone 51 and bicycle 52 was treated with 
catalytic acid, alcohol 53 was afforded as a single isomer in a convergent manner. 
Hayashi noted that the order of the last two steps was important as 52 underwent a 
proposed retro-aldol reaction in the presence of TBAF. Thus, the first total synthesis 
of (-)-azaspirene 5 was achieved with longest linear sequence of 16 steps.14
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Et
O
OMe
40
(DHQ)2PHAL
K2Os04.2H20
K3Fe(CN)6
K2C03
MeS02NH2
88%
OH O
Et
Me2C(OMe)2
TsOH.H20
OMe
OH
41
79% 
95% ee
Et
^r-OMe 
°42
1) LDA 
TBSOTf
2) 37
MgBr2.OEt2
69%
H H OH 
43
Ph- -CHO 37 TIPSOTf2,6-Lutidine
98%
NaH
92%
1) (COCI)2 
NEt3l DMF
2) Liq. NH3
45%
TFA:MeOH
(10:1)
92%
1) DMP
2) TLC 
94% (1:1)
Scheme 3.6 Total Synthesis of (-)-Azaspirene 5 by Hayashi et al
The landmark synthesis of (-)-azaspirene 5 by Hayashi et al inspired the 
total synthesis of the other membei*s of the family. In 2003, Hayashi described the 
first total synthesis of pseurotin A 2, which had proven to be a particularly 
challenging target. Hayashi modified the strategy utilised in the total synthesis of (—)- 
azaspirene 5 (Scheme 3.7).14 Aldol condensation of the methyl ketone 49 (11 steps 
from methyl 2-pentenoate 40) with the aldehyde 1812 furnished a 2:1 diastereomeric 
mixture of aldol products 54 in 54% yield.43
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1) DMP
2) TBAF 
41%
t
AcCI, MeOH 26% (57 recovered in 52%)
Scheme 3.7 Total Synthesis of Pseurotin A 2 by Hayashi et al 
Fortunately, this diastereomeric mixture was inconsequential as the epimeric 
alcohols 54 were oxidised to the corresponding ketone (Scheme 3.7). DMDO 
epoxidation/epoxide opening afforded the diol 55 in 42% yield. Further oxidation of 
the alcohol 55 to the ketone and deprotection provided the diol 56 in 41% yield. The 
synthesis was completed by the exposure of 56 to methanol pre-treated with acetyl 
chloride to provide pseurotin A 2 and 8-0-demethyIpseurotin A 57 in 92% overall 
yield. Interestingly, 8-0-demethylpseurotin A 57 is a natural product, which was 
isolated with pseurotin A 2 as a 1:2.7 mixture.16 8-0-DemethyIpseurotin A 57 can be 
converted to pseurotin A 2 by resubmitting it to the acetyl chloride/methanol 
conditions, albeit as a similar mixture. This completed the total synthesis of pseurotin 
A in 18 longest linear steps.4a
With a reliable strategy developed in the total syntheses of (-)-azaspirene 5 
and pseurotin A 2, Hayashi targeted another member of the l-oxa-7- 
azaspiro[4.4]non-2-ene-4,6-dione family, namely the total synthesis of synerazol 6, 
which was isolated by Ando et al in 1991 from the cultured broth of Aspergillus 
fumigatus SANK 10588.7 Synerazol 6 has remarkable biological activity against
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Candida albicans and other fungi, and possesses synergistic antibiotic activity with
17azole-type antifungal agents.
The total synthesis of synerazol 6 proceeded in a similar fashion to pseurotin 
A using the common building block 49 (Scheme 3.8).7 The aldehyde 58 was 
prepared from D-tartaric acid diethyl ester in 9 steps,18 and used in the aldol 
condensation with ketone 49 to afford a 2:1 diastereomeric mixture of aldol products 
59 in 32% yield.7 As in the synthesis of pseurotin A, the selectivity of 59 was 
irrelevant because the subsequent oxidation reaction provided the bicycle 60c as 
single stereoisomer in 52% yield over the two steps.
HO )^NH
O OTMS 
49
LDA
HMPA
OH O OTMS 
dr =2:1 59
HO ^NH _ 1) DMP 
Ph 1___
2) TLC 
52%
O
O, ,? 1) DMP
Ph -«------- Et
OMe 2) TBAF 
O OH 86%
Synerazol (6)
NH Ph
O OTMS 
60c
DMDO
MS3A
MeOH
65%
OMe 
O OTMS
61c
Scheme 3.8 Total Synthesis of Synerazol 6 by Hayashi et al.
In the previous synthesis of pseurotin A 2, the benzylidene moiety of 54 was 
epoxidised and ring-opened to access the diol functionality, with concomitant 
oxidation to provide the ketone 56 (Scheme 3.7).4a This approach was utilised in the 
first generation synthesis, although the efficiency of the tertiary alcohol methylation 
was poor (10% yield). Thus, an alternative plan was devised, in which it was 
envisaged that the epoxidation of the benzylidene moiety 60a-c with DMDO in the 
presence of methanol would provide the alcohol 61a-c (Scheme 3.9).7 The 
examination of the silyl ether 60a-c provided insight into the feasibility of this 
transformation, in which the TMS-protected 60c in the presence of 3A MS (to
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scavenge water), afforded the methyl ether 61c in 75% yield as 6.5:1 mixture of 61c 
and the diol 62c.
DMDO
MS3A
MeOH, -60 °C
O OR
60a-c R = TIPS 60a, 46% 61 a:62a (0:46) 
R = TES 60b, 60% 61b:62b (1:1) 
R = TMS 60c, 75% 61c:62c (6.5:1)
Scheme 3.9 Epoxidation Optimisation in the Total Synthesis ofSynerazol 6.
The total synthesis was then completed by the oxidation and deprotection of 
the secondary alcohol 61c, to furnish synerazol 6 in 86% yield over the two steps 
(Scheme 3.8). Hence, the first total synthesis of synerazol 6 was achieved with a 
longest linear sequence of 19 steps or 8 steps from the known ketone 49.7
9H o
/?
Et ho
T OMe 
O OH 
Pseurotin A (2)
7 steps
O
Q Vnh
Ph ---------
OMe 8 steps
O OH
Synerazol (6)
O
HO >-NH
Et Ph
O OTIPS
49
11 steps
6 steps
5 steps
b OH 
(-)-Azaspirene (5)
O
^-o. }^NH 9
O OH 
FD-838 (7)
Figure 3.2 Highly Divergent Syntheses of (-)-Azaspirene 5, Pseurotin A 2, Synerazol 
6 and FD-838 7from 1.
Hayashi also illustrated a highly divergent synthetic strategy for the synthesis 
of the l-oxa-7“azaspiro[4.4]non-2-ene-4,6-dione family members (Fig. 3.2).4a’6,7 In
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addition to (-)-azaspirene 5, pseurotin A 2 and synerazol 6, the furan-containing 
derivative FD-838 7 was also prepared. FD-838 7 was isolated from A. fumigatus 
fresenius FD-838 by Mizoue et al in 19858a and demonstrated both antibiotic and 
anti-cancer activity. It was prepared using a 17 step synthesis (6 steps from 49).8c
In 2008, Rovis and Orellana reported the synthesis of the core of FD-838 7, 
utilising a catalytic asymmetric Stetter reaction (Scheme 3.10).19 A-Benzyl 
maleimide 63 was converted into the alcohol 64 through a dibromination, elimination 
and addition-elimination sequence in 48% overall yield. Oxidation of the alcohol 64 
afforded the necessary aldehyde 65 for the aforementioned key catalytic asymmetric 
Stetter reaction.20 Treatment of 65 with 20 mol % of chiral triazolium salt 66 and
KHMDS furnished the desired spirocycle 67 in 60-80% yield, and with excellent
enantioselectivity (99% ee).19
o
| N-Bn
O
63
1) Br2
2) Et3N
3) 1,3-propanediol 
Et3N 
48%
HO o
N~Bn
64
DMP
72%
O
\\
O'
O
^N-Bn
O
NHC 66
KHMDS
60-80% Bn
65 99% ee 67
OTES
TESOTf
2-Methylfuran
2,4,6-collidine
67%
.O
66 (20 mol %)
TESOTf
Et3N
90%
OTES
■O
Bn
O
69
Ph3C+BF4- 
2,4,6-collidine 
95%
o\
O
Bn
68
Scheme 3.10 Synthesis of the Core of FD-838 by Rovis et al
Conversion of 67 into the furanone 69 involved fonnation of the silyl enol 
ether 68, and subsequent oxidation via a hydride abstraction using the trityl cation
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(Scheme 3.10)..21 The pendant furan was installed by the reaction of furanone 69 
with a strong lewis acid and methylfhran to afford 71 in 67% yield. The 
transformation is proposed to proceed via the intermediate 70, where the resonance- 
stabilised oxocarbenium ion is trapped by the fiiran, followed by rearomatisation to 
provide 71. Interestingly, the solvent is critical since the reaction fails in 
dichloromethane and nitromethane, but is successful in acetonitrile, which is thought 
to stabilise the oxocarbenium ion by the fonnation of a nitrilium ion.22 The synthesis 
of the core was completed by the regioselective Barbier-type alkylation of 
succinimide 71 with samarium diiodide and benzyl bromide, to generate the 
hemiaminal 72 in an unoptimised 33% yield.19,23
The total syntheses of the l-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione natural 
products has prompted the preparation of analogues.3 Figure 3.3 outlines some of the 
analogues reported, which are based on the fermentation and precursor-directed 
biosynthesis of pseurotin A 2. The chemical modifications vaiy the side chain 73a-f, 
oxygen/nitrogen capping 74a-b, tetraol 75, and fluorination of the aryl-ring 76a-b.24a'
e
O OAc
R = H,74a
R = Ac, 74b
O OHO OH
R-! = H, R2 = F, 76b
Figure 3.3 Reported Pseurotin A Analogues 73-76.
In 2009, Ishikawa reported die syntheses of pseurotin A analogues 78 and 80, 
and their activity for the inhibition of immunoglobulin E (IgE) production (Scheme
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3.11).3 Pseurotin A 2 was subjected to oxidative cleavage to furnish the aldehyde 77, 
which was subjected to reductive amination to afford the secondary amine 78 in poor 
yield.3 Analogously, pseurotin A 2 was conveited to the 10-<3-thioacylated 79 in 
46% yield, and reductive cleavage of the xanthate ester provided the 10- 
deoxypseurotin A 80 in 26% yield.3
H\oa
B HO
O OH 
Pseurotin A (2)
Ph
n-BuNH2 n'Bu'|sj
NaBH3CN
n%
^MU O
PhO(CS)CI
Pyridine
46%
0(CS)0Ph
O OH O OH
Scheme 3.11 Synthesis of Pseurotin A Analogues 78 and 80 by Ishikawa et al
Table 3.1 outlines the results of the biological studies in which pseurotin A 2 
and the analogue 78 are modest inhibitors (3.6 and 3.1 (iM, respectively) (Table 3.1, 
entries 1 and 3).3 Synerazol 6 and 10-deoxypseurotin A 80 provided improved 
activities of 0.26 and 0.066 jiM, respectively (entries 2 and 4). The results suggest 
that the 10-hydroxyl group of pseurotin A 2 is not required for activity {cf 80) and 
that the amino group in 78 presumably mimics the 11 -hydroxyl group.3 
Table 3.1 IgE Inhibitory Activity and Specificity of Pseurotin Analogues 78 and 80.
Entry Compound IgE
IC5o (pM)
A
IC50 (pM)
B
ICS0 (pM)
c D
IC50 (pM)
1 2 3.6 >10 >10 0% >10
2 6 0.26 >10 >10 54% 3.1
3 78 3.1 >10 >10 2% N/A
4 80 0.066 >10 4.4 0% N/A
5 Prednisolone 0.0059 N/A >10 84% 0.078
A = K562 cytotoxicity. B = B-cell viability. C = T-cell proliferation % inhibition at 10 pM. D = 
MLR.
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Pseurotin A 2, synerazol 6 and the analogues 78 and 80 were further tested 
for specificity against K562 cytotoxicity, B-cell viability, T-cell proliferation and 
mixed-lymphocyte reaction (MLR).3 Table 3.2 outlines the results with 10- 
deoxypseurotin A 80, which indicate it is a potent and specific inhibitor of IgE 
production (Table 3.1, entiy 4). Furthermore, synerazol 6 provides potent inhibition 
of T-cell proliferation and MLR, in addition to IgE production, suggesting that 
synerazol 6 has immunosuppressive activity (entry 2).3
3.2. Studies Towards the Total Synthesis of Cephalimysin A
3.2.1. Retrosynthetic Analysis
Cephalimysin A 1 is one of the members of the l-oxa-7-azaspiro[4.4]non-2- 
ene-4,6-dione skeleton containing natural product family, which has not been 
prepared.1 The retrosynthetic analysis of cephalimysin A 1 is outlined in Scheme 
3.12. The desired route would allow the application of a late stage copper(I)-NHC- 
catalysed allylic oxidation of intennediate 105 to afford the furanone.25 The allylic 
oxidation of 105 is potentially problematic, owing to the presence of a secondary 
alcohol and acyclic alkene. We envisioned the copper(I)-NHC-catalysed allylic 
oxidation would permit the chemoselective oxidation.25 The aldol product 105 would 
in turn be derived from the chemoselective nucleophilic epoxidation of the a, p- 
unsaturated ketone 101 in the presence of methanol to regioselectively open the 
epoxide alpha to nitrogen, in a similar manner to the route towards synerazol 6 
(Scheme 3.12).7 The cyclic alkene 101 could be prepared from the base-mediated 
elimination of iodide 98, which would be prepared by the iodoetherification of the 
homoallylic alcohol 95 via a 5-endo-trig cyclisation. The homoallylic alcohol 95 
would be installed using a regio- and chemoselective Hosomi-Sakurai allylation of 
dioxopyrroline 83, providing the alkene side chain with the correct absolute and
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relative stereochemistry. The key dioxopyrroline 83 would originate from the 
cyclisation of imine 82 with oxalyl chloride, which is prepared from the ketone 81 by 
imine condensation. This retrosynthetic route should facilitate the total synthesis of 
cephalimysin A 1 in a concise manner, as compared to previously reported l-oxa-7-
azaspiro[4.4]non-2-ene-4,6-dione skeleton containing natural products.
OMe Regloseleotlve 
Epoxldation/Opening
Cu(i)-NHC 
Allylic Oxidation
Cephalimysin A (1)
Base Elimination
Sakural-Hosoml
Allylatlon
lodoetlwrilicatlon
Arv
Ph
O
Ph X = (OMe)2 or S(CH2)3S
X X
82 81
Scheme 3.12 Retrosynthetic Analysis of the Total Synthesis of Cephalimysin A 1.
3.2.2. Efforts Towards the Total Synthesis of Cephalimysin A
The synthesis was initiated with the preparation of imine 82., from the known 
ketone 8126 using /?-anisidine under a variety of condensation conditions (Table 3.2). 
The />anisidine group should facilitate the removal of the resulting />methoxyphenyl 
(PMP) group under mild oxidative conditions.27 The imine 82 was anticipated to 
adopt the favoured ^-configuration due to steric interactions in the Z-isomer. 
Treatment of the ketone 81 with the anisidine in refluxing benzene afforded trace 
amounts of the desired imine 82 (Table 3.2, entry 1). Performing the condensation 
reaction under Dean-Stark conditions with acid or base provided similar results, with 
only trace quantities of 82 being observed (entries 2 and 3).28
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Table 3.2 Synthesis oflmine 82.
Entry Additive Solvent Time (h) Yield8 (%)
1 - PhH 48 Trace
2 PTSA (0.05 mol %) PhMe 48 Trace
3 NaHCOs (2 eq) PhMe 48 10
4 TiCl4 (0.5 eq), Et3N (2 eq) DCM 24 20
5 TiCl4 (1 eq) PhMe 24 36
6 Ti(0-i-Pr)4 (1 eq) PhMe 24 65
“Isolated yields.
It is known that the imine condensation reactions of ketones are extremely 
difficult and inefficient, especially with a bulky group (dithiane) alpha to the ketone. 
Nevertheless, there were numerous successful variants that utilise a Lewis acidic 
titanium reagent to activate the carbonyl group for the addition.29 Although the 
titanium tetrachloride mediated condensation only afforded the imine 82 in 20% 
yield, the analogous process in refluxing toluene gave an improved yield (Table 3.2, 
entries 4 and 5). The dissociation of hydrochloric acid from the titanium tetrachloride 
was envisioned to hydrolyse the imine 82 to the ketone 81, thus an alternative 
titanium(IV) complex was investigated.29 Treatment of the ketone 81 and /?-anisidine 
with titanium isopropoxide in refluxing toluene furnished the imine 82 in 65% yield 
after 24 hours (entry 6). Interestingly, the imine 82 can be recrystallized in a range of 
organic solvents, providing a bench stable colourless solid.
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The dioxopyiioline 83 was prepared in 84% yield from the imine 82, 
employing a modified procedure reported by Mohri using oxalyl chloride (Scheme
MeO
Ph
Oxaxyl chloride (2 eq)
THF 
rt, 12 h 
84%
O
-HCI
MeO,
MeO. MeO.
O
Ph
-HCI
82I Y
Scheme 3.13 Synthesis of the Dioxopyrroline 83.
The proposed mechanism of the dioxopyrroline fonnation involves the 
nucleophilic addition of the nitrogen to the oxalyl chloride, to generate the iminium 
82i (Scheme 3.13). Tautomerisation of the iminium ion 82i to the enamine 82ii, 
followed by an intramolecular addition to the acid chloride affords the iminium 
intermediate 82iii. Finally, tautomerisation of the intennediate 82iii provides the 
dioxopyrroline 83. Hence, the desired dioxopyrroline 83 was prepared on a multi­
gram scale in two steps from the ketone 81 in 55% overall yield.
Scheme 3.14 outlines the strategy envisioned for the preparation of the 
requisite allylsilane 89.31 The allylsilane 89 would be prepared by an Sn2’ reaction of 
88 with a silyl cuprate. The substrate would be derived from the y, d-unsaturated 
ester 84.
s OLg \ " OEt
88 84 O
Scheme 3.14 Retrosynthetic Analysis of Allylsilane 89.
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The synthesis of allylsilane 89 commenced with the reduction of the known y, 
8-unsaturated ester 8432 under modified DIBAL-H conditions to afford the aldehyde 
85 (Scheme 3.15).33 The crude aldehyde 85 was subjected to a Homer-Wadsworth- 
Emmons reaction, modified by Roush and Masamune, to provide the ot, fi- 
unsaturated ester 86 in 80% yield over the two steps, as predominantly the E- 
isomer.34 The proposed mechanism leading to high fs-selectivity is a result of the 
addition of the carbanion to the aldehyde 85 to furnish the oc-hydroxyphosphonate 86i 
(Scheme 3.15). The final elimination of intermediate 86ii yields the £-alkene 86 in 
excellent stereoselectivity.35
84 o
1. DIBAL-H (1.1 eq) 
Hexane, -78 °C 
0.25 h
2. Triethyl 2-phosphono- 
propionate (1 eq)
LiCl (1 eq), DBU (1 eq) 
MeCN, rt, 4 h 
80% over 2 steps
85
Scheme 3.15 Synthesis of the a, p-Unsaturated Ester 86.
Reduction of the a, /?-unsaturated ester 86 with excess LiAlEE was
uneventful, affording the desired allylic alcohol 87 in 95% yield (Scheme 3.16).
86 o
OEt
LiAIH4 (1.5 eq)
Et20
0 °C to rt, 1 h 
95%
OH
87
Scheme 3.16 The Synthesis of the Allylic Alcohol 87.
Completion of the allylsilane synthesis was accomplished by conversion of 
the allylic alcohol 87 to the corresponding allylic mesylate 88, which was used 
immediately (Scheme 3.17).36 Treatment of TMSCuP(OMe)i (prepared from TMSLi
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and ICuP(OMe)2)37 with the crude ally lie mesylate 88 afforded the Sn2’ 
displacement product 89 in 75% yield over two steps.36
1. MsCI (1.3 eq) 
Et3N {1.3 eq) 
DCM, 0 “C, 4 h
87 2. TMSCuP(OMe)2 (1 eq)
THF/HMPA/Et20
88
-78 °C 
75%
Scheme 3.17 Synthesis of the Allylsilane 89,
The Hosomi-Sakurai allylation of dioxopyrroline 83 was investigated with a 
variety of Lewis acids (Table 3.3). A solution of dioxopyrroline 83 and allylsilane 89 
in dichloromethane at -78 °C was treated with a solution of boron trifluoride etherate 
to provide the desired homoallylic alcohol 90 in 10% yield, albeit with >19:1 
regioselectivity (Table 3.3, entry l).36
Table 3.3 Regios elective Hosomi-Sakurai Allylation of Dioxopyrroline 83.
sf
pr"^\c=o
MeO
83
Entry Lewis acid T. (°C) Time (h) 90:91 Yieldb (%)
1 BF3.Et20 -78 2 >19:1 10
2C SnCL, -78 12 >19:1 10
3 SnCU 0 2 >19:1 71
4 TiCLt 0 2 >19:1 48
"Determined by H-NMR of crude mixture. Isolated yields. "20% conversion.
Presumably, the initial 1,2-addition product 90 is fonned rather than the 1,4-
addition product 91, and after prolonged stilling under the reaction conditions, the 
intermediate 90 undergoes the [3,3]-sigmatropic oxy-Cope rearrangement to generate 
the product 93 (Scheme 3.18).38 Unfortunately, the rearrangement is particularly 
facile under the boron trifluoride etherate conditions. Hence, a variety of Lewis acids
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were examined to improve the efficiency of the Hosomi-Sakurai allylation, and
eliminate formation of the oxy-Cope side product. Interestingly, tin(IV) chloride is
unsuitable at -78 °C, albeit producing a single regioisomer after 12 hours (Table 3.3, 
entry 2). Gratifyingly, when the reaction was performed at 0 °C for 2 hours, the 
product 90 was obtained in 71% yield, with a minimal amount of oxy-Cope side 
product (entry 3). Finally, titanium(IV) chloride also provides 90 in a selective 
manner, albeit in modest yield (entiy 4).
Scheme 3.18 Proposed Oxy-Cope Sigmatropic Rearrangement of 90 with BFs.Et20.
The alkenyl alcohol 90 was then subjected directly to iodoetherification using 
standard conditions, namely, iodine and jV-iodosuccinimide with sodium bicarbonate,
which failed to afford any of the desired product 94 (Scheme 3.19).39 We envisaged
that the presence of the dithiane may interfere with the iodoetherification reaction, 
which prompted its conversion to the acetal 95.40
Scheme 3.19 Direct Iodoetherification of Dithiane 90.
Table 3.4 outlines the result of the study. Treatment of the dithiane 90 using 
the modified conditions, developed by Russell and Ochrymowycz (iodine/sodium 
bicarbonate in methanol), provided 95 in 23% yield after 6 hours (Table 3.4, entiy 
l).41 Alternatively, the Corey and Erickson protocol, which utilises N-
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bromosuccinimide/silver nitrate in methanol furnished 95 in 32% yield after 30 
minutes (entry 2).42 Nevertheless, each of these protocols can produce HI or HBr, 
which can lead to other side reactions (entries 1-2). Gratifyingly, the modified Stork 
and Zhao procedure, utilising [bis(trifluoroacetoxy)iodo]benzene [PhI(TFA)2] in 
methanol with calcium carbonate, generated the desired product 95 in 75% yield 
after only 30 minutes (entry 3).43 
Table 3.4 Transacetalisation of Dithiane 90 to Acetal 95.
Entry Additive11 T. (°C) Time (h) Conv. (%) Yieldb (%)
1 la/NaHCOa 0 6 100 23
2 NBS/AgN03 0 0.5 100 32
3 PhI(TFA)2/CaC03 0 0.5 100 75
% (2 eq)/NaHC03 (3 eq), NBS (2 eq)/AgN03 (2.2 eq), PhI(TFA)2 (2 eq)/CaC03 (3 eq). isolated 
yields.
The acetal 95 was then resubjected to iodoetheriflcation in the presence of 
iodine/potassium carbonate at 0 °C to generate a 3:1 diastereomeric mixture of the 
desired bicyclic product 98 in 48% yield after 48 hours (Scheme 3.20). Although the 
reaction is slow, the starting material 95 can be recovered in 40% yield to afford 98 
in 80% yield based on recovered starting material (BORSM). The mixture of 
diastereomers is inconsequential, as the alkyl iodide stereocentre is destroyed in the 
subsequent elimination step. The low reactivity can be explained by the reversible 
addition of iodine to the desired double bond in 95, forming the iodonium ion 96 
(Scheme 3.20). Although, the 5-endo-trig cyclisation of the tertiary alcohol is fast 
due to the intramolecular opening of the highly reactive iodonium ion 96, the rate-
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determining step is the initial formation of the iodonium ion. Thus, the fonnation of 
the critical iodonium ion intermediate 96 could be improved by using a more 
electrophilic iodide species.44
Scheme 3.20 lodoetherification of Acetal 95.
Iodide 98 was subjected to DBU-mediated elimination to afford a 2:1 
regiomeric mixture of alkenes 99 and 100 in 90% yield (Scheme 3.21).45 The exo­
methylene 99 was obtained as a 3:1 diastereomeric mixture of products by ^-NMR. 
The desired enol ether 100 was observed as the minor regioisomer, presumably from 
the alkene isomerisation of 99. The exo-methylene 99 is presumably the kinetic 
product, which under heating in toluene affords the more thermodynamically stable 
tetra-substituted enol ether 100, Additional efforts are currently ongoing to optimise 
the conditions to isomerise the exo-methylene 99 to give the enol ether 100.46
MeO OMeMeO OMe MeO OMe
DBU (2 eq)
PhMe, 80 °C 
24 h 
90%
Scheme 3.21 DBU Elimination of Iodide 98.
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3.2.3. Future Work Towards the Total Synthesis of Cephalimysin A
With access to the bicyclic enol ether 100 in a longest linear sequence of just
six steps and 11 steps in total, the total synthesis of cephalimysin A 1 required a 
three-step sequence. It was envisaged that the acetal and ^-methoxyphenyl (PMP) 
groups in 100 could be removed using cerium ammonium nitrate under aqueous 
conditions to expose the key enone moiety and the free amide of 101 (Scheme 
3.22).47 This would provide the complete carbon backbone of cephalimysin A 1, with 
only the three oxygenated functionalities to be installed.
MeO OMe O HO O
Scheme 3.22 Deprotection of Acetal and PMP Groups in 100.
Treatment of enone 101 with tert-b\\ty\ hydroperoxide in the presence of 1,8- 
diazabicyclo[5.4.0]undec-7-ene (DBU) is expected to facilitate a non-chelation 
nucleophilic epoxidation proceeding via the carbanion 102, to afford the epoxy­
ketone 103, with the desired a«/i-stereochemistry (Scheme 3.23).48 Intramolecular 
opening of the epoxide 103 by the adjacent nitrogen, which is activated by the 
protonated DBU, is expected to afford the iminium ion 104. In the presence of 
methanol, the reactive iminium ion 104 is attacked on the opposite face to the 
neighbouring alcohol, to generate the desired anti/anti aldol product 105 in a single 
step.49
It was anticipated that the late-stage copper(I)-NHC-catalysed allylic 
oxidation of aldol product 105 would be highly chemo- and regioselective (Scheme 
3.24).25 Although there are potentially six sites of oxidation in 105, the copper(I)- 
NHC-catalysed allylic oxidation should target only one.25 It has already been 
demonstrated that acyclic allylic C-H and primary C-H bonds are resistant to allylic
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oxidation, while the oxidation of secondary alcohols to ketones which utilise copper, 
normally require very harsh conditions, or strong oxidising agents (sodium
hypochlorite).50
Scheme 3.23 Epoxidation/Ring-Opening ofEnone 101.
Using the copper(I)-NHC catalyst//erf-butyl hydroperoxide conditions, a 
chemo- and regioselective allylic hydrogen abstraction of the desired cyclic C-H 
bond of 105 will provide the allyl radical 106 (Scheme 3.24).25 The recombination of 
the te/T-butoxy radical and the allyl radical would be expected to occur at the least 
hindered side, based on previous experimental data, to furnish the desired furanone 
of cephalimysin A 1.
Scheme 3.24 Late Stage Copper(I)~NHC-CatalysedAllylic Oxidation of 105.
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3.3 Conclusions
In conclusion, it has been demonstrated that the essential bicycle 100 can be 
constructed in an expedient manner from the readily prepared dithiane 81 in a longest 
linear sequence of six steps, or 11 steps in total. The synthesis of 100 incorporates a 
regio- and chemoselective Hosomi-Sakurai allylation and an iodoetherification to 
generate the tetrahydrofuran ring system. The Hosomi-Sakurai allylation required the 
synthesis of the allyl silane 89 in 5 steps from the y, d'-unsaturated ester 84, utilising a 
copper-mediated Sn2’ displacement reaction. Additional progress is currently being 
made on the synthesis of an enantiopure boronate for the enantioselective allylation 
via a chiral transfer procedure. Future work is aimed at the completion of the total 
synthesis of cephalimysin A 1 by the deprotection, epoxidation/ring-opening and 
copper(I)-NHC-catalysed allylic oxidation sequence outlined above. The successful 
application of the copper(I)-NHC-catalysed allylic oxidation on a highly 
functionalised intermediate, as the last step, would showcase the application of this 
methodology in natural product synthesis. Hence, the total synthesis of cephalimysin 
A 1 would be envisioned in a longest linear sequence of nine steps from the known 
dithiane 81. Moreover, the enantioselective synthesis would provide a significant 
reduction in the number of steps compared to the earlier reported syntheses of 1-oxa- 
7-azaspiro[4.4]non-2-ene-4,6-dione natural products {cf. Fig. 3.2).
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3.4 Experimental
3.4.1. Experimental Procedures
l-(2-Phenyl-l,3-dithian-2-yl)ethanone 81.26
Colour and state: Pale orange oil. R/ = 0.6 (Hexane:Ethyl acetate =
0 80:20).
Representative Experimental Procedure'. Phenyl dithiane (19.63 g, 100 mmol) in 
tetrahydrofuran (500 mL) at -78 °C was treated with n-butyllithium (2.5 M in 
hexanes, 60 mL, 150 mmol) and stirred for 30 minutes. Acetaldehyde (8.42 mL, 150 
mmol) was added to the red solution at -78 °C and slowly wanned to room 
temperature over 1 hour. The reaction was quenched with saturated aqueous 
ammonium chloride (200 mL), extracted three times with diethyl ether (200 mL) and 
washed with brine. The organics were dried (MgSCL), filtered and concentrated in 
vacuo to yield the alcohol. Dimethylsulfoxide (21.31 mL, 300 mmol) was stirred in 
dichloromethane (500 mL) at -78 °C and oxalyl chloride (12.69 mL, 150 mmol) was 
added dropwise. After 15 minutes, the crude alcohol was added drop wise to the 
reaction mixture and sthred at -78 °C for 1 hour*. Triethylamine (69.69 mL, 500 
mmol) was added dropwise to the reaction and slowly wanned to room temperature 
over 1 hour. The reaction was quenched with saturated aqueous ammonium chloride 
(200 mL), extracted three times with diethyl ether (200 mL) and washed with brine 
(300 mL). The organics were dried (MgSCL), filtered and concentrated in vacuo to 
yield the crude ketone. Purification by flash chromatography (silica, 10% ethyl 
acetate/hexane) furnished 19.31 g (81%) of the ketone 81.
'H NMR (500 MHz, CDC13) 8 7.55-7.53 (m, 2H), 7.42-7.39 (m, 2H), 7.37-7.34 (m, 
1H), 3.15 (ddd,./ = 14.4, 11.9, 2.6 Hz, 2H), 2.74 (ddd, J= 14.5, 5.0, 3.2 Hz, 2H), 
2.15-2.07 (m, 1H), 2.11 (s, 3H), 1.93-1.84 (m, 1H).
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IR (Neat) 2904 (w), 1705 (vs), 1488 (w), 1445 (m), 1423 (m), 1350 (m), 1164 (s) 
cm"1.
(E)-4-methoxy-N-(l-(2-phenyl-l,3-dithian-2-yl) 
ethylidene)aniline 82.
Colour and state: Colorless solid. R/ = 0.5 (Hexane:Ethyl 
OMe acetate = 80:20). mp = 84-86 °C.
Representative Experimental Procedure'. Ketone 81 (11.92 g, 50 mmol),/7-anisidine 
(7.39 g, 60 mmol) and titanium isopropoxide (22.20 mL, 75 mmol) was stirred in 
toluene (50 mL) at 120 °C for 24 hours. The reaction mixture was cooled to room 
temperature and filtered through a plug of celite, washing with dichloromethane. 
Purification by flash chromatography (silica, 100% dichloromethane) furnished 
11.16 g (65%) of the imine 82.
^ NMR (500 MHz, CDC13) 5 7.82-7.81 (m, 2H), 7.43-7.40 (m, 2H), 7.34-7.31 (m, 
1H), 6.87-6.85 (m, 2H), 6.75-6.72 (m, 2H), 3.79 (s, 3H), 3.14 (ddd, 14.1, 8.9, 3.0 
Hz, 2H), 2.78 (ddd, J= 14.2, 7.9, 3.1 Hz, 2H), 2.13-2.06 (m, 1H), 2.03-1.96 (m, 1H), 
1.70 (s, 3H).
13C NMR (125 MHz, CDC13) 5 169.37 (e), 156.13 (e), 143.93 (e), 139.46 (e), 128.94 
(o), 128.25 (o), 128.13 (o), 120.49 (o), 114.28 (o), 64.57 (e), 55.53 (0), 28.54 (e), 
25.03 (e), 17.27 (o).
IR (Neat) 2962 (w), 2935 (w), 2904 (w), 2888 (w), 2832 (w), 1649 (s), 1502 (vs), 
1455 (m), 1357 (m), 1285 (m), 1240 (vs), 1200 (s), 1031 (s) 907 (s) cm'1.
HRMS (ESI, [M+H]+) calcd for C19H22NOS2 344.1143, found 344.1134.
l-(4-Methoxyphenyl)-5-(2-phenyl-l,3-dithian-2-yl)-lH- 
pyrrole-2,3-dione 83.
Colour and state: Orange solid. R/ = 0.3 (Hexane:Ethyl
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acetate = 50:50). mp = 197-200 °C (decomposes).
Representative Experimental Procedure: Imine 82 (6.87 g, 20 mmol) was stirred in 
tetrahydrofuran (100 mL) at room temperature and oxalyl chloride (3.38 mL, 40 
mmol) was added dropwise. The reaction was stirred for 12 hours and concentrated 
in vacuo. Purification by flash chromatography (silica, 2% 
methanol/dichloromethane) furnished 6.68 g (84%) of the dioxopyrolline 83.
‘H NMR (500 MHz, CDCU) 8 7.37-7.28 (m, 5H), 6.51-6.50 (m, 2H), 6.35-6.33 (m, 
2H), 3.72 (s, 3H), 3.13 (ddd, J= 14.3, 11.8, 2.8 Hz, 2H), 2.82 (dt, J= 14.5, 4.1 Hz, 
2H), 2.16-2.13 (m, 1H), 1.97-1.88 (m, 1H).
13C NMR (125 MHz, CDC13) 8 184.20 (e), 174.88 (e), 160.32 (e), 159.41 (e), 137.71 
(e), 131.69 (o), 129.69 (o), 129.13 (o), 126.82 (o), 125.75 (e), 113.41 (o), 104.51 (o), 
55.43 (o), 54.76 (e), 29.03 (o), 23.44 (o).
IR (Neat) 3115 (w), 2912 (w), 2833 (w), 1752 (s), 1708 (vs), 1545 (s), 1509 (vs), 
1298 (s), 1246 (vs), 1031 (m) cm'1.
HRMS (ESI, [M+Na]+) calcd for C2iHi9N03NaS2 420.0704, found 420.0718.
(E)-Ethyl hept-4-enoate 84.32
Colour and state: Colourless oil. R/~ 0.4 (Hexane:Ethyl acetate = 95:5). 
Representative Experimental Procedure: l-Penten-3-ol (10.27 mL, 100 mmol), 
propionic acid (3.70 mL, 5 mmol) and triethyl orthoacetate (91.66 mL, 400 mL) was 
stirred at 120 °C with a short-path distillation adapter (to remove ethanol formed) for 
6 horns. The excess triethyl orthoacetate was distilled off at 160 °C, and the 
remaining reaction mixture was quenched with saturated aqueous sodium 
bicarbonate (200 mL). The mixture was extracted three times with diethyl ether (150 
mL) and washed with brine (200 mL). The organics were dried (MgSCL), filtered and 
concentrated in vacuo to afford 14.06 g (90%) of the ester 84.
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lH NMR (500 MHz, CDC13) 5 5.53-5.48 (m, 1H), 5.42-5.36 (m, 1H), 4.13 (q, J = 
14.3, 7.2 Hz, 2H), 2.37-2.28 (m, 4H), 2.02-1.96 (m, 2H), 1.25 (t, 7.2 Hz, 3H),
0.95 (t,J= 7.2 Hz, 3H).
IR (Neat) 2965 (w), 2935 (w), 1735 (vs), 1446 (w), 1372 (w), 1244 (w), 1163 (s), 
966 (m) cm'1.
(2/j,6£)-Ethyl 2-methylnona-2,6-dienoate 86.
Colour and state: Colourless oil. R/= 0.4 (Hexane:Ethyl
acetate = 95:5).
Representative Experimental Procedure: Ester 84 (3.91 g, 25 mmol) was stirred in 
hexane (250 mL) at -78 °C and DIBAL-H (1 M in hexanes, 37.50 mL, 37.50 mmol) 
was added, keeping the internal temperature at -78 °C. After 30 minutes, the reaction 
was quenched with methanol (2 mL) and warmed to room temperature. Saturated 
aqueous potassium sodium tartrate (500 mL) was added, stirred vigorously for 1 hour 
until homogeneous, extracted three times with diethyl ether (200 mL) and washed 
with brine (300 mL). The organics were dried (MgS04), filtered and concentrated in 
vacuo (100 mL) to yield the crude aldehyde, which was used immediately. Lithium 
chloride (11.13 g, 26.25 mmol) and triethyl 2-phosphonopropionate (5.36 mL, 25 
mmol) was stirred in acetonitrile (200 mL) at 0 °C, to which DBU (3.74 mL, 25 
mmol) was added dropwise. The reaction mixture was stirred for 15 minutes and the 
crude aldehyde was added via cannula to the reaction. The mixture was slowly 
wanned to room temperature over 1 hour, and was quenched with saturated aqueous 
ammonium chloride (200 mL), extracted three times with diethyl ether (150 mL) and 
washed with brine (200 mL). The organics were dried (MgSCL), filtered and 
concentrated in vacuo to give the crude ester. Purification by flash chromatography 
(silica, 5% ethyl acetate/hexane) furnished 3.93 g (80%) of the ester 86.
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‘H NMR (500 MHz, CDC13) 5 6.77-6.73 (m, 1H), 5.53-5.47 (m, 1H), 5.42-5.36 (m,
1H), 4.19 (q, J= 14.3, 7.2 Hz, 2H), 2.25-2.20 (m, 2H), 2.14-2.10 (m, 2H), 2.03-1.97
(m, 2H), 1.82 (s, 3H), 1.29 (t, 7= 7.2 Hz, 3H), 0.96 (t, 7= 7.2 Hz, 3H).
I3C NMR (125 MHz, CDCU) 5 168.43 (e), 141.80 (o), 133.23 (0), 128.07 (e), 127.94
(0), 60.53 (e), 31.56 (e), 28.96 (e), 25.70 (e), 14.43 (o), 14.00 (0), 12.55 (0).
IR (Neat) 2963 (w), 1709 (vs), 1445 (w), 1367 (w), 1262 (s), 1107 (m), 966 (m) cm' 
1
HRMS (Cl, [M+NH4]+) calcd for found 214.1524.
(2jE,,6£)-2-Methylnona-2,6-dien-l-ol 87.
Colour and state: Colourless oil. R/= 0.3 (Hexane:Ethyl acetate = 80:20). 
Representative Experimental Procedure: Lithium aluminium hydride (1.14 g, 30 
mmol) was added portion wise to diethyl ether (200 mL) at 0 °C and ester 86 (3.93 g, 
20 mmol) was carefully added to the reaction slurry over 5 minutes. The stining was 
maintained at 0 °C for 15 minutes and then slowly warmed to room temperature over 
1 hour. The reaction was quenched with saturated aqueous potassium sodium tartrate 
(200 mL), stirred vigorously until homogeneous, extracted three times with diethyl 
ether (100 mL) and washed with brine (200 mL). The organics were dried (MgSCL), 
filtered and concentrated in vacuo to yield the crude alcohol. Purification by flash 
chromatography (silica, 20% ethyl acetate/hexane) furnished 2.93 g (95%) of the 
alcohol 87.
^ NMR (500 MHz, CDC13) 5 5.50-5.37 (m, 3H), 4.00 (s, 2H), 2.12-1.97 (m, 7H), 
1.67 (s, 3H), 0.96 (t, J= 1A Hz, 3H).
13C NMR (125 MHz, CDC13) 5 135.00 (e), 132.54 (o), 128.66 (o), 125.91 (o), 68.98 
(e), 32.50 (e), 27.88 (e), 25.69 (e), 14.02 (o), 13.81 (o).
IR (Neat) 3316 (br), 2962 (m), 2918 (m), 1438 (w), 1006 (s), 964 (vs) cm"1.
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(£)-Trimethyl(2-methylnona-l,6-dien-3-yl)silane 89.
TMS Colour and state: Colourless oil. R/= 0.7 (100% Hexane). 
Representative Experimental Procedure: Copper iodide (2.00 g, 10.50 mmol) and 
trimethyl phosphite (1,24 mL, 10.50 mmol) were stirred in tetrahydrofuran (50 mL) 
with occasional heating using a heat gun until the solution went colourless. In a 
separate flask, hexamethylsilane (2.15 mL, 10.50 mmol) was stirred in 
tetrahydrofuran/HMPA (4:1, 50 mL) at -10 °C (ice/acetone bath) and methyllithium 
(1,6 M in diethyl ether, 6.56 mL, 10.50 mmol) was added dropwise, maintaining the 
internal temperature at -10 °C. The resulting solution was stirred for 15 minutes until 
it went dark red. The dark red solution was transferred via cannula to the 
(MeO)3PCuI solution at -78 °C and stirred for 15 minutes at -78 °C until it went dark 
brown. Alcohol 87 (1.54 g, 10 mmol) and triethylamine (1.81 mL, 13 mmol) was 
stirred in dichloromethane (50 mL) at -10 °C (ice/acetone bath) and methanesulfonyl 
chloride (1.01 mL, 13 mmol) was added slowly, resulting in a white slurry. This 
mixture was stirred vigorously for 30 minutes and quenched with water (50 mL). The 
blue/green mixture was extracted three times with diethyl ether (50 mL) and washed 
with brine (150 mL). The organics were dried (MgS04), filtered and concentrated in 
vacuo to yield the crude silane. Purification by flash chromatography (silica, 100% 
hexane) furnished 1.58 g (75%) of the silane 89.
'H NMR (500 MHz, CDCI3) 8 5.46-5.41 (m, 1H), 5.39-5.33 (m, 1H), 4.60 (d,./ = 
101.1 Hz, 2H), 2.13-1.95 (m, 4H), 1.88-1.81 (m, 1H), 1.65 (s, 3H), 1.60-1.45 (m, 
2H), 0.96 (t, J= 7.5 Hz, 3H), -0.01 (s, 6H).
13C NMR (125 MHz, CDC13) 8 146.82 (e), 132.41 (o), 129.34 (o), 108.58 (e), 37.60 
(o), 32.16 (e), 29.86 (e), 28.62 (e), 25.79 (e), 23.70 (o), 14.15 (o), -2.38 (o).
IR (Neat) 2961 (m), 2924 (m), 2853 (w), 1633 (w), 1439 (w), 1248 (m), 835 (s), 735 
(s) cm'1.
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HRMS (Cl, [M+H]+) calcd for CnlfeSm 1.1802, found 211.1807.
MeO
3-Hydroxy-l-(4-methoxyphenyl)-3-((2Zs,,62i)-2~ 
methylnona-2,6-dien-l-yI)-5-(2-phenyl-l,3-dithian- 
2-yl)-lfi-pyrrol-2(3fi)-one 90.
Colour and state: Pale yellow solid. R/ = 0.3 
(Hexane:Ethyl acetate = 60:40). mp = 68-72 °C.
Representative Experimental Procedure: Dioxopyrolline 83 (1.99 g, 5 mmol) and 
silane 89 (1.05 g, 5 mmol) was stirred in dichloromethane (50 mL) at 0 °C to which, 
tin chloride (0.59 mL, 5 mmol) was added dropwise to the resulting solution. The 
reaction was stirred at 0 °C for 2 horns and quenched with saturated aqueous sodium 
bicarbonate (50 mL). The mixture was extracted three times with ethyl acetate (100 
mL) and washed with brine (100 mL). The organics were dried (MgS04), filtered and 
concentrated in vacuo to yield the crude alcohol. Purification by flash 
chromatography (silica, 35% ethyl acetate/hexane) furnished 1.90 g (71%) of the 
alcohol 90.
^ NMR (500 MHz, CDC13) 6 7.40-7.38 (m, 2H), 7.28-7.24 (m, 2H), 7.18-7.15 (m, 
1H), 6.49-6.48 (m, 2H), 6.35-6.31 (m, 2H), 6.17 (s, 1H), 5.52-5.47 (m, 1H), 5,45- 
5.39 (m, 2H), 3.71 (s, 3H), 3.19-3.11 (m, 2H), 2.75-2.70 (m, 2H), 2.69-2.61 (m, 2H), 
2.36 (bs, 1H), 2.18-2.13 (m, 2H), 2.10-2.06 (m, 3H), 2.04-1.98 (m, 2H), 1.94-1.84 
(m, 1H), 1.82 (s, 3H), 0.97 (t, /= 7.5 Hz, 3H).
13C NMR (125 MHz, CDC13) 5 181.29 (e), 158.91 (e), 146.05 (e), 139.35 (e), 132.80 
(o), 131.51 (o), 130.59 (o), 129.82 (e), 128.74 (o), 128.59 (o), 128.55 (o), 127.69 (e), 
127.23 (o), 115.23 (o), 113.20 (o), 55.39 (o), 54.41 (e), 48.22 (e), 32.61 (e), 29.16
(e), 28.65 (e), 25.73 (e), 24.08 (e), 18.52 (o), 14.05 (o).
IR (Neat) 3383 (br), 2958 (w), 2913 (w), 2838 (w), 1702 (s), 1609 (w), 1509 (vs),
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1445 (w), 1244 (vs), 1033 (m) cm"1.
HRMS (ESI, [M+Na]^ calcd for CsiHsvNC^NaSz 558.2113, found 558.2115.
MeO OMe 5-(Dimethoxy(phenyl)methyl)-3-hydroxy-l-(4- 
methoxyphenyl)-3-((2£',6E)-2-methylnona-2,6-dien- 
l-yl)-l//-pyrrol-2(3jfir)-one 95.
Colour and state: Pale yellow oil. R/ = 0.4 
(Hexane:Ethyl acetate = 60:40).
Representative Experimental Procedure: Dithiane 90 (0.54 g, 1 mmol) and calcium 
carbonate (0.30 g, 3 mmol) were stirred in dry methanol (10 mL) at 0 °C. 
[Bis(trifluoroacetoxy)iodo]benzene (0.86 g, 2 mmol) was added to the slurry in one 
portion and stirred at 0 °C for 30 minutes. The reaction was quenched with a 1:1 
mixture of saturated aqueous sodium bicarbonate/sodium thiosulfate (10 mL) and 
stirred vigorously for 1 hour. The mixture was extracted three times with ethyl 
acetate (20 mL) and washed with brine (30 mL). The organics were dried (MgSC>4), 
filtered and concentrated in vacuo to yield the crude acetal. Purification by flash 
chromatography (silica, 30% ethyl acetate/hexane) furnished 0.66 g (75%) of the 
acetal 95.
lU NMR (500 MHz, CDC13) 5 7.20-7.17 (m, 1H), 7.13-7.10 (m, 2H), 7.06-7.04 (m, 
2H), 6.56-6.54 (m, 2H), 6.35 (bs, 2H), 5.96 (s, 1H), 5.52-5.47 (m, 1H), 5.44-5.39 (m, 
1H), 5.35-5.33 (m, 1H), 3.74 (s, 3H), 3.08 (s, 6H), 2.60-2.54 (m, 2H), 2.12-2.05 (m, 
6H), 2.01 (tt, 7.3 Hz, 2H), 1.77 (s, 3H), 0.98 (t, J= 7.5 Hz, 3H).
13C NMR (125 MHz, CDC13) 6 180.77 (e), 159.10 (e), 145.78 (e), 137.45 (e), 132.76 
(o), 130.44 (o), 130.05 (o), 129.58 (e), 128.68 (o), 128.36 (o), 127.76 (o), 127.50 (e), 
127.33 (o), 113.56 (o), 112.00 (o), 98.82 (e), 77.08 (e), 55.52 (o), 49.05 (o), 48.90
(o), 48.00 (e), 32.61 (e), 28.60 (e), 25.73 (e), 18.61 (o), 14.05 (o).
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IR (Neat) 3395 (br), 2960 (w), 1712 (m), 1512 (vs), 1451 (w), 1296 (w), 1248 (s), 
1154 (m), 1064 (s) cm"1.
HRMS (ESI, [M+Na]-1) calcd for CgoHayNOsNa 514.2569, found 514.2571.
(Zi)-8-(Dimethoxy(pheiiyl)methyl)-2-(hex-3-en-l- 
yl)-3-iodo-7-(4-methoxyphenyl)-3“methyI-l-oxa- 
7-azaspiro [4.4] non-8-en-6-one 98.
Colour and state: Pale yellow oil. R/ = 0.3 
(Hexane:Ethyl acetate = 90:10). = 3:1.
Representative Experimental Procedure: Acetal 95 (0.25 g, 0.5 mmol) and potassium 
carbonate (0.55 g, 4 mmol) was stirred in tetrahydrofuran (10 mL) at 0 °C. Iodine 
(0.76 g, 3 mmol) was added to the mixture in the dark and stirred at 0 °C for 48 
hours. The reaction was quenched with a 1:1 mixture of saturated aqueous sodium 
bicarbonate/sodium thiosulfate (10 mL) and stirred vigorously for 1 hour. The 
mixture was extracted three times with ethyl acetate (20 mL) and washed with brine 
(30 mL). The organics were dried (MgS04), filtered and concentrated in vacuo to 
yield the crude iodide. Purification by flash chromatography (silica, 10% ethyl 
acetate/hexane) furnished 0.15 g (48%) of the iodide 98.
^ NMR (500 MHz, CDC13) 6 7.24-7.18 (m, 1H), 7.16-7.11 (m, 2H), 7.09-7.05 (m, 
2H), 6.54-6.53 (m, 2H), 6.41-6.34 (m, 2H), 5.87 (s, 1H), 5.57-5.51 (m, 1H), 5.49- 
5.43 (m, 1H), 3.74 (s, 3H), 3.16-3.07 (m, 2H), 3.10 (s, 3H), 3.07 (s, 3H), 2.34-2.28 
(m, 1H), 2.19-1.99 (m, 6H), 1.96 (s, 3H), 0.97 (t, J= 7.5 Hz, 3H).
13C NMR (125 MHz, CDC13) 8 180.39 (e), 159.09 (e), 146.78 (e), 137.20 (e), 132.83 
(o), 130.22 (o), 128.42 (o), 127.84 (o), 127.56 (o), 127.48 (e), 127.27 (o), 127.16 (o), 
113.49 (o), 111.27 (o), 90.17 (o), 81.88 (e), 55.64 (o), 54.69 (e), 48.93 (o), 40.75 (e), 
30.24 (e), 29.91 (o), 28.44 (e), 25.74 (e), 14.06 (o).
MeO OMe
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IR (Neat) 2934 (w), 1715 (m), 1513 (vs), 1450 (w), 1298 (w), 1249 (s), 1147 (w), 
1065 (m) cm'1.
HRMS (ESI, [M+Na]4) calcd for CaoHaeNOsNal 640.1536, found 640.1558.
8-(Dimethoxy(phenyl)methyl)-2-((£)-hex-3-en-l- 
yI)-7-(4-methoxyphenyI)-3-methylene-l-oxa-7- 
azaspiro[4.4]non-8-en-6-one 99.
Colour and state: Pale yellow oil. R/ = 0.4 
(Hexane:Ethyl acetate = 80:20). 99:100 = 3:1.
Representative Experimental Procedure: Iodide 98 (0.06 g, 0.10 mmol) was 
dissolved in toluene (1 mL) and l,8-Diazabicyclo[5.4.0]undec-7-ene (0.02 mL, 0.20 
mmol) was added. The reaction was stirred at 80 °C for 24 hours, cooled to room 
temperature and quenched with water (5 mL). The mixture was extracted three times 
with ethyl acetate (10 mL) and washed with brine (15 mL). The organics were dried 
(MgSC^), filtered and concentrated in vacuo to yield the crude product. Purification 
by flash chromatography (silica, 15% ethyl acetate/hexane) furnished 0.04 g (90%) 
of the alkenes 99/100.
^ NMR (500 MHz, CDC13) 5 7.39-7.35 (m, 2H), 7.21-7.18 (m, 1H), 7.14-7.11 (m, 
2H), 6.54-6.52 (m, 2H), 6.42-6.35 (m, 2H), 5.87 (s, 1H), 5.08 (d, 7= 2.2 Hz, 1H), 
4.96 (d, 7= 2.2 Hz, 1H), 3.73 (s, 3H), 3.10-3.09 (m, 6H), 2.93 (d, A of AB, JAB = 
15.7 Hz, 1H), 2.85 (d, B of AB, JAB = 15.6 Hz, 1H), 2.35 (t, 7= 7.6 Hz, 1H), 2,24- 
2.16 (m, 2H), 2.07-1.96 (m, 2H), 1.85-1.77 (m, 2H), 0.98 (t, 7= 7.6 Hz, 3H).
HRMS (ESI, [M+Naf) calcd for CsoHssNOsNa 512.2413, found 512.2409.
MeO OMe
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(£)-8-(dimethoxy(phenyl)methyl)-2-(hex-3-en-l- 
yl)-7-(4-methoxyphenyI)-3-methyl-l-oxa-7- 
azaspiro[4.4]nona-2,8-dien-6-one 100.
Colour and state: Pale yellow oil. R/ = 0.4
(Hexane:Ethyl acetate = 80:20).
^ NMR (500 MHz, CDC13) 8 7.24-7.18 (m, 1H), 7.16-7.11 (m, 2H), 7.09-7.05 (m, 
2H), 6.54-6.53 (m, 2H), 6.41-6.34 (m, 2H), 5.87 (s, 1H), 5.57-5.51 (m, 1H), 5.49- 
5.43 (m, 1H), 4.65 (d, 9.7 Hz, 1H), 3.84-3.77 (m, 2H), 3.74 (s, 3H), 3.10 (s, 3H),
3.07 (s, 3H), 2.34-2.28 (m, 2H), 2.19-1.99 (m, 4H), 1.96 (s, 3H), 0.97 (t, J= 7.5 Hz, 
3H).
HRMS (ESI, [M+Na]+) calcd for CsoHssNOsNa 512.2413, found 512.2409.
MeO OMe
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